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I. SUMMARY 
At the request of Representative Kathleen Teahan, the East Bridgewater Board of Health, and 
concerned residents, the Community Assessment Program (CAP) of the Massachusetts 
Department of Public Health (MDPH), Center for Environmental Health (CEH), conducted an 
evaluation of cancer and possible environmental exposures in East Bridgewater, Massachusetts.  
The evaluation was initiated based on community concerns about possible environmental 
exposures and cancer in relation to the Old Colony Railroad (OCRR) site, which consists of three 
smaller properties, Precise Engineering, Eastern States Steel, and an old Massachusetts Bay 
Transportation Authority (MBTA) railroad bed.  Various manufacturing operations occupied the 
Precise Engineering property from about 1920 to 1991 and the Eastern States Steel property from 
1851 to the late 1990s.  The MBTA railroad bed operated from 1847 to at least the 1930s and 
was originally part of the Old Colony Railroad.  The OCRR site is located at the corner of Cook 
and West Union Streets.  Community concerns also focused on cancer in the Ashley Drive 
neighborhood and possible environmental exposures related to Alloy Castings Company, an 
active aluminum foundry operating since 1948 at 151 West Union Street.  This project was 
conducted under a cooperative agreement with the United States Agency for Toxic Substances 
and Disease Registry (ATSDR) for MDPH to conduct public health assessments in 
Massachusetts. 
The investigation provides a review of available environmental data for the OCRR site, considers 
potential ways people may come in contact with chemicals from this facility, and evaluates the 
pattern of cancer in East Bridgewater with a particular focus on neighborhoods near areas of 
community environmental concern.  Information about Alloy Castings Company was obtained 
from the Massachusetts Department of Environmental Protection and the East Bridgewater 
Board of Health; however, there was no available environmental data related to the company.  
Therefore, evaluation of community concerns in relation to Alloy Castings Company was limited 
to a qualitative evaluation of the geographic pattern of cancer diagnoses in neighborhood areas 
surrounding the company. 
Using data from the Massachusetts Cancer Registry (MCR), incidence rates for eight cancer 
types were calculated for the town of East Bridgewater as a whole as well as for each of the three 
  
 2
census tracts (CTs) that divide the town.  Available information about risk factors, including 
environmental factors, related to the development of cancer was considered.  In general, the eight 
cancer types evaluated occurred near expected rates from 1982 to 2000, the period for which the 
most recent and complete cancer incidence data were available from the MCR at the time of this 
analysis, for the town of East Bridgewater as a whole and for the census tracts (CTs) that 
comprise the town.  In addition, none of the cancer types thought to be associated with exposures 
to contaminants of concern identified at the OCRR site were statistically significantly elevated in 
CT 5231, the census tract that contains both the site and Alloy Castings Company.  Leukemia 
was statistically significantly elevated among females in East Bridgewater as a whole from 1988 
to 1993.  However, no apparent geographic concentrations of cases were noted.  In addition, a 
variety of different subtypes of leukemia were represented.  This indicates the occurrence of 
different diseases because the four major subtypes and rarer subtypes each have different risk 
factors related to their development. 
Review of the geographic distribution of each of the cancer types in East Bridgewater revealed 
no apparent spatial patterns at the neighborhood level.  Further, no unusual concentrations of 
individuals diagnosed with cancer were observed in the vicinity of the OCRR site, Alloy 
Castings Company, in the Ashley Drive area, or in any other area of East Bridgewater. 
There are some potential exposure pathways that may have occurred in the past related to the 
OCRR site.  Past intermittent exposures to onsite surface soil, surface water, and sediment and 
offsite surface soil may have been possible for trespassers, former workers, or nearby residents.  
However, based on the contaminant levels detected and the frequency and duration of contact 
expected, it is unlikely that potential exposures related to the OCRR site would have resulted in 
adverse health effects for trespassers, former workers, or nearby residents.  While soil, surface 
water, and sediment in some areas of the OCRR site were contaminated in the past, the United 
States Environmental Protection Agency (EPA) performed contaminant removal activities at the 
site in 2001.  Therefore, exposure to contamination in soil, surface water, or sediment in the 
present and future for individuals visiting or residing in neighborhoods adjacent to the site is 
unlikely.  Potential exposure to vinyl chloride volatilized to indoor air may be possible for 
downgradient Spring Street residents if this contaminant is present in shallow groundwater 
beneath homes at concentrations similar to those detected in onsite monitoring wells in 1988.  
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Because offsite groundwater conditions are unknown, it would be beneficial to address this data 
gap with additional investigation, for example, hydrogeological modeling or groundwater 
sampling at downgradient locations.  Based on criteria established by ATSDR, the OCRR site 
would be classified as posing an Indeterminate Health Hazard in the past, present, and future.   
Based on the information reviewed in this evaluation, including available environmental data for 
the OCRR site and risk factor information for individuals diagnosed with cancer, it does not 
appear that a common factor (environmental or nonenvironmental) played a major role in the 
incidence of cancer in the census tract containing the OCRR site and Alloy Castings Company or 
in the town of East Bridgewater as a whole during the 19-year time period, 1982–2000. 
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II. BACKGROUND AND STATEMENT OF ISSUES 
At the request of Representative Kathleen Teahan, the East Bridgewater Board of Health, and 
concerned residents, the Community Assessment Program (CAP) of the Massachusetts 
Department of Public Health (MDPH), Center for Environmental Health, conducted an 
evaluation of cancer and possible environmental exposures in East Bridgewater, Massachusetts.  
The Old Colony Railroad site is located at the corner of West Union and Cook Streets and 
consists of three distinct properties: Precise Engineering, Eastern States Steel, and an old 
Massachusetts Bay Transportation Authority (MBTA) railroad bed.  Various manufacturing 
operations occupied the Precise Engineering site from about 1920 to 1991 and the Eastern States 
Steel property from 1851 to the late 1990s.  The MBTA railroad bed operated from 1847 to at 
least the 1930s and was originally part of the Old Colony Railroad.  For the purposes of this 
report, all former activities at this location are referred to as the Old Colony Railroad (OCRR) 
site.  Community concerns also focused on cancer in the Ashley Drive neighborhood and 
possible environmental exposures related to Alloy Castings Company, an active aluminum 
foundry operating since 1948 at 151 West Union Street.  This project was conducted under a 
cooperative agreement with the United States Agency for Toxic Substances and Disease Registry 
(ATSDR) for MDPH to conduct public health assessments in Massachusetts.  Refer to Figure 1 
for the locations of the OCRR site, Alloy Castings Company, and the census tracts that divide the 
town of East Bridgewater.  
This investigation provides a review of potential exposure pathways to chemicals from the 
OCRR site as well as a review of the pattern of cancer in East Bridgewater through comparison 
of the incidence of eight cancer types with the incidence of these cancers in the state of 
Massachusetts as a whole.  Additionally, available information about risk factors, including 
environmental factors, related to the development of cancer was evaluated.  To evaluate concerns 
about potential environmental exposures from the OCRR site, MDPH contacted Region 1 of the 
United States Environmental Protection Agency (EPA) and the Massachusetts Department of 
Environmental Protection (MDEP) to obtain and review available environmental data.  
Information about Alloy Castings Company was obtained from the MDEP and the East 
Bridgewater Board of Health; however, there was no available environmental data related to the 
company.  Therefore, evaluation of community concerns in relation to this company was limited 
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to a qualitative evaluation of the geographic pattern of cancer diagnoses in neighborhood areas 
surrounding the company.   
Cancer incidence rates were calculated for the town of East Bridgewater during the years 1982–
2000, the time period for which the most recent and complete cancer incidence data were 
available from the Massachusetts Cancer Registry (MCR) at the initiation of this analysis.  The 
town of East Bridgewater is divided into three smaller areas, or census tracts (CTs).  A census 
tract is a smaller geographic subdivision of a city or town designated by the United States Census 
Bureau.  Because age group and gender specific population information is necessary to calculate 
cancer incidence rates, the census tract is the smallest geographic area for which cancer rates can 
be accurately calculated.  Both the OCRR site and Alloy Castings Company are located in CT 
5231, in the southwest area of the town.  East Bridgewater CT 5231 comprises an area of 
approximately 25 square kilometers and has a total population of 2,872 (U.S. Census Bureau 
2000).  Refer to Figure 1.   
The results of this descriptive analysis can be useful in identifying cancer patterns or trends in a 
geographic context, to determine if a common etiology (i.e., cause associated with the 
development) is possible, and may serve to identify areas where further public health 
investigations or actions may be warranted.  Descriptive analyses may also indicate that an 
excess of known risk factors associated with a disease, such as environmental exposures, exists 
in a certain geographic area.  This descriptive analysis of cancer incidence data cannot be used to 
establish a causal link between a particular risk factor (either environmental or 
nonenvironmental) and the development of cancer.  In addition, this analysis cannot determine 
the cause of any one individual's cancer diagnosis.  The purpose of this evaluation is to report the 
findings on the patterns of cancer in East Bridgewater, with a particular focus on the 
neighborhoods in the vicinity of the OCRR site and the Alloy Castings Company, and discuss 
them in the context of the available environmental information to determine whether 
recommendations for further public health action are needed.   
  
 6
 
III. OBJECTIVES  
The specific objectives of this investigation were as follows: 
• To evaluate opportunities for environmental exposure(s) to nearby residents to 
contamination identified at the OCRR site; 
• To evaluate the incidence rates of eight cancer types (leukemia, non-Hodgkin’s 
lymphoma and cancers of the bladder, brain and central nervous system [CNS], breast, 
kidney, liver, and lung and bronchus) in East Bridgewater and in areas near the OCRR 
site and Alloy Castings Company to determine if cancer is occurring more or less often 
than expected; 
• To evaluate the geographic distribution of individuals diagnosed with cancer in East 
Bridgewater in order to determine if there are any patterns in particular areas of town or 
in relation to areas of potential environmental concern; 
• To review available descriptive information from the Massachusetts Cancer Registry 
(MCR) for individuals diagnosed with cancer in East Bridgewater to see if there are any 
particular characteristics related to known or suspected risk factors, including 
environmental factors, for developing these diseases; and 
• To discuss the results of this evaluation in the context of the available scientific and 
medical literature on cancer and the contaminants of concern in order to determine 
whether further investigation or public health action is warranted. 
IV. COMMUNITY ENVIRONMENTAL CONCERNS 
In order to address community environmental concerns related to the OCRR site, the United 
States EPA Region I Office in Boston, Massachusetts, and the Southeast Regional Office of the 
MDEP in Lakeville, Massachusetts, were contacted to obtain and review available environmental 
information pertaining to the site.  Information related to Alloy Castings Company was obtained 
from MDEP and the East Bridgewater Board of Health.  In addition, information regarding other 
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potential environmental sources located in the area and listed with MDEP as a hazardous release 
or spill location was reviewed (MDEP 2003c).   
The public health assessment titled “Evaluation of Cancer, 1982–2000, and Environmental 
Concerns Related to the Old Colony Railroad Site and Alloy Castings Company in East 
Bridgewater, Plymouth County, Massachusetts” was released on December 26, 2006, for a 30-
day public comment period.  No public comments were received by the MDPH during the public 
comment period.   
A. Old Colony Railroad Site 
The OCRR site is located in southeastern Massachusetts at the intersection of Cook and West 
Union Streets in the town of East Bridgewater, Plymouth County, Massachusetts (Figure 2).  The 
site is 26 miles south of Boston and is situated in a mixed commercial and residential area, 
approximately 1/4 mile from the center of East Bridgewater.  Two abandoned businesses, Precise 
Engineering and Eastern States Steel, and an inactive Massachusetts Bay Transportation 
Authority (MBTA) bed comprise the site.  Various manufacturing operations occupied the 
Precise Engineering property from about 1920 to 1991 and the Eastern States Steel property from 
1851 to the late 1990s.  The MBTA railroad bed operated from 1847 to at least the 1930s and 
was originally part of the Old Colony Railroad.  The inoperative railroad line bisects the 8-acre 
site.  The site is bordered to the north by West Union Street, the west by Cook Street, and the 
southeast by Spring Street.  Approximately 531 people live within a 1/4 mile radius, and 2,567 
people live within 1 mile (U.S. EPA 2001).  Cook Street homes are located across the street from 
the site.  Nine residential properties on Spring Street and one residential property on West Union 
Street directly abut the site.  A post office is located across from the site on West Union Street.     
The topography of the OCRR site is generally level.  A seasonal drainage ditch extends from the 
southeast corner of the property, adjacent to the former Precise Engineering manufacturing 
building, to the southwest corner and terminates just south of the abandoned Eastern States Steel 
building (Figure 2) (Roy F. Weston, Inc. 2001).  The drainage ditch is on the Precise Engineering 
property, but is outside the fence that surrounds the site, and is adjacent to a wooded, marshy 
area on Spring Street residential properties (R. Haworth, EPA, personal communication, 2005).  
Groundwater in the shallow portion of the aquifer exists approximately 2 feet below the ground 
  
 8
surface and flows in a south, southwestern direction (SEA Consultants 1998).  Groundwater in 
the deeper aquifer, approximately 20 to 25 feet below the surface, has a more westerly 
component than the shallow groundwater.  The site is located within a Zone II wellhead 
protection area, the area of an aquifer that could be pumped through a well under 180-day 
drought conditions.  Limited removal activities for the entire OCRR site were completed by the 
EPA in June 2001.  Prior to removal activities, access to the site was unrestricted due to 
inadequate fencing (Roy F. Weston, Inc. 2001).  Presently, the buildings and equipment on the 
site are in disrepair and an 800-foot section of the fencing has fallen down (R. Haworth, EPA, 
personal communication, 2005).   
It is possible that former operations at Eastern States Steel and Precise Engineering, as well as 
contaminants from the MBTA railroad bed, resulted in the presence of contaminants in various 
areas within the total 8-acre area of the OCRR site.  For example, Horsley and Witten, Inc. 
reported that groundwater beneath the Eastern States Steel might be impacted by migration of 
contaminants from the abutting Precise Engineering property or MBTA railroad bed (Horsley 
and Witten, Inc. 1998).     
1. Massachusetts Bay Transportation Authority Railroad Bed 
The MBTA railroad bed extends from the southwest corner to the northeast corner of the OCRR 
site (Figure 2) and was part of the Old Colony Railroad line to Boston, Massachusetts, that began 
operating in 1847 (K. Grabau, East Bridgewater Selectmen’s Office, personal communication, 
2005).  The railroad transported passengers, including Civil War troops in the 1860s, to and from 
East Bridgewater.  Passenger service ended in 1925.  Freight service to the Brockton Edison 
Company plant on Spring Street continued until approximately the 1930s or 1940s.  At present, 
some residents are interested in creating a recreational rail trail on the now inactive MBTA 
railroad bed (G. Martin, MDEP, personal communication, 2005). 
The Precise Engineering property and five Spring Street residences border the MBTA railroad 
bed to the east.  To the west, it is bordered by the Eastern States Steel property.  Soil sampling of 
the railroad bed was conducted in 1999 by Roy F. Weston, Inc.  Levels of lead and arsenic were 
identified in surface soil above screening values established by ATSDR and MDEP.  Due to the 
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historical use of the pesticide lead arsenate along railroad lines, lead and arsenic are commonly 
detected on and near railroad beds in Massachusetts (MDEP 2003c).   
2. Precise Engineering 
The Precise Engineering property at 24 West Union Street, East Bridgewater, occupies 2.26 
acres of the OCRR site.  The property is bordered on the north by West Union Street and one 
residential property on West Union Street, to the west by the MBTA railroad bed and Eastern 
States Steel property, and to the southeast by five Spring Street residences (Figure 2).  A factory 
on the Precise Engineering property manufactured wooden shoe lasts (i.e., the solid form around 
which a shoe is molded) from as early as 1920 until it manufactured plastic shoe lasts beginning 
in the 1960s.  Small boats were assembled on the property from 1976 to 1978.  Precise 
Engineering operated on the site as a metalworking and stamping facility from 1978 until the 
property was abandoned in the early 1990s.  In 2001, the EPA conducted limited removal actions 
at the OCRR site in order to reduce potential exposures to site contaminants.  At present, the 
Precise Engineering portion of the OCRR site is an inactive industrial facility comprising a one-
story brick factory building, paved area, and surrounding acreage.   
In 1987, site investigators observed petroleum-impacted soil and groundwater adjacent to an 
abandoned underground fuel storage tank on the Precise Engineering property (SEA Consultants 
1996).  They also detected a strong chemical odor adjacent to a truck body historically used to 
store tetrachlorethylene (PCE).  Later in 1987, the site was reported to MDEP.  Briggs 
Associates confirmed the presence of PCE and xylenes in soil and groundwater in 1988.  Also in 
1988, the property owner removed approximately 100 drums of pigments, paints, cutting oils, 
toluene, and tetrachloroethane from the building (SEA Consultants 1998).                                                             
During a 1988 investigation, Briggs Associates found more areas of volatile organic compounds 
(VOCs) and petroleum hydrocarbon contamination in subsurface soils near the underground 
storage tank (SEA Consultants 1998).  In 1996, surface water samples collected at Precise 
Engineering confirmed the presence of VOCs in the drainage ditch (Cambridge Environmental 
1998).  When polychlorinated biphenyls (PCBs) and arsenic in a soil pile and trichloroethylene 
(TCE) in groundwater were detected at elevated levels, the soil pile was covered with a tarp 
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(SEA Consultants 1996).  The underground storage tank was removed in 1996 (Cambridge 
Environmental 1998).   
SEA Consultants completed additional site assessments in 1997 and 1998.  Investigators noted 
signs of illegal entry into the factory building.  A former employee reported an historical crane 
fuel oil release near the former underground storage tank (SEA Consultants 1998).  The former 
underground storage tank was identified as the probable source of polycyclic aromatic 
hydrocarbon (PAH) contamination in sediments of the adjacent drainage ditch.  Investigators 
concluded that offsite sources, namely other portions of the OCRR site, probably contributed to 
contamination on the Precise Engineering property.   
In preparation for removal actions at the OCRR site, Roy F. Weston, Inc. sampled onsite and 
some offsite soil in 1999 (Roy F. Weston, Inc. 2001).  Lead and arsenic were detected in surface 
soil in the railroad bed, drainage ditch, and adjacent Spring Street residences.  During removal 
activities, which began in August 2000 and were completed in June 2001, buried military 
munitions were discovered and removed from an area near the building on the Precise 
Engineering property and at an undeveloped residential property adjacent to the building.  
According to the MDEP, the Town of East Bridgewater is currently conducting an assessment of 
the presence of VOCs in groundwater to the south of the OCRR site (G. Martin, MDEP, personal 
communication, 2007). 
3. Eastern States Steel 
The inactive Eastern States Steel facility is located at 36 Cook Street in East Bridgewater.  The 
property consists of approximately 4.5 acres of the 8-acre OCRR site (Figure 2).  The property is 
bordered on the north by West Union Street, the west by Cook Street, the southeast by the 
inoperative MBTA railroad bed, and the northeast by Precise Engineering.  Railroad locomotives 
were manufactured on the property beginning in 1851 (K. Grabau, East Bridgewater Selectmen’s 
Office, personal communication, 2005).  The facility also functioned as a foundry and most 
recently as a new and scrap metal operation (Roy F. Weston, Inc 2001).  The metal operation 
was active until the late 1990s (K. Grabau, East Bridgewater Selectmen’s Office, personal 
communication, 2005).   
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Structures on the Eastern States Steel property include a wood frame house once used as office 
space, a small warehouse in the northwest corner of the property, a main brick building, and 
several attached brick structures (Cambridge Analytical Associates 1986).  Prior to removal 
activities, there were numerous metal shaving piles south of the main building (Roy F. Weston, 
Inc. 2001).  A soil pile extended along the southeastern portion of the main building for 
approximately 50 feet. 
In 1986, Cambridge Analytical Associates reported the presence of heavy metals and PAHs in 
soil on the Eastern States Steel property.  Two unregistered underground fuel storage tanks 
located to the west of the main building were removed that year.  The presence of residual 
petroleum hydrocarbons from the tanks was confirmed in 1990 (Kupferman and Weber, Inc. 
1990).   
During a fire inspection in August 1996, the East Bridgewater Fire Department discovered 
several drums of chlorinated solvents, calcium carbide, and waste oil (Horsley and Witten, Inc. 
1997).  MDEP immediately issued a Notice of Responsibility to the property owner (MDEP 
1997), who completed removal of the drums from the property in October 1996 (Horsley and 
Witten, Inc. 1997).   
In April 1997, MDEP issued a second Notice of Responsibility to the owner of Eastern States 
Steel and ordered an Imminent Hazard Evaluation of the site after reviewing the 1986 Cambridge 
Analytical Associates environmental site assessment (Horsley and Witten, Inc. 1997).  In June 
1997, Horsley and Witten, Inc. conducted a limited site investigation and confirmed the presence 
of PCB- and arsenic-contaminated soil piles behind the main building.  In August 1997, Horsley 
and Witten, Inc. collected soil samples from test pits in the area of the former underground 
storage tanks and the locations sampled by Cambridge Analytical Associates in 1986.  Results 
revealed the presence of petroleum hydrocarbons in the area of the former tanks and elevated 
levels of PAHs and lead at the southern tip of the property.   
In a 1999 investigation prior to EPA removal activities at the OCRR site, Roy F. Weston, Inc. 
reported elevated levels of lead, arsenic, and PCBs in surface soil surrounding the Eastern States 
Steel main building (Roy F. Weston, Inc. 2001).  During the assessment, investigators also 
observed several young people on the property and were told that groups of young people often 
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enter the accessible buildings.  During removal activities from August 2000 to June 2001, buried 
military munitions were discovered and removed from seven locations on the Eastern States 
Steel property.    
B. Alloy Castings Company 
Alloy Castings Company is located at 151 West Union Street, approximately 1/10 of a mile 
northwest of the OCRR site (Figure 2).  A residential neighborhood of 13 homes on Ashley 
Drive is located to the northwest and across a stream from Alloy Castings Company.  
Alloy Castings Company is an active aluminum foundry that manufactures decorative light 
poles, fire alarms, and traffic light bases for municipalities.  The company has been in operation 
since 1948.  Community concerns related to this facility focus on intermittent odorous stack 
emissions, and residents in the surrounding neighborhood have reported unpleasant odors to the 
Board of Health (R. Fillbrick, East Bridgewater Board of Health, personal communication, 
2004).  According to the Board of Health, Alloy Castings Company sometimes uses a particular 
material that emits a very pungent odor; however, the company attempts to limit this to days 
when wind conditions carry the odor away from residences.  In 2000, MDEP inspected the 
facility for air quality and hazardous waste and found no violations (A. Antonelli, MDEP, 
personal communication, 2004).  The inspection was random and was not prompted by specific 
community concerns.  Since the facility does not discharge industrial wastewater to the stream 
adjacent to the property and because air emissions from the company fall under the 1-ton per 
year regulatory threshold, there were no available environmental data to evaluate for Alloy 
Castings Company.        
C. Massachusetts Department of Environmental Protection 21E Hazardous Material 
and Oil Releases 
In 1983, the Massachusetts Legislature established a statewide hazardous waste site cleanup 
program (the state Superfund program) under Chapter 21E of Massachusetts General Laws 
(M.G.L c21E, 310 CRM 40.0000).  Under this legislation, MDEP administers investigation and 
clean-up of hazardous material and oil release sites, known as “21E sites”, in the 
Commonwealth. 
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The 21E sites are characterized by one or more releases of oil or other hazardous material.  
Releases can result from a variety of sources, including trucks and other vehicles, underground 
storage tanks, and aboveground storage drums.  Releases vary widely with respect to materials 
involved, the relative amount of materials released, and the geographic extent of contamination.  
Information on hazardous material and oil releases is available from 1977 to the present, from 
the MDEP Bureau of Waste Site Cleanup (MDEP 2003c).  However, records prior to 1984 are 
known to contain significant data gaps.  
Hazardous material and oil releases are potential sources of exposure to contamination.  More 
detailed information is needed to determine whether individuals residing near these reported 
release areas were actually exposed to contaminants.  This includes information about 
contaminant movement through the environment, the population at risk of exposure, a location of 
actual human contact with the contaminant, and evidence that the contaminant actually entered 
the body of persons at risk of exposure through ingestion, dermal absorption, or inhalation.   
In addition to the evaluation of environmental data associated with the OCRR site, MDPH 
reviewed the most recent information regarding oil or other hazardous material releases for the 
town of East Bridgewater and mapped the approximate location of release sites with sufficient 
address information using a geographic information system (Figure 3) (ESRI 2002).  A total of 
71 releases were reported in the town of East Bridgewater from 1987 to 2003.  The majority of 
these releases were mapped to an address in town; however, approximately 11% of the releases 
(n = 8) could not be mapped due to insufficient address information.  There were five releases 
reported at properties on the OCRR site and none at Alloy Castings Company.  The full list of 
releases recorded as “21E sites” in East Bridgewater is shown in Table 1.   
V.  REVIEW OF ENVIRONMENTAL SAMPLING DATA 
To address concerns about possible environmental exposures associated with the OCRR site and 
the properties that comprise the site, MDPH reviewed information from several reports on file 
with MDEP and EPA.  Available environmental sampling data were reviewed, and a screening 
evaluation was conducted to identify those substances that are either not expected to result in 
adverse health effects or substances that need to be considered for further analysis to determine 
whether they may be of potential health concern.  The screening analysis identifies maximum 
  
 14
concentrations of contaminants detected in various types of environmental media (i.e., air, soil, 
water) and compares these concentrations to health-based comparison values established by 
ATSDR (ATSDR 2003a, 2003b).  If an ATSDR comparison value was not available for a 
specific chemical, the maximum detected concentration of that chemical was compared to Risk-
Based Concentrations (RBCs) developed by United States EPA Region III (U.S. EPA 2004a) or 
the applicable groundwater and soil standards developed by MDEP (2003a), in that order.  For 
compounds detected in groundwater, maximum concentrations were also compared with state or 
federal drinking water standards.   
The ATSDR comparison values are specific concentrations of a chemical for air, soil, or water 
that are used by health assessors to identify environmental contaminants that require further 
evaluation.  These comparison values are developed based on health guidelines and assumed 
exposure situations that represent conservative estimates of human exposure.  Chemical 
concentrations detected in environmental media that are less than a comparison value are not 
likely to pose a health threat.  However, chemical concentrations detected in environmental 
media above a comparison value do not necessarily indicate that a health threat is present.  In 
order for a compound to impact one’s health, it must not only be present in the environmental 
media, but one must also come in contact with the compound.  Therefore, if a concentration of a 
chemical is greater than the appropriate comparison value, the potential for exposure to the 
chemical should be further evaluated to determine whether exposure is occurring and whether 
health effects might be possible as a result of that exposure.  The factors related to exposure that 
are unique to the specific situation under investigation need to be considered to determine if an 
adverse health effect from this chemical could occur.    
The ATSDR compiled levels of metals and PAHs that are considered normal for soil of urban 
and suburban communities (ATSDR 2003c).  The United States Geological Survey (USGS) 
identified levels of metals that are considered typical for soil in the eastern United States 
(Shacklette and Boerngen 1984), and the MDEP compiled soil background data that are specific 
to Massachusetts (MDEP 2002).  These levels are “background” and were used along with 
comparison values for both metals and PAHs in this analysis.   
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A. Soil  
In the absence of excavation activities, opportunities for exposures to chemicals are generally 
expected to be greater for surface soil than for subsurface soil.  Hence, surface and subsurface 
soil sampling results are addressed separately.  A summary of the maximum concentration of 
contaminants detected above comparison values in surface and subsurface soil is presented in 
Table 2.   
1. Surface Soils 
From 1999 to 2000, 148 surface samples from the top 3 inches of soil were collected in 
preparation for EPA removal activities from areas throughout the entire OCRR site.  A 50-foot 
by 50-foot sampling grid was constructed, and a sample was collected at each grid point.  
Additionally, 201 samples were collected from the top 3 inches of soil at the soil piles, drainage 
ditch, adjacent residential properties, and other areas with stained soil and stressed vegetation.  
All samples were analyzed for lead, arsenic, and polychlorinated biphenyls (PCBs), and all three 
contaminants were detected onsite at concentrations exceeding comparison values.   
Near the Eastern States Steel office building, the highest lead level detected in surface soil at the 
site was 7,840 parts per million (ppm), which was above the MDEP action level of 300 ppm and 
typical soil background levels for lead (less than 10–300 ppm) (Table 2) (USGS 1984).  The 
highest levels of lead, well above the action level and background levels, in surface soil were 
concentrated along the western and southern perimeter of the Eastern States Steel main building 
and around the outbuildings and concrete slabs along Cook Street.  The area north of the main 
Eastern States Steel building and the soil piles in this area also tested well above the action level 
and background levels for lead.  Samples from the southern corner of the Precise Engineering 
property and the large soil pile on that parcel, in addition to a sample from the southern end of 
the MBTA railroad bed, were well above the action level and background levels for lead.  Other 
areas of the site generally tested above both the action level and background levels for lead.   
The highest concentration of arsenic (201 ppm) in surface soil was located near the northern 
section of the MBTA railroad bed.  This concentration was above the Cancer Risk Evaluation 
Guide (CREG) value (0.5 ppm) and background levels [mean of 7.4 ppm (USGS 1984), 90th 
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percentile of 20 ppm (MDEP 2002)].  In general, the highest arsenic levels in surface soil 
exceeded background levels and were located at the Eastern States Steel soil pile and on or near 
the railroad bed.   
The highest concentration of PCBs (22,500 ppm) found in surface or subsurface soil at the 
OCRR site occurred in the northeastern corner of the Eastern States Steel property.  The next 
highest PCB level measured in site surface soil (1,400 ppm) was located in the same area.  The 
CREG for PCBs is 0.4 ppm.  PCBs were also detected above the CREG value in soil samples 
collected west of the main Eastern States Steel building and among the outbuildings in this area 
(up to 840 ppm).    
Twenty-five samples from the top 3 inches of soil were taken from the backyards of eight 
adjacent residential properties on Spring Street (one of which was undeveloped) and one 
residential property on West Union Street that is adjacent to the Precise Engineering Building.  
Each sample was analyzed for lead, arsenic, and PCBs.  Eight additional samples were analyzed 
for lead only.  Lead was detected above the MDEP action level (300 ppm) and typical 
background levels (less than 10–300 ppm) at 4,780 ppm at the undeveloped residential property, 
which is next to the Precise Engineering building.  Lead was detected at this undeveloped 
property above the action level and background levels in four samples in the immediate vicinity 
of buried military munitions and was not measured above the action level at any other residential 
property.   
The maximum concentration of arsenic measured on residential property was detected above the 
CREG value (0.5 ppm) at 58 ppm and background levels [mean of 7.4 ppm (USGS 1984), 90th 
percentile of 20 ppm (MDEP 2002)] at a Spring Street residence adjacent to the MBTA railroad 
bed.  Arsenic was also detected above the CREG at five other Spring Street residences 
(maximum concentrations of 4.4 ppm, 5.9 ppm, 12.2 ppm, 20.4 ppm, 43.8 ppm) and at the West 
Union Street residence (maximum concentration of 5.8 ppm).  Arsenic levels detected in 
residential soil were highest in backyards adjacent to the southern edge of the railroad bed, where 
a maximum concentration of arsenic (120 ppm) in railroad bed surface soil was located.  
Elevated levels of arsenic are common on and near railroad beds because of the use of arsenic-
based herbicides to control weed growth (MDEP 2003c).  In all, 18 out of 25 surface soil 
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samples from the nine residential backyards tested had arsenic levels above the CREG.   
According to the available sampling data, PCBs were not detected above the CREG value (0.4 
ppm) in any sample from a residential property along Spring Street or from the West Union 
residence.   
Seven samples from the top 3 inches of soil were also taken from an area directly adjacent to the 
street in the front yards of Cook Street residences (R. Haworth, EPA, personal communication, 
2005).  They were analyzed for lead, arsenic, and PCBs.   The highest lead level in these seven 
samples was 243 ppm, which is below the action level of 300 ppm and within typical 
background levels (less than 10–300 ppm).  The highest concentration of arsenic was 11.2 ppm, 
which is above the CREG (0.5 ppm), but within typical background levels of this metal (less than 
0.1–73 ppm).  There were also three detections of PCBs slightly above the CREG (0.4 ppm) that 
ranged from 0.42–0.84 ppm.  However, these concentrations were below the MDEP action level 
(2 ppm) for PCBs.  
As part of the EPA removal activities that were completed in 2001, surface and subsurface soil 
with PCB concentrations exceeding 50 ppm (which occurred onsite only) was excavated and 
transported offsite for disposal.  Specifically, PCB-contaminated soil was removed from square 
grids measuring 25 feet on each side, and additional excavation was performed based on samples 
from the bottom and top edges of each excavated grid.  The entire site was covered with 
geotextile fabric, and an average of 10 inches of clean soil (excluding the depth of clean soil 
added to excavated areas) was spread across the site.  Clean soil cover was much deeper in areas 
where the soil piles and soil with PCBs above 50 ppm had been excavated.  At three adjacent 
Spring Street residential properties, soil with concentrations of lead or arsenic exceeding MDEP 
action levels (30 ppm for arsenic and 300 ppm for lead) was excavated and replaced with clean 
soil (PCBs were not detected above the MDEP action level of 2 ppm at any residential property) 
(R. Haworth, EPA, personal communication, 2002).  Subsurface soil was removed as necessary 
based on soil testing of the excavated bottom until all samples were below MDEP action levels 
(these sample results were unavailable).  The three Spring Street properties include the 
undeveloped parcel next to the Precise Engineering building where buried military munitions 
were discovered and two residential backyards adjacent to the MBTA railroad bed.  While 
neither lead, arsenic, nor PCBs were detected in surface soil at the West Union residential 
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property, half of the backyard surface soil on this property was excavated and replaced with 
clean soil because arsenic (75.5 ppm) was detected on the Precise Engineering property directly 
adjacent to this backyard at a level above the MDEP action level of 30 ppm (R. Haworth, EPA, 
personal communication, 2002).              
2. Subsurface Soils 
A total of 64 subsurface soil samples up to 48 feet deep were tested for lead during 
environmental investigations at the OCRR site.  In 1997, a composite sample of the first foot of 
soil from the large soil pile southwest of the Precise Engineering building had a lead level of 
18,100 ppm, which was well above the MDEP action level (300 ppm) and background levels 
(less than 10–300 ppm) (Table 2).  This was the highest level measured at the entire OCRR site.  
Subsurface lead levels above the action level and background levels were located at the large 
Precise Engineering soil pile, the Eastern States Steel soil pile, and the soil piles in the northern 
area of the site.   
Twenty subsurface soil samples were analyzed for cadmium and 22 were analyzed for total 
chromium from depths up to 48 feet.  A composite sample from a depth of 0–1 feet from the 
large Precise Engineering soil pile had maximum concentrations detected at the 8-acre site for 
cadmium (20.7 ppm) and total chromium (428 ppm).  The maximum detected concentration of 
cadmium was above the chronic Environmental Media Evaluation Guide (EMEG) for childhood 
exposure (10 ppm) and below the chronic EMEG for an adult (100 ppm).  This level also 
exceeded cadmium background levels (0.01–1 ppm) (ATSDR 2003c).  Cadmium contamination 
greater than background levels was located primarily in soil piles.  The maximum concentration 
of total chromium detected (428 ppm) was above the hexavalent chromium Reference Dose 
Media Evaluation Guide (RMEG) for a child (200 ppm) and below the RMEG for adult exposure 
(2,000 ppm).  This concentration was within background levels for total chromium (1–1,000 
ppm) (USGS 1984).  Only one other sample, taken from the same soil pile, exceeded the RMEG 
for childhood exposure.   
Nine soil samples from various depths up to 48 feet were tested for antimony.  Antimony (26.3 
ppm) was detected from a depth of 0–1 feet in the large Precise Engineering soil pile.  This level 
exceeded the child RMEG (20 ppm), but was below the adult RMEG (300 ppm).  This 
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concentration also exceeded backgrounds levels for antimony (less than 1–8.8 ppm) (USGS 
1984).  Two other subsurface soil samples, located in the same soil pile, exceeded background 
levels.  
Investigations of the OCRR site analyzed 25 subsurface soil samples ranging up to 48 feet in 
depth for several PAHs.  Indeno(1,2,3-c,d)pyrene (29 ppm) was detected above the comparison 
value, but within background levels (8.0–61 ppm for urban soil), in 1985 in a composite sample 
from test pits 0–7 feet deep at Eastern States Steel (ATSDR 2003c).  For indeno(1,2,3-c,d)pyrene 
in residential soil, the EPA Risk Based Concentration (RBC) is 0.87 ppm.  South of the main 
Eastern States Steel building, five PAHs were detected in 1997 above comparison values in a soil 
sample collected from 4–8 feet deep.  Benzo(a)anthracene (33 ppm) was detected above the EPA 
RBC for residential soil (0.87 ppm), but within background levels (0.169–59 ppm for urban soil) 
(ATSDR 2003c).  Benzo(a)pyrene (42 ppm) was detected above the CREG value (0.1 ppm) and 
above background levels (0.165–0.22 ppm for urban soil) (ATSDR 2003c).  Benzo(b)-
fluoranthene (65 ppm) was detected above the EPA RBC for residential soil (0.87 ppm) and 
slightly above background levels (15–62 ppm for urban soil) (ATSDR 2003c).  Benzo(k)-
fluoranthene was detected (27 ppm) above the EPA RBC for residential soil (8.7 ppm) and 
slightly above background levels (0.3–26 ppm for urban soil) (ATSDR 2003c).  Dibenzo(a,h)-
anthracene was detected (11 ppm) above the EPA RBC for residential soil (0.087 ppm).   
Thirteen subsurface soil samples were analyzed for the PCB Arochlor 1254 at the OCRR site.  A 
sample from 6 inches below the surface of the soil pile behind the main Eastern States Steel 
building had an elevated concentration of Arochlor 1254 (310 ppm), which is above both the 
child (1 ppm) and adult (10 ppm) chronic EMEG.  One other sample from the Eastern States 
Steel soil pile had a concentration of Arochlor 1254 (4.3 ppm) above the child EMEG.  Arochlor 
1254 was not detected at Precise Engineering.  Another sample from 6 inches below the surface 
of the Eastern States Steel soil pile had a concentration of 2.7 ppm for Arochlor 1260, which 
exceeds the CREG value for total PCBs (0.4 ppm).   
A 1997 investigation at Eastern States Steel focused on subsurface soil near the former 
underground storage tanks.  Concentrations of arsenic (18,100 ppm) and Arochlor 1248 (1,000 
ppm) in soil 4 feet below the surface exceeded comparison values.  The CREG value for arsenic 
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is 0.5 ppm.  The CREG value for total PCBs is 0.4 ppm.  Subsurface arsenic levels also exceeded 
background levels (<0.1–73 ppm). 
In 1999, 38 subsurface soil samples were collected from locations on the OCRR site in 
preparation for the EPA removal activities that occurred from 2000 to 2001.  The highest level of 
PCBs detected in subsurface soil (1,300 ppm) was collected from the northern part of the site, to 
the west of the railroad bed, and exceeded the CREG value (0.4 ppm).  The soil sampled was 0–
1.5 feet below the surface, in the same grid location as the surface soil sample that tested the 
highest for PCBs (22,500 ppm) at the OCRR site.  As part of the EPA removal activities, 
subsurface soil with PCB concentrations exceeding 50 ppm (occurred only onsite) was excavated 
and transported offsite for disposal.  Specifically, PCB-contaminated soil was removed from 
square grids measuring 25 feet on a side, and additional excavation was performed based on 
testing of samples from the bottom and top edges of each excavated grid.  In all, seven 25-feet by 
25-feet grids were excavated.  Three grids were excavated to a depth of 1 foot, two grids to a 
depth of 1.5 feet, one grid to a depth of 2 feet, and one grid to a depth of 2.5 feet.  
 B. Groundwater 
The OCRR site lies on the edge of the Zone II groundwater protection area for East Bridgewater 
Well #5.  A Zone II is defined as an area of an aquifer that contributes water to a well under the 
most severe pumping and recharge conditions that can be realistically anticipated.  It is the area 
of an aquifer that might be pumped under 180-day drought conditions.  Well #5 is one of five 
wells operated by the East Bridgewater Water Department and is about 1.6 miles to the southeast 
of the OCRR site (S. McCann, East Bridgewater Water Department, personal communication, 
2004).  This single well operates continuously.  The other municipal wells are farther away in the 
southeastern part of the town.   
No drinking water wells exist on the OCRR site, and there are no known private wells in the 
area.  Residents and businesses along the surrounding streets are connected to the municipal 
water supply.  Based on a hydrogeological survey, site groundwater in the shallow aquifer is 
approximately 2 feet below the surface and appears to flow in a south-southwestern direction at a 
rate of 2 to 5 feet per year (SEA Consultants 1998).  Groundwater flow in the deeper aquifer, 
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between 20 and 25 feet below the surface, has a more westerly component than the shallow 
groundwater.   
Table 3 summarizes the maximum concentrations of contaminants detected in onsite 
groundwater samples that exceeded comparison values.  Because ATSDR comparison values do 
not exist for groundwater, drinking water comparison values were used as screening values.  In 
1988, six shallow monitoring wells (OW-1 through OW-6) were sampled at Precise Engineering 
for VOCs.  Some VOCs, including 1,2-trans-dichloroethylene (trans-DCE), TCE, and vinyl 
chloride, were detected above comparison values in 1988 in a monitoring well (OW-3) about 20 
feet west of the southwest corner of the Precise Engineering building and former underground 
storage tank.  DCE (trans-) (1,020 ppb) was detected below the child (2,000 ppb) and adult 
(7,000 ppb) Intermediate EMEG, but above the child (200 ppb) and adult (700 ppb) RMEG.  
TCE (313 ppb) was detected above the EPA RBC for tap water of 0.026 ppb.  Vinyl chloride 
(1,170 ppb) was detected above the EPA Maximum Contaminant Level Goal (MCLG) for 
drinking water (0 ppb).  In a monitoring well (OW-2) near the former chlorinated solvent storage 
area, benzene was detected above the comparison value (CREG = 0.6 ppb) at 18.4 ppb.  A 
composite sample was collected from three of the monitoring wells (OW-1, OW-2, and OW-3) 
and analyzed for metals.  Arsenic was detected at 10 ppb, which is above the CREG (0.02 ppb) 
and equal to the EPA Maximum Contaminant Level (MCL).  Mercury was detected (140 ppb) 
above the EPA MCL of 2 ppb for inorganic mercury.   
In 1996, three of the  shallow monitoring wells at Precise Engineering that were sampled in 1988 
(OW-3, OW-4, OW-5) were tested for VOCs, PCBs, and metals.  Cadmium (60 ppb) was 
measured above the child (2 ppb) and adult (7 ppb) chronic EMEG for drinking water.  
Chromium (90 ppb) was detected above the child RMEG (30 ppb) and below the adult RMEG 
(300 ppb) for hexavalent chromium.  Lead was detected at 100 ppb, which exceeds the EPA 
MCLG of 0 ppb.  These three metals were detected in the same well (OW-5) on the Precise 
Engineering property.  The exact location of this well is unknown.  DCE (cis-) was detected 
above the EPA RBC for tap water (61 ppb) at 65 ppb in monitoring well OW-3, which was about 
20 feet west of the southwest corner of the Precise Engineering building and the former 
underground storage tank. 
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In 1997, five shallow groundwater samples (from 12–18 feet deep) and three deep groundwater 
samples (one 48-feet deep and two 71-feet deep) were collected from eight new monitoring wells 
at Precise Engineering.  One existing shallow monitoring well (OW-4) was also sampled.  All 
samples were analyzed for VOCs.  Additionally, two shallow wells were analyzed for polycyclic 
aromatic hydrocarbons (PAHs), and one shallow well was analyzed for PAHs, PCBs, and metals.  
PCE was detected in one of the shallow wells (SEA-2S) in the northeast corner of the property 
near the railroad bed at 186 ppb, which is above the RMEG for children (100 ppb) and below the 
adult RMEG (400 ppb).  TCE was also detected in the same well at 9.9 ppb, which is above the 
EPA RBC for tap water (0.026 ppb).  Monitoring well SEA-2S was the most upgradient well of 
those sampled in 1997 on the Precise Engineering property.  At the most downgradient well 
(SEA-5S) sampled in 1997, PCE was detected at 5.7 ppb and TCE was not detected; therefore, 
investigators suggested that VOCs might be coming from an offsite source (SEA Consultants 
1998).  MDEP confirmed that, in addition to potential onsite sources, VOCs in groundwater at 
Precise Engineering may have also originated from wastewater that was improperly disposed of 
at a nearby dry cleaner (G. Martin, MDEP, personal communication, 2005). 
No other contaminant was detected above comparison values in the monitoring wells that were 
sampled in 1997.  Therefore, based on the available data, it appears that contaminant 
concentrations in groundwater at Precise Engineering decreased from the time groundwater was 
first sampled in 1988 to when it was last sampled in 1997.   
VOCs and metals have never been detected in East Bridgewater Well #5 (S. McCann, East 
Bridgewater Water Department, personal communication, 2005).  The water department 
regularly tests Well #5 for VOCs and metals, according to state and federal laws, and does not 
maintain monitoring waivers for these contaminants.      
C. Surface Water 
Because ATSDR comparison values do not exist for surface water, drinking water comparison 
values were used as screening values.  This is a conservative evaluation because guidelines for 
chemicals in drinking water assume adults ingest two liters of water per day.  Exposures to 
chemicals present in surface water not used for drinking water purposes would be expected to be 
less than exposures to chemicals in drinking water. 
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A seasonal drainage ditch extends from the eastern edge of the site to the western portion along 
the southern boundary of the Precise Engineering property.  It is on the Precise Engineering 
property, but is outside the fence that surrounds the site, and is adjacent to a wooded area on 
Spring Street residential properties (R. Haworth, EPA, personal communication, 2005).  In 1988, 
two surface water samples were collected from an upstream and downstream location and 
analyzed for VOCs (SEA Consultants 1998).  Only toluene was detected in the upstream sample 
and at a level below comparison values.  DCE, PCE, TCE, and vinyl chloride were detected at 
concentrations exceeding comparison values in the downstream sample only.  DCE was 
measured at 145 ppb, which is above the EPA MCL for drinking water (100 ppb) and below both 
the Intermediate EMEG (2,000 ppb) and RMEG (200 ppb) for children.  PCE was detected (176 
ppb) above the child RMEG of 100 ppb and below the adult RMEG of 400 ppb.  TCE was 
measured in the downstream sample at 59.7 ppb, which exceeds the MCLG of 0 ppb and the 
MCL of 5 ppb.  Vinyl chloride was detected (14.5 ppb) above the MCLG value (0 ppb).  Site 
investigators concluded that contaminated onsite groundwater discharging to the drainage ditch 
impacted the downstream sample (SEA Consultants 1998).  A summary of the maximum 
concentrations of contaminants detected in surface water samples that exceeded comparison 
values is located in Table 4.   
In 1997, three surface water samples (upstream, midstream, downstream) were collected from 
the drainage ditch and analyzed for VOCs.  No VOCs were detected in the upstream sample.  
TCE, PCE, and DCE were detected in the midstream sample, which was located adjacent to the 
former solvent storage area and near the crane fuel oil release.  TCE and PCE levels slightly 
exceeded comparison values.  TCE was detected (6.3 ppb) above the MCLG value (0 ppb) and 
the MCL value (5 ppb).  PCE was measured at 16.8 ppb, which exceeds the MCL of 5 ppb, but is 
below the RMEG for children (100 ppb).  DCE was the only VOC detected in the downstream 
sample, and it was detected below comparison values.  Thus, it appears that contaminant 
concentrations in surface water have decreased from the time the drainage ditch was sampled in 
1988 to when it was sampled again in 1997.  
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D. Sediment 
Because ATSDR comparison values do not exist for sediment, soil comparison values were used.  
A summary of the maximum concentrations of contaminants detected in onsite sediment samples 
that exceeded comparison values for soil is presented in Table 5.  In 1997, three sediment 
samples from upstream, mid-stream, and downstream locations in the drainage ditch were tested 
for PAHs, metals, PCBs, and VOCs.  PAHs were reported in each sample at levels above 
comparison values.  The mid-stream sample had the highest PAH concentrations.  In this sample, 
benzo(a)anthracene, benzo(a)pyrene, benzo(b)fluoranthene, and dibenzo(a,h)anthracene levels 
exceeded comparison values.  Benzo(a)anthracene was measured at 8.72 ppm, which exceeds the 
EPA RBC for residential soil (0.87 ppm), but is within background levels (0.169–9 ppm for 
urban soil.  Benzo(a)pyrene (19.7 ppm) was detected above the CREG value (0.1 ppm) and 
above background levels (0.165–0.22 ppm for urban soil).  Benzo(b)fluoranthene (30.9 ppm) 
was detected above the RBC for residential soil (0.87 ppm), but within background levels (15–62 
ppm for urban soil).  Dibenzo(a,h)anthracene (49.4 ppm) was also detected above the RBC for 
residential soil (0.087 ppm).  Lead was reported in the upstream sample at 436 ppm, which 
exceeds the MDEP soil cleanup standard of 300 ppm, but is within background levels for urban 
soil (160–840 ppm).  Arsenic was detected in the downstream sample at 42.6 ppm, which 
exceeds the CREG value (0.5 ppm), but is within soil background levels (0.1–73 ppm).   
During EPA removal activities from 2000 to 2001, the drainage ditch bank adjacent to Spring 
Street residences was reconstructed using clean soil.  During a subsequent cleanup by the MDEP, 
soil from the segment near the former underground storage tank was excavated up to the 
foundation of the Precise Engineering building in order to control the problem of subsurface 
petroleum leaching into the ditch.    
VI. EVALUATION OF POTENTIAL COMMUNITY EXPOSURE 
PATHWAYS AND HEALTH CONCERNS  
An evaluation of potential pathways of exposure was conducted to determine whether releases or 
activities at the OCRR site could be impacting residents of East Bridgewater in the past, present, 
or future.  Exposure to a chemical must first occur before any potential adverse health effects can 
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result.  Five conditions must be present for exposure to occur.  First, there must be a source of 
that chemical.  Second, an environmental medium must be contaminated by either the source or 
by chemicals transported away from the source.  Third, there must be a location where a person 
can potentially contact the contaminated medium.  Fourth, there must be a means by which the 
contaminated medium could enter a person’s body, such as ingestion, inhalation, and dermal 
absorption.  Finally, the chemical must actually reach the target organ susceptible to the toxic 
effects caused by that particular substance at a sufficient dose and for a sufficient exposure time 
for an adverse health effect to occur (ATSDR 1993a). 
A completed exposure pathway indicates that exposure to humans occurred in the past, is 
occurring in the present, or will occur in the future.  A completed exposure pathway exists when 
all of the five elements are present.  A potential exposure pathway exists when one or more of 
the five elements is missing or uncertain and indicates that exposure to a contaminant could have 
occurred in the past, could be occurring in the present, or could occur in the future.  An exposure 
pathway can be eliminated if at least one of the five elements is missing and will not likely be 
present in the future.  
To evaluate the potential for health effects, ATSDR Minimal Risk Levels (MRLs) were 
compared to exposure estimates for the contaminants of concern at the OCRR site.  Specifically, 
the contaminants of concern are lead, arsenic, and PCBs in soil and TCE in surface water.  The 
MRL is an estimate of daily exposure to a contaminant below which noncancer, adverse health 
outcomes are unlikely to occur.  In addition, exposure estimates for contaminants of concern 
were combined with EPA cancer slope factors provided by ATSDR to evaluate potential cancer 
risk.  
A. Exposure to Soil 
Prior to cleanup by the EPA, access to the OCRR site was unrestricted.  There is evidence that 
nearby residents, youths in particular, accessed the site.  In the past, trespassers may have been 
exposed through incidental ingestion of or dermal contact with contaminants such as lead, 
arsenic, and PCBs detected in onsite surface soil at levels above comparison values.  However, it 
is important to consider that comparison values are based on a residential exposure scenario, and 
  
 26
it is unlikely that a trespasser would have had contact with onsite surface soil for a comparable 
frequency and duration of time.   
The EPA and the International Agency for Research on Cancer (IARC) have classified PCBs as 
a probable human carcinogen.  Although scientists do not know if PCBs can cause cancer in 
humans, some studies have found that rats exposed to PCBs developed liver cancer.  Studies 
investigating a possible association between environmental exposure to PCBs in the general 
population and development of breast cancer and NHL are inconclusive.  Assuming that an older 
child trespassed on the site and incidentally ingested the maximum concentration of PCBs 
detected in surface soil (22,500 ppm) for 2 days every week for 26 weeks over 10 years, they 
could have been exposed to PCBs at a level that could have presented an increased cancer risk1.  
However, these exposure assumptions are conservative, and it is very unlikely that a trespasser 
would have had consistent contact with soil containing the highest concentration of PCBs, which 
was located in one particular area of the OCRR site.  It is more likely that soil with a range of 
contaminant concentrations could have been ingested over time.  Under a more realistic 
assumption that an older child who trespassed regularly on the site could have been exposed to 
the average concentration of PCBs (85 ppm), an increased cancer risk would not have been 
likely2.   
Arsenic is classified as a known human carcinogen by the EPA and IARC, and ingestion of 
inorganic arsenic has been reported to increase the risk of developing cancers of the bladder, 
                                                 
1 Cancer Effects Exposure Factor = (2 days/week) (26 weeks/year) (10 years) = 0.02 
(70 years) (365 days/year) 
 
Cancer Effects Exposure Dose = (max. contaminant concentration) (ingestion rate) (exposure factor) (1 kg/106 mg) 
      body weight 
 
       = (22,500 mg/kg) (200 mg/day) (0.02) (1 kg/106 mg) = 2.6 x 10-3 mg/kg/day 
     35 kg  
 
Cancer Risk = Cancer Effects Exposure Dose x Cancer Slope Factor  
 
      = 2.6 x 10-3 mg/kg/day x 2.0 (mg/kg/day)-1 = 5 x 10-3 
 
2 Cancer Effects Exposure Dose = (85 mg/kg) (200 mg/day) (0.02) (1 kg/106 mg) = 1 x 10-5 mg/kg/day 
      35 kg  
 
Cancer Risk = 1 x 10-5 mg/kg/day x 2.0 (mg/kg/day)-1 = 2 x 10-5 
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kidney, liver, lung and certain types of skin cancer (ATSDR 1993b, 2003c).  If a trespasser 
inadvertently ingested surface soil with the maximum concentration of arsenic detected on the 
site (210 ppm) for 2 days every week for 26 weeks over 10 years, the exposure would not be 
expected to result in an increased cancer risk3.  Although an increased cancer risk is not 
expected, Section VII provides an evaluation of cancers possibly associated with arsenic 
exposure (i.e., bladder, kidney, liver, and lung).  The MCR does not collect data on individuals 
diagnosed with the types of skin cancer that have been identified in the scientific literature as 
being associated with arsenic exposure (i.e., non-melanoma skin cancer); therefore, this cancer 
type was not able to be evaluated in relation to the OCRR site.  If a trespasser inadvertently 
ingested surface soil with the maximum concentration of arsenic under the same exposure 
conditions described above, the level would be below ATSDR’s MRL4.  Therefore, noncancer 
health effects to a trespasser would also not be expected.   
In humans, the main target for lead toxicity is the nervous system.  Lead exposure is of most 
concern for young children because children exposed to lead, primarily due to the presence of 
lead paint in housing, may experience neurological damage (including learning disabilities) and 
behavioral changes.  In order to evaluate potential health concerns related to exposure 
opportunities to lead in soil at the OCRR site, MDPH used the U.S EPA Integrated Exposure 
Uptake Biokinetic (IEUBK) Model for Lead in Children.  This model is widely used throughout 
the country to predict blood lead levels based on lead intake via several sources (e.g., soil, food, 
water).  Environmental data specific to a site are input into the model to predict blood lead levels 
for young children (aged 6 months to 7 years).  The model generally uses typical or average 
concentrations in the various source media, assumes daily exposures, and predicts blood lead 
concentrations based on chronic exposures (e.g., 1 year or more). 
                                                 
3 Cancer Effects Exposure Dose = (210 mg/kg) (200 mg/day) (0.02) (1 kg/106 mg) = 2.4 x 10-5 mg/kg/day 
      35 kg  
 
Cancer Risk = 2.4 x 10-5 mg/kg/day x 1.5 (mg/kg/day)-1 = 4 x 10-5 
 
4 Noncancer Effects Exposure Factor = (2 days/week) (26 weeks/year) (10 years) = 0.14 
(10 years) (365 days/year) 
 
Noncancer Effects Exposure Dose = (210 mg/kg) (200 mg/day) (0.14) (1 kg/106 mg) = 1.7 x 10-4 mg/kg/day 
      35 kg  
Chronic MRL = 3 x 10-4 mg/kg/day 
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At the OCRR site, the average soil lead concentration was 560 ppm.  It is unlikely that children 
under the age of 7 years would have trespassed on a daily basis on the site in the past.  However, 
to be conservative, MDPH ran the IEUBK model with the assumptions that daily exposure 
occurred at the site and that half of a child’s typical daily incidental soil ingestion occurred 
during the time spent on the site.  Using these assumptions, the model predicted that 4 percent of 
children under the age of 7 years trespassing/playing on the site would be predicted to have 
blood lead levels greater than 10 micrograms per deciliter (μg/dL), which the Centers for Disease 
Control and Prevention (CDC) define as a level of concern (ATSDR 2004).  The predicted mean 
blood lead concentration was 4.4 μg/dL.  If we assumed that children played on the site for 180 
days per year, the model predicted that 2% of children under the age of 7 years would have blood 
lead levels at 10 μg/dL or greater and that the mean blood lead concentration would be 3.7 
μg/dL.  Thus, it appears unlikely that young children would have had blood lead levels above the 
current CDC level of concern given historical exposure opportunities at the site.  In addition, the 
predictions from both scenarios are below the EPA Office of Solid Waste and Emergency 
Response specified level of protectiveness of no more than 5% risk of an elevated blood lead 
level (U.S. EPA 2002).  
In addition to using the IEUBK model, data on blood lead levels in children living near the site 
were obtained from the CEH Childhood Lead Poisoning Prevention Program (CLPPP).  CLPPP 
was established for the prevention, screening, diagnosis, and treatment of lead poisoning in 
children residing in Massachusetts.  The Massachusetts Lead Law requires that all children be 
tested for blood lead levels once between the ages of 9 months and 12 months, and again at ages 
2 and 3 (CLPPP 2005).     
Between 1991, the first year that CLPPP testing data are readily available, and June 2005, there 
were two children with elevated blood lead levels (i.e., greater than 10 μg/dL) living on streets 
very near the site.   One of the two children had an initial screening result of 19 μg/dL with a 
capillary test that was not confirmed with a follow-up venous test; therefore, it is unknown 
whether the initial result would have been confirmed with the more reliable and accurate venous 
sample.  The second child was tested with a venous test and had a blood lead level of 19 μg/dL.  
When retested 3 months later with a venous test, the child had a blood lead level of 10 μg/dL.   
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The most important source of elevated blood lead levels in Massachusetts children is lead paint 
in older homes (CLPPP 2005).  Many homes built before 1978 have lead paint on the interior 
and exterior of the building (CLPPP 2005).  Available data from CLPPP indicate that the 
residence of one of the children with an elevated blood lead level near the OCRR site had some 
lead abatement performed 8 years before the child’s blood lead test, indicating that the residence 
had lead paint in the past (CLPPP 1991).  Although abatement resulted in compliance with the 
Massachusetts Lead Law at that time, available information did not indicate whether all lead 
paint was removed or whether other violations may have surfaced in subsequent years due to 
further degradation of remaining lead paint.  No information on the residence of the other child 
in terms of the presence of lead paint was available; however, 36% of housing units in East 
Bridgewater were built before 1950 (U.S. Census Bureau 1990).  The housing stock in the 
vicinity of the site appeared to be of a mid-1900s vintage (D. LaPointe, CEH, site visit, 2004); 
therefore, it is possible that houses in the vicinity of the site have had lead paint.  In addition, the 
percentage of blood lead test results that exceeded a level of concern (10 ug/dL) in children 
living near the site appeared to be no different than that observed townwide.  Specifically, of all 
test results reported to CLPPP for blood lead level from 1991 to June 2005 among East 
Bridgewater children, 10% (n = 515) were equal to or greater than 10 μg/dL.  Of all test results 
during the same time period among children residing within approximately 1/4 of a mile of the 
OCRR site, 11% (n = 9) were equal to or greater than 10 μg/dL.  Thus, it does not appear that 
children living close to the OCRR site are experiencing higher blood lead levels when compared 
to the town as a whole.   
Lead is classified by IARC as a possible human carcinogen based on some evidence of kidney 
cancer in animals (ATSDR 2003c).  Because there is no cancer slope factor for evaluating 
potential cancer risk from exposure to lead, the incidence and pattern of kidney cancer were 
evaluated in Section VII for the town of East Bridgewater as a whole and in relation to the 
OCRR site.   
Because the entire site was covered with clean soil during EPA removal activities, present and 
future ingestion of contaminants in onsite surface soils by trespassers were eliminated as 
exposure pathways.   
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When the facilities on the OCRR site were in operation, employees may have been exposed 
through incidental ingestion to contaminants such as PCBs and arsenic (lead is of concern for 
children and has not been conclusively linked to cancer in humans).  Assuming that an employee 
inadvertently ingested surface soil with the maximum PCB concentration (22,500 ppm) for 5 
days a week, for 50 weeks, over 30 years, the site could have presented a moderate risk of cancer 
to some exposed workers5.  However, the exposure assumptions are conservative, and it is 
unlikely that an employee would have consistently ingested soil with the maximum PCB 
concentration detected onsite.  If an employee was exposed to the average concentration of PCBs 
(85 ppm) under the same conditions, exposure would not pose an increased cancer risk for 
workers6.   
For employees who might have inadvertently ingested the maximum concentration of arsenic 
detected at the OCRR site for 5 days a week, for 50 weeks, over 30 years, no increased cancer 
risk would be expected7.  The same exposure conditions would also be unlikely to result in 
adverse noncancer health effects8.   
                                                 
5 Cancer Effects Exposure Factor = (5 days/week) (50 weeks/year) (30 years) = 0.29 
(70 years) (365 days/year) 
 
Cancer Effects Exposure Dose = (22,500 mg/kg) (50 mg/day) (0.29) (1 kg/106 mg) = 4.7 x 10-3 mg/kg/day 
      70 kg  
 
Cancer Risk = 4.7 x 10-3 mg/kg/day x 2.0 (mg/kg/day)-1 = 9 x 10-3 
 
6 Cancer Effects Exposure Dose = (85 mg/kg) (50 mg/day) (0.29) (1 kg/106 mg) = 1.8 x 10-5 mg/kg/day 
      70 kg  
 
Cancer Risk = 1.8 x 10-5 mg/kg/day x 2.0 (mg/kg/day)-1 = 4 x 10-5 
 
7 Cancer Effects Exposure Dose = (210 mg/kg) (50 mg/day) (0.29) (1 kg/106 mg) = 4.4 x 10-5 mg/kg/day 
      70 kg  
 
Cancer Risk = 4.4 x 10-5 mg/kg/day x 1.5 (mg/kg/day)-1 = 7 x 10-5 
 
8 Noncancer Effects Exposure Factor = (5 days/week) (50 weeks/year) (30 years) = 0.68 
(30 years) (365 days/year) 
 
Noncancer Effects Exposure Dose = (210 mg/kg) (50 mg/day) (0.68) (1 kg/106 mg) = 1 x 10-4 mg/kg/day 
      70 kg  
 
Chronic MRL = 3 x 10-4 mg/kg/day 
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If future redevelopment or changes in land use result in subsurface activities on the OCRR site, it 
is possible that construction and utility workers might have contact with onsite subsurface soils 
contaminated with arsenic, PCBs (less than 50 ppm), and PAHs during future construction 
activities.  However, given the level of site characterization, such activities are likely to be 
undertaken using proper health and safety precautions to minimize potential exposure, or 
additional site cleanup could be undertaken. 
Regarding adjacent residential properties, lead was detected above the action level at an 
undeveloped property and was not detected above the action level in soil samples collected from 
the other residential properties along Spring Street.  Since lead exposure is of most concern for 
0–6 year-olds, who probably did not trespass on the undeveloped property because they were 
very young, it is unlikely that children in this age group would have been exposed to lead above 
the action level.   
For children at adjacent residences who might have inadvertently ingested the maximum 
concentration of arsenic detected in residential backyards for 7 days a week, for 50 weeks, over 
18 years, no increased cancer risk would be expected9.  The same exposure conditions would 
also be unlikely to result in adverse noncancer health effects10. 
Because contaminated soil on residential properties was replaced with clean soil during EPA 
removal activities, current and future exposure pathways of residents to soil were eliminated.   
                                                 
9 Cancer Effects Exposure Factor = (7 days/week) (50 weeks/year) (18 years) = 0.25 
(365 days/year) (70 years)  
 
Cancer Effects Exposure Dose = (58 mg/kg) (200 mg/day) (0.25) (1 kg/106 mg) = 8 x 10-5 mg/kg/day 
      35 kg  
 
Cancer Risk = 8 x 10-5 mg/kg/day x 1.5 (mg/kg/day)-1 = 1 x 10-4 
 
10 Noncancer Effects Exposure Factor = (7 days/week) (50 weeks/year) (18 years) = 0.96 
(18 years) (365 days/year) 
 
Noncancer Effects Exposure Dose = (58 mg/kg) (200 mg/day) (0.96) (1 kg/106 mg) = 3 x 10-4 mg/kg/day 
      35 kg  
Chronic MRL = 3 x 10-4 mg/kg/day 
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B. Exposure to Groundwater 
The groundwater wells sampled at the OCRR site are for monitoring purposes only, and no one 
drinks water from these wells.  The surrounding neighborhood is supplied with municipal 
drinking water.  There are no known private drinking water wells in the area (S. McCann, East 
Bridgewater Water Department, personal communication, 2004).  Since groundwater in this area 
is not being used as a source of drinking water, ingestion of or dermal contact with groundwater 
is not a completed exposure pathway for residents.   
The OCRR site is on the edge of a Zone II wellhead protection area for East Bridgewater Well 
#5.  Under extreme drought conditions (i.e., 180 days with no precipitation to recharge aquifers) 
groundwater from the site might reach Well #5 and affect water quality.  However, these 
conditions would occur infrequently, if at all.  In addition, public water supplies are tested and 
treated on a routine basis in accordance with state and federal laws (S. McCann, East 
Bridgewater Water Department, person communication, 2005).  Hence, exposure to 
contaminants in groundwater was eliminated as a possible route of exposure.  
C. Exposure to Surface Water/Sediment  
It is possible that incidental ingestion and dermal contact with surface water and sediment 
contaminants in a drainage ditch onsite and immediately adjacent to some Spring Street 
properties may have occurred in the past for children accessing the site.  However, it is important 
to note that the comparison values used in this evaluation represent a daily drinking water 
exposure or residential soil exposure.  Because a wooded, marshy area separates the drainage 
ditch from backyard lawns, a child accessing the ditch would have likely been exposed less 
frequently and to significantly less contaminated surface water and sediment through incidental 
ingestion and dermal contact.   
EPA has withdrawn its cancer slope factor for TCE pending further evaluation and, therefore, the 
increased cancer risks from exposure to TCE detected in surface water cannot be quantified.  
However, assuming that a child had dermal contact with surface water for 1 hour/day, 2 
days/week, 26 weeks/year, for 10 years, using their hands, arms, and legs, and they ingested 
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about a mouthful (50 mL) per day of surface water with the maximum concentration of TCE 
detected (59.7 ppb) for the same amount of time, the estimated exposure dose would be  
3.2 x 10-5 mg/kg/day11.  This estimated exposure would be 3 x 107 times lower than the Lowest 
Observed Adverse Effect Level (LOAEL) for cancer observed in scientific studies of rats 
exposed to TCE (ATSDR 2003c)12.  For noncancer effects related to inadvertent ingestion and 
dermal contact with surface water containing the maximum concentration of TCE under the 
same exposure conditions described above, the estimated exposure would be below ATSDR’s 
MRL, and noncancer health effects in a child would not be expected13.   
Under the same assumptions as used to estimate exposure for children inadvertently ingesting 
surface soil when accessing the site, children ingesting drainage ditch sediment contaminants 
                                                 
11 Cancer Effects Exposure Dose (Ingestion) = (max. contaminant conc.) (water ingestion rate) (exposure factor) 
        body weight 
 
              = (0.0579 mg/L) (0.05 L/day) (0.02) = 1.7 x 10-6 mg/kg/day 
       35 kg  
 
Cancer Effects  
Exposure Dose = (max. contam. conc.) (permeability constant) (exposed body surface area) (exposure time) (1L) 
(Dermal)     (body weight) (1,000 cm3) 
 
            = (0.0597 mg/L) (0.21 cm/hra) (4,310 cm2) (0.02 hr/day) (1 L) = 3 x 10-5 mg/kg/day 
    (35 kg) (1,000 cm3) 
                 a ATSDR 2003c 
 
Cancer Effects  
Exposure Dose = Cancer Effects Exposure Dose (Ingestion) + Cancer Effects Exposure Dose (Dermal) 
(Total) 
           = 1.7 x 10-6 mg/kg/day + 3 x 10-5 mg/kg/day = 3.2 x 10-5 mg/kg/day 
     
12 Margin of Exposure = LOAEL/Cancer Effects Exposure Dose (Total)  
 
        =       1000 mg/kg/day    = 3 x 107 
3.2 x 10-5 mg/kg/day 
 
13 Noncancer Effects Exposure Dose (Ingestion) = (max. contaminant conc.) (water ingestion rate) (exposure factor) 
        body weight 
 
      = (0.0579 mg/L) (0.05 L/day) (0.14) = 1.2 x 10-5 mg/kg/day 
       35 kg  
 
Total Noncancer Effects Exposure Dose = 1.2 x 10-5 mg/kg/day + 3 x 10-5 mg/kg/day = 4 x 10-5 mg/kg/day 
 
 
Acute MRL = 0.2 mg/kg/day 
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that were detected at lower levels than surface soil contaminants would not likely experience 
adverse health effects or increased cancer risk.   
Because the drainage ditch was remediated during site clean-up, present and future exposures to 
contaminated surface water and sediment were eliminated from further consideration. 
D. Exposure to Indoor Air 
The volatilization of VOCs to indoor air in nearby homes would be possible if groundwater is 
shallow and VOCs are present in groundwater beneath homes at sufficient concentrations.  The 
shallow groundwater flow direction at the OCRR site is to the south-southwest, in the general 
direction of some Spring Street homes.  To evaluate the possibility of a potential vapor 
infiltration exposure pathway, the maximum concentrations of VOCs detected in shallow 
groundwater at the site were compared with GW-2 groundwater cleanup standards set by MDEP.  
GW-2 standards are intended for use at contaminated sites where shallow groundwater is 
considered to be a potential source of volatile oil and/or hazardous material to indoor air.  They 
are applicable when contaminated groundwater is located within 30 feet of an existing occupied 
building and when the average annual depth to groundwater in that area is 15 feet or less.  For 
houses and buildings in the vicinity of the OCRR site, application of the GW-2 standards 
represents a conservative approach since offsite downgradient concentrations are expected to be 
lower than those detected at the site.      
Environmental data from shallow groundwater (i.e., 15 feet or less) included results from 
monitoring wells on the Precise Engineering property.  Six wells were sampled in 1988, three of 
which were sampled again in 1996.  Six new wells were sampled in 1997.  In 1988, trans-DCE 
was detected at a maximum concentration of 1,020 ppb, which is below the GW-2 standard 
(20,000 ppb) for indoor air exposure.  Also in 1988, vinyl chloride was detected in three of six 
wells above GW-2 standards (2 ppb) for indoor air exposure to vinyl chloride.  The maximum 
concentration of vinyl chloride in 1988 was 1,170 ppb in monitoring well OW-3.  OW-3 was 
located in a southern area of the OCRR site about 20 feet west of the southwest corner of the 
Precise Engineering building, just north of the drainage ditch.  Vinyl chloride was not detected in 
OW-3 or in two other existing wells that were resampled in 1996.  Vinyl chloride was not 
detected in any new monitoring well in 1997; however, none of the new 1997 wells was located 
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downgradient (to the south-southwest) of monitoring well OW-3 where vinyl chloride was 
detected at 1,170 ppb in 1988.  Therefore, no data on vinyl chloride concentrations in 
groundwater downgradient from well OW-3 exist.  Thus, it was not possible based on available 
data to assess potential exposure opportunities to vinyl chloride (through volatilization from 
shallow groundwater to indoor air) for residents living downgradient from the OCRR site.  The 
MDEP reported that indoor air exposures to vinyl chloride for residents in downgradient Spring 
Street homes were unlikely (G. Martin, MDEP, personal communication, 2005).  When surface 
water was present in the seasonal drainage ditch that is located between Precise Engineering and 
downgradient homes, onsite groundwater likely discharged to the ditch and possible 
contaminants, including vinyl chloride, would have volatilized and dispersed (G. Martin, MDEP, 
personal communication, 2005).  Vinyl chloride was detected in drainage ditch surface water in 
1988 at a level of 14.5 ppb and was not detected upstream, which suggests that contaminated 
onsite groundwater was likely discharging to the ditch (SEA Consultants 1998).  Therefore, 
MDEP reported that vinyl chloride is unlikely to be present in shallow groundwater near homes 
at a concentration of concern for possible indoor air exposure.  However, because there were 
insufficient environmental data available to evaluate this pathway, the pattern of liver cancer 
diagnoses, which is a cancer type associated with exposure to vinyl chloride, was evaluated for 
Spring Street residents.      
VII. ANALYSIS OF CANCER INCIDENCE 
A. Methods for Analyzing Cancer Incidence 
1. Case Identification/Definition 
Cancer incidence data, reports of new cancer diagnoses, for the years 1982–2000 were obtained 
for the town of East Bridgewater from the MCR, a division of the Center for Health Information, 
Statistics, Research, and Evaluation within MDPH.  Eight cancers types were evaluated in this 
investigation and include leukemia, non-Hodgkin’s lymphoma (NHL), and cancers of the 
bladder, brain and central nervous system (CNS), breast, kidney, liver, and lung and bronchus.  
[Coding for cancer types in this report follows the International Classification of Diseases for 
Oncology (ICD-O system).  See Appendix A for the incidence coding definitions used in this 
report for these cancer types.]  These cancer types were selected for evaluation based on 
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potential associations with contaminants of concern identified at the OCRR site, as well as 
resident concerns over suspected elevations of some cancer types in the surrounding 
neighborhoods, including the Ashley Drive area.  For example, because trespassers and workers 
could have been exposed to soil contamination (e.g. arsenic, lead, and PCBs) in the past, cancer 
types with known or possible associations with these contaminants of concern at the OCRR site 
were selected for evaluation.   
Only cases reported to the MCR as a primary cancer for one of the eight cancer types and 
diagnosed among a resident of East Bridgewater were included in the analysis.  Cases were 
selected for inclusion based on the address reported to the hospital or reporting medical facility 
at the time of diagnosis.  Each case was matched to the corresponding census tract.  
The MCR is a population based surveillance system that began collecting information on 
Massachusetts residents diagnosed with cancer in the state in 1982.  All newly diagnosed cancer 
cases among Massachusetts residents are required by law to be reported to the MCR within 6 
months of the date of diagnosis (M.G.L. c.111s.111B).  The 19-year period, 1982–2000, 
constitutes the period for which the most recent and complete cancer incidence data were 
available from the MCR at the time of this analysis14. 
The term “cancer” is used to describe a variety of diseases associated with abnormal cell and 
tissue growth.  Epidemiologic studies have revealed that different types of cancer are individual 
diseases with separate causes, risk factors, characteristics, and patterns of survival (Berg 1996).  
Cancers are classified by the location in the body where the disease originated (the primary site) 
and the tissue or cell type of the cancer (histology).  Therefore, each of the cancer types reviewed 
in this report was evaluated separately.  Cancers that occur as the result of the metastasis or the 
spread of a primary site cancer to another location in the body are not considered as separate 
cancers and, therefore, were not included in this analysis. 
It should be noted that the MCR research file might contain duplicate reports of individuals 
diagnosed with cancer.  Duplicate cases are additional reports of the same primary site cancer 
                                                 
14 The data summarized in this report are drawn from data entered on MCR computer files before March 10, 2004.  
The numbers presented in this report may change slightly in future reports, reflecting late reported cases, address 
corrections, or other changes based on subsequent details from reporting facilities. 
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case.  The data in this report have been controlled for duplicate cases by excluding them from the 
analyses.  The decision that a case was a duplicate and should be excluded from the analyses was 
made by the MCR after consulting with the reporting hospital/diagnostic facility and obtaining 
additional information regarding the histology and/or pathology of the case.  However, reports of 
individuals with multiple primary site cancers were included as separate cases in the analyses in 
this report.  A multiple primary cancer case is defined by the MCR as a new cancer in a different 
location in the body, or a new cancer of the same histology (cell type) as an earlier cancer, if 
diagnosed in the same primary site (original location in the body) more than 2 months after the 
initial diagnosis (MCR 1996).  Therefore, duplicate reports of an individual diagnosed with 
cancer were removed from the analyses whereas individuals who were diagnosed with more than 
one primary site cancer were included as separate cases.  In the town of East Bridgewater, one 
duplicate report was identified during the years 1982–2000 and excluded from the analyses.   
2. Calculation of Standardized Incidence Ratios (SIRs) 
To determine whether elevated numbers of cancer cases occurred in East Bridgewater, cancer 
incidence data were tabulated by gender according to 18 age groups to compare the observed 
number of cancer cases to the number that would be expected based on the statewide cancer rate.  
Standardized incidence ratios (SIRs) were then calculated for the period 1982–2000 for each of 
the eight primary cancer types for East Bridgewater as a whole and the census tracts that 
comprise the town.  SIRs were also calculated for three smaller time periods, 1982–1987, 1988–
1993, and 1994–2000, in order to evaluate patterns or trends in cancer incidence over time. 
In order to calculate SIRs, it is necessary to obtain accurate population information.  The 
population figures used in this analysis were interpolated based on 1980, 1990, and 2000 United 
States census data for East Bridgewater (U.S. DOC 1980, 1990, 2000).  Midpoint population 
estimates were calculated for each time period evaluated (i.e., 1984, 1990, and 1997).  To 
estimate the population between census years, an assumption was made that the change in 
population occurred at a constant rate throughout the 10-year interval between each census15.   
                                                 
15 Using slightly different population estimates or statistical methodologies, such as grouping ages differently or 
rounding off numbers at different points during calculations, may produce results slightly different from those 
published in this report. 
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Because accurate age group and gender specific population data are required to calculate SIRs, 
the census tract (CT) is the smallest geographic area for which cancer rates can be accurately 
calculated.  Specifically, a CT is a smaller statistical subdivision of a county as defined by the 
United States Census Bureau.  CTs usually contain between 2,500 and 8,000 persons and are 
designed to be homogenous with respect to population characteristics (U.S. DOC 1990).   
According to the Unites States Census, the town of East Bridgewater is subdivided into three 
census tracts (i.e., CTs 5231, 5232.01, and 5232.02) (U.S. DOC 2000).  As stated previously, the 
OCRR site and Alloy Castings Company are located in East Bridgewater CT 5231 (see Figure 
1).   
3. Interpretation of a Standardized Incidence Ratio (SIR) 
An SIR is an estimate of the occurrence of cancer in a population relative to what might be 
expected if the population had the same cancer experience as a larger comparison population 
designated as “normal” or average.  Usually, the state as a whole is selected to be the comparison 
population. Using the state of Massachusetts as a comparison population provides a stable 
population base for the calculation of incidence rates. 
Specifically, an SIR is the ratio of the observed number of cancer cases in an area to the expected 
number of cases multiplied by 100.  The population structure of each town is adjusted to the 
statewide incidence rate to calculate the number of expected cancer cases.  The SIR is a 
comparison of the number of cases in the specific area (i.e., city/town or census tract) to the 
statewide rate.  Comparisons of SIRs between towns or census tracts are not possible because 
each community has different population characteristics. 
An SIR of 100 indicates that the number of cancer cases observed in the population being 
evaluated is equal to the number of cancer cases expected in the comparison or “normal"” 
population.  An SIR greater than 100 indicates that more cancer cases occurred than were 
expected, and an SIR less than 100 indicates that fewer cancer cases occurred than were 
expected.  Accordingly, an SIR of 150 is interpreted as 50% more cancer cases than the expected 
number; an SIR of 90 indicates 10% fewer cancer cases than expected. 
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Caution should be exercised, however, when interpreting an SIR.  The interpretation of an SIR 
depends on both the size and the stability of the SIR.  Two SIRs can have the same size but not 
the same stability.  For example, an SIR of 150 based on four expected cases and six observed 
cases indicates a 50% excess in cancer, but the excess is actually only two cases.  Conversely, an 
SIR of 150 based on 400 expected cases and 600 observed cases represents the same 50% excess 
in cancer, but because the SIR is based upon a greater number of cases, the estimate is more 
stable.  It is very unlikely that 200 excess cases of cancer would occur by chance alone.  As a 
result of the instability of incidence rates based on small numbers of cases, SIRs were not 
calculated when fewer than five cases were observed for a particular cancer type. 
4. Calculation of the 95% Confidence Interval 
To help interpret or measure the stability of an SIR, the statistical significance of each SIR was 
assessed by calculating a 95% confidence interval (95% CI) to determine if the observed number 
of cases is “significantly different” from the expected number or if the difference may be due 
solely to chance (Rothman and Boice 1982).  Specifically, a 95% CI is the range of estimated 
SIR values that have a 95% probability of including the true SIR for the population.  If the 95% 
CI range does not include the value 100, then the population being evaluated is significantly 
different from the comparison or “normal” population.  “Significantly different” means there is 
less than a 5% chance that the observed difference (either increase or decrease) is the result of 
random fluctuation in the number of observed cancer cases. 
For example, if a confidence interval does not include 100 and the interval is above 100 (e.g., 
105–130), there is a statistically significant excess in the number of cancer cases.  Similarly, if 
the confidence interval does not include 100 and the interval is below 100 (e.g., 45–96), the 
number of cancer cases is statistically significantly lower than expected.  If the confidence 
interval range includes 100, the true SIR may be 100.  In this case, it cannot be determined with 
certainty that the difference between the observed and expected number of cases reflects a real 
cancer increase or decrease or is the result of chance.  It is important to note that statistical 
significance does not necessarily imply public health significance.  Determination of statistical 
significance is just one tool used to interpret SIRs. 
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In addition to the range of the estimates contained in the confidence interval, the width of the 
confidence interval also reflects the stability of the SIR estimate.  For example, a narrow 
confidence interval, such as 103–115, allows a fair level of certainty that the calculated SIR is 
close to the true SIR for the population.  A wide interval, for instance 85–450, leaves 
considerable doubt about the true SIR, which could be much lower than or much higher than the 
calculated SIR.  This would indicate an unstable statistic.  Again, due to the instability of 
incidence rates based on small numbers of cases, statistical significance was not assessed when 
fewer than five cases were observed. 
5. Evaluation of Cancer Risk Factor Information 
Available information reported to the MCR related to risk factors for cancer development was 
reviewed and compared to known or established incidence patterns for the cancer types 
evaluated in this report.  This information is collected for each individual at the time of cancer 
diagnosis and includes age at diagnosis, stage of disease, smoking history and occupation.  One 
or even several factors acting over time can be related to the development of cancer.  For 
example, tobacco use has been linked to bladder, kidney, and lung and bronchus cancers.  Other 
cancer risk factors may include lack of crude fiber in the diet, high fat consumption, alcohol 
abuse, and reproductive history.  Heredity, or family history, is an important factor for several 
cancers.  To a lesser extent, some occupational exposures, such as jobs involving contact with 
asbestos, have been shown to be carcinogenic (cancer-causing).  Environmental contaminants 
have also been associated with certain types of cancer.  The available risk factor information 
from the MCR was evaluated for East Bridgewater residents diagnosed with any of the eight 
cancer types included in this report.  However, information about personal risk factors that might 
include family history, hormonal events, diet, and other factors that may also influence the 
development of cancer is not collected by the MCR, and therefore, it was not possible to evaluate 
them in this investigation. 
6. Determination of Geographic Distribution of Cancer Cases 
In addition to calculation of SIRs, address at the time of diagnosis for each individual diagnosed 
with cancer was mapped using a computerized geographic information system (GIS) (ESRI 
2002).  This allowed assignment of census tract location as well as an evaluation of the spatial 
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distribution of individual cases at a smaller geographic level within a census tract (i.e., 
neighborhoods).  The geographic pattern was determined using a qualitative evaluation of the 
point pattern of cases in East Bridgewater.  In instances where the address information from the 
MCR was incomplete, that is did not include specific streets or street numbers, all cases were 
able to be mapped using telephone books and town residential lists issued within 2 years of an 
individual's diagnosis.  For confidentiality reasons, it is not possible to include maps showing the 
locations of individuals diagnosed with cancer in this report.  [Note: MDPH is bound by law not 
to reveal the name or identifying information of an individual diagnosed with cancer whose case 
is reported to the MCR.] 
B. Results of Cancer Incidence Analysis 
The following section presents cancer incidence rates for the 19-year time period, 1982–2000, 
for East Bridgewater and the census tracts that divide the town, with a particular focus on CT 
5231, where the OCRR site and Alloy Castings are located.  To evaluate possible trends over 
time, these data were also analyzed by three smaller time periods, 1982–1987, 1988–1993, and 
1994–2000.  Table 6a through Table 6d summarize cancer incidence data for the town of East 
Bridgewater as a whole.  Table 7a through Table 9d summarize cancer incidence data for East 
Bridgewater CTs 5231, 5232.01 and 5232.02.  SIRs were not calculated for some cancer types 
due to the small number of observed cases (less than five).  However, the expected number of 
cases was calculated during each time period, and the observed and expected numbers of cases 
were compared to determine whether excess numbers of cancer cases were occurring. 
1. Cancer Incidence in East Bridgewater 
The eight cancer types evaluated in this report generally occurred approximately at or near 
expected rates in the town of East Bridgewater as a whole during the 19-year time period, 1982–
2000, as well as smaller time periods (i.e., 1982–1987, 1988–1993, and 1994–2000) (see Table 
6a through Table 6d).  One statistically significant elevation was observed (i.e., female leukemia 
during the middle time period, 1988–1993) and is discussed later in this report.  No other 
statistically significant elevations were observed in the town of East Bridgewater as a whole.  
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Overall, cancers of the bladder, breast, kidney, and lung and bronchus all occurred at about the 
rates expected.  For example, there were 29 diagnoses of bladder cancer during the time period, 
1982–2000, whereas approximately 30 diagnoses were expected (SIR = 97).  During the earliest 
time period, 1982–1987, there were 11 diagnoses of bladder cancer compared to 9.2 expected.  
During 1988–1993, bladder cancer occurred less often than expected (6 diagnoses observed vs. 
9.2 expected), though the difference was not statistically significant.  Finally, during the most 
recent time period, 1994–2000, bladder cancer occurred at approximately the expected rate (12 
diagnoses observed vs. 11.8 expected).  Residents of East Bridgewater experienced breast cancer 
at about the rate expected during 1982–2000 (139 diagnoses observed vs. 135.1 expected, SIR = 
103) and during each of the three smaller time periods evaluated.  Kidney cancer occurred at 
approximately the expected rate in East Bridgewater during the overall time period 1982–2000 
(18 diagnoses observed vs. 19.2 expected, SIR = 94).  The incidence of kidney cancer during the 
first time period, 1982–1987, was less than expected (1 diagnosis observed vs. 4.2 expected) and 
at about the rate expected during the two later time periods.   
The incidences of lung and bronchus cancer among males and females combined (123 diagnoses 
observed vs. 115.6 expected, SIR = 106) and among males (75 diagnoses observed vs. 68.9 
expected, SIR = 109) were slightly higher than expected from 1982–2000.   However, the 
elevations were not statistically significant.  Females were diagnosed with lung and bronchus 
cancer at about the rate expected during 1982–2000 (48 diagnoses observed vs. 46.7 expected; 
SIR = 103).   
Brain and CNS cancer and liver cancer occurred less often than expected during the 1982–2000 
time period.  There were nine diagnoses of brain and CNS cancer during 1982–2000, whereas 
approximately 15 diagnoses were expected (SIR = 58).  Fewer brain and CNS cancer diagnoses 
were also observed than were expected during each of the three smaller time periods evaluated.  
Three diagnoses of liver cancer were observed in East Bridgewater during 1982–2000 versus 
about five expected.  When examined over time, liver cancer occurred about as expected in all 
three smaller time periods. 
Leukemia occurred more often than expected in East Bridgewater during the 19-year time period 
1982–2000 (22 diagnoses observed vs. 17.3 expected, SIR = 127).  However, the elevation was 
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not statistically significant (95% CI = 80–193).  This elevation was largely due to a statistically 
significant elevation in the incidence of leukemia among females during the middle time period 
1988–1993 (6 diagnoses observed vs. 2.1 expected, SIR = 289, 95% CI = 105–630).  Although 
this result was statistically significant, the wide 95% confidence interval indicates that the SIR is 
unstable.  Leukemia has four main subtypes and several rare types and, for that reason, is 
generally evaluated as separate diseases because each subtype has different risk factors.  An 
evaluation of the incidence of leukemia by subtype revealed that, among the six females 
diagnosed during 1988–1993, there were five leukemia subtypes represented.  During both the 
earlier and later time periods, leukemia among females occurred about as expected.  During all 
three time periods, the incidence of leukemia among males occurred at the expected rate.   
NHL occurred more often than expected in East Bridgewater during 1982–2000 (36 diagnoses 
observed vs. 30.0 expected; SIR = 121).  The elevation was largely attributed to NHL incidence 
among males (22 diagnoses observed vs. 16.0 expected, SIR = 138); however, neither elevation 
was statistically significant.  NHL among males was also elevated during the two earlier time 
periods when the observed number of males diagnosed with NHL was about three more than 
expected for each time period.  Again, these elevations are not statistically significant.  The 
occurrence of NHL among males during the latest time period (1994–2000) was about as 
expected (7 diagnoses observed vs. 7.8 expected). 
2. Cancer Incidence in East Bridgewater Census Tracts 
Of the eight cancer types evaluated in this report, none were statistically significantly elevated in 
East Bridgewater CT 5231, where the OCRR site and Alloy Castings Company are located, for 
any of the time periods evaluated.  Five cancer types (brain and CNS, breast, kidney, and liver 
cancer and leukemia) occurred approximately equal to or less often than expected during 1982–
2000 among males and females combined (Table 7a).  When examined by the three smaller time 
periods, these five cancers occurred about as or less than expected for each gender.  Tables 7b-7d 
show the observed and expected rates for each of the eight cancer types.   
In CT 5231, nine individuals were diagnosed with bladder cancer compared to 7.3 expected (SIR 
= 123).   This elevation was not statistically significant.  The incidence of lung cancer among 
males was elevated in East Bridgewater CT 5231 during 1982–2000 (23 diagnoses observed vs. 
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16.9 expected, SIR = 136), but again the elevation was not statistically significant.  Lung cancer 
diagnosed among females during 1982–2000 occurred slightly less often than expected (9 
diagnoses observed vs. 10.9 expected, SIR = 82).   
NHL in East Bridgewater CT 5231 was elevated during 1982–2000 among females (6 diagnoses 
observed vs. 3.2 expected; SIR = 185); however, this elevation was not statistically significant.  
During 1982–2000, NHL occurred at about the rate expected among males in CT 5231 (4 
diagnoses observed vs. 3.8 expected).  
Of the eight cancer types evaluated in this report, none were statistically significantly elevated in 
East Bridgewater CT 5232.01 for any of the time periods examined (Tables 8a-8d).  All eight 
cancer types occurred approximately equal to or less often than expected during 1982–2000 
among males and females combined (Table 8a).  For example, there were 30 diagnoses of breast 
cancer vs. 32.4 expected (SIR = 92).  When examined by the three smaller time periods, seven of 
the cancer types (bladder, brain and CNS, breast, kidney, and liver cancer, leukemia, and NHL) 
occurred about as or less than expected for each gender.  Any elevations noted were generally 
based on about one or two excess cases.   
Lung and bronchus cancer was elevated for the time period 1982–1987 (12 diagnoses observed 
vs. 7.3 expected, SIR = 166).  Among males in CT 5232.01 there were nine diagnoses observed 
versus 4.7 expected (SIR = 191).  During this time period, lung and bronchus cancer occurred at 
about the rate expected among females in CT 5232.01 (3 diagnoses vs. 2.5 expected).  During the 
latter two time periods, lung and bronchus cancer occurred less than expected among males (i.e., 
3 diagnoses observed vs. 5.1 expected during 1988–1993).   
In East Bridgewater CT 5232.02, four cancer types (bladder, brain and CNS, liver, lung and 
bronchus cancer) occurred approximately equal to or less often than expected during 1982–2000 
among males and females combined (Table 9a).  When examined by the three smaller time 
periods, these four cancers occurred about as or less than expected for each gender.  A slight 
elevation in lung and bronchus cancer diagnoses among males (20 observed vs. 15.7 expected, 
SIR = 127) occurred in the time period 1994–2000; however, the elevation was not statistically 
significant.   
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The incidence of breast cancer was slightly elevated in East Bridgewater CT 5232.02 during 
1982–2000 (80 diagnoses observed vs. 71.8 expected, SIR = 111), but the elevation was not 
statistically significant.  Breast cancer occurred as expected among females during 1982–1987.   
There were 14 diagnoses of kidney cancer compared to 10.0 expected (SIR = 139) in CT 5232.02 
during 1982–2000.  This elevation was based on approximately two additional diagnoses over 
the expected number for males and females when evaluated separately and was not statistically 
significant.  When examined by smaller time periods, kidney cancer occurred about as expected 
during the two earlier time periods and was elevated during 1994–2000 (9 diagnoses observed 
vs. 5.1 expected), but the elevation was not statistically significant.   
The incidence of leukemia was elevated in East Bridgewater CT 5232.02 during 1982–2000 (13 
diagnoses observed vs. 9.0 expected, SIR = 144), but the elevation was not statistically 
significant.  Seven females were diagnosed, while approximately four would be expected.  There 
were five different leukemia subtypes reported among these females.  Leukemia diagnosed 
among males during 1982–2000 occurred about as expected (6 diagnoses observed vs. 5.1 
expected, SIR = 118).   
NHL in East Bridgewater CT 5232.02 was elevated among males during 1982–2000 (15 
diagnoses observed vs. 8.4 expected; SIR = 179).  The elevation was nearly statistically 
significant (95% CI = 100–296) and largely due to a statistically significant elevation in the 
incidence of NHL among males in the middle time period, 1988–1993 (7 diagnoses observed vs. 
2.6 expected, SIR = 272, 95% CI = 109–560).  Although NHL incidence among males in 1988–
1993 was statistically significant, the wide 95% confidence interval indicates that the SIR is 
unstable.  During the middle time period, 1988–1993, NHL occurred less often than expected 
among females in CT 5232.02 (1 diagnosis observed vs. 2.2 expected).  NHL diagnoses occurred 
at about the expected rate for both males and females during the other two time periods, 1982–
1987 and 1994–2000. 
C. Review of Cancer Risk Factor Information 
As previously mentioned, cancer is not just one disease but is a term used to describe a variety of 
different diseases.  As such, studies have generally shown that different cancer types have 
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different causes, patterns of incidence, risk factors, latency periods (the time between exposure 
and development of disease), characteristics, and trends in survival.  Available information from 
the MCR related to age and gender, as well as other factors related to the development of cancer 
such as smoking and occupation, was reviewed for individuals diagnosed with cancer in East 
Bridgewater.  Information for each of the eight cancer types was compared to known or 
established incidence trends to assess whether any unexpected patterns exist among these cases.  
It is important to note, however, that personal risk factors such as family history, pre-existing 
medical conditions, hormonal events, diet, and other factors also influence the development of 
these cancer types.  This information is not collected by the MCR or any other readily accessible 
source, and therefore, it was not possible to evaluate the role these types of risk factors may have 
played in the incidence of cancer in East Bridgewater.  For detailed information regarding risk 
factors associated with the cancer types evaluated in this report, please refer to Appendix B. 
Age and gender are risk factors in many types of cancers, including all eight types evaluated in 
this report.  Tobacco use is also a known or suggested causal risk factor in several types of 
cancer, including bladder cancer, kidney cancer, and lung and bronchus cancer.  The smoking 
history of individuals diagnosed with these cancer types was reviewed to assess the role tobacco 
smoking may have played in the development of these cancers among residents of East 
Bridgewater.  However, results of smoking history analysis should be interpreted with caution 
because of the number of individuals for which smoking status was unknown. 
In some studies, an association has been found with exposures specific to certain occupations 
and an increase in the incidence of bladder cancer, brain and CNS cancer, kidney cancer, 
leukemia, liver cancer, lung and bronchus cancer, and NHL.  Therefore, occupational 
information as reported by the MCR at the time of diagnosis was reviewed for individuals 
diagnosed with these cancer types to determine the role that occupational factors may have 
played in the development of these cancers in East Bridgewater.  It should be noted, however, 
that occupational data reported to the MCR are generally limited to job title and often do not 
include specific job duty information that could further define exposure potential for individual 
cases.  Further, these data are often incomplete as occupational information can be reported as 
unknown, at home, or retired.  
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Finally, histologic (cell type) distribution was reviewed for diagnoses of leukemia and lung and 
bronchus cancer in East Bridgewater.  Patterns of disease were compared to known or 
established incidence trends to assess whether any unusual patterns exist in these areas. 
1. Bladder Cancer 
The American Cancer Society estimates that bladder cancer will affect 61,420 people in the 
Unites States in 2006, accounting for 6% of all cancers diagnosed in the United States among 
men and 2% among women (ACS 2006).  White males have the highest prevalence of bladder 
cancer across all racial groups.  A male to female ratio of four to one has been observed among 
whites, while a slightly lower male to female ratio of three to one has been observed among most 
other racial groups.  Further, the occurrence of bladder cancer rises with increasing age.  The 
mean age at diagnosis in Massachusetts for the years 1982–2000 was 70 years.  
Bladder cancer is strongly associated with a history of cigarette smoking.  Smokers are more 
than twice as likely to develop bladder cancer compared to nonsmokers (ACS 2000a).  Tobacco 
use is associated with approximately 25-60% of all bladder cancers (Johansson and Cohen 1997).   
Studies have revealed a number of occupations that are associated with bladder cancer.  In fact, 
exposures to chemicals in the workplace account for an estimated 20-25% of all bladder cancers 
diagnosed among men in the United States (Johansson and Cohen 1997).  Occupational exposure 
to aromatic amines, such as benzidine and 2-naphthylamine, increases the risk of bladder cancer 
(ACS 2000a).  These chemicals were common in the dye industry in the past.  A higher risk of 
bladder cancer has also been observed among aromatic amine manufacturing workers as well as 
among workers in the rubber, leather, textiles, printing, and paint products industries (ACS 
2000a, Silverman et al. 1996).  The development of new chemicals, changed worker exposures, 
and the elimination of many known bladder carcinogens in the workplace have caused shifts in 
those occupations considered to be high risk.  For example, risks among dye, rubber, and leather 
workers have declined over time, while other occupations such as motor vehicle operation (e.g., 
drivers of trucks, buses, and taxis) and the aluminum industry have emerged as potential high-
risk occupations (Silverman et al. 1996).  However, specific occupational exposures in these 
occupations have not been confirmed and study findings are not consistent.  Further, the risk of 
bladder cancer from occupational exposures may be increased among smokers (ACS 2000a). 
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a) Age and Gender 
A review of individuals diagnosed with bladder cancer in East Bridgewater from 1982–2000 
revealed that the majority of diagnoses in the town were male (69%, n = 20).  Males comprised 
72% of bladder cancers statewide for this time period.  The mean age at diagnosis in East 
Bridgewater was 66 years, which is consistent with statewide bladder cancer incidence.     
b) Tobacco Use 
Of the 29 individuals in East Bridgewater who were diagnosed with bladder cancer during the 
years 1982–2000, two-thirds of those with known smoking history were current/former smokers 
(n = 12), which is nearly identical to the 67% of individuals diagnosed with bladder cancer in 
Massachusetts during 1982–2000 with known smoking history who were current/former 
smokers.   
c) Occupation 
Review of occupation for individuals diagnosed with bladder cancer in East Bridgewater 
revealed that at least two individuals might have worked at a job in which occupational 
exposures potentially related to the development of bladder cancer may have been possible.  
However, information regarding specific job duties that could help to further define exposure 
potential for these individuals was not available.  Occupations reported for the remaining 
individuals are not likely to be related to an increased risk of this cancer type.  However, 
occupation was reported as retired or unknown for many of these individuals (38%, n = 11). 
2. Brain and Central Nervous System Cancer 
The American Cancer Society estimates that 18,820 Americans (10,730 men and 8,090 women) 
will be diagnosed with brain and CNS cancer in 2006 (ACS 2006).  According to 
epidemiological literature, brain tumor incidence (cancerous and non-cancerous) declines after a 
peak in childhood (under 10 years of age), increases from age 25 to 75, and levels off after age 
75 (Preston-Martin and Mack 1996).  Certain types of brain tumors are more likely to develop in 
children and others are more typically seen in adults (Black 1991, NCI 1996).  Brain and spinal 
  
 49
cord cancers account for over 20% of all cancer types diagnosed among children 0-14 years of 
age (ACS 2004).   
Various studies on worker exposure to vinyl chloride and chemicals in the petrochemical 
industry have had conflicting results as to the association between these chemicals and the 
development of brain tumors.  Studies investigating the possible association between parental 
occupational exposures (e.g., paper or pulp mill, aircraft, rubber, and electric workers) and the 
onset of brain tumors (cancerous and non-cancerous) in their children have also provided 
inconsistent results (Preston-Martin and Mack 1996).    
a) Age and Gender 
From 1982 to 2000, males and females statewide were diagnosed with brain and CNS cancer 
about equally.  A review of gender patterns among brain and CNS cancer cases in East 
Bridgewater revealed that more males than females were diagnosed with brain and CNS cancer 
during that time period (6 males and 3 females).  However, because of the relatively small 
number of individuals diagnosed with brain and CNS cancer in East Bridgewater (nine 
individuals during the entire time period of 1982–2000), the difference in gender distribution is 
likely due to chance.  The age at diagnosis for individuals with brain and CNS cancer was 
consistent with the pattern expected based on the scientific literature for this cancer type.  All but 
one of the individuals diagnosed with brain or CNS cancer were diagnosed after age 25.  There 
was one child diagnosed with brain or CNS cancer.  This child lived in a different census tract 
and more than 1 mile away from both the OCRR site and Alloy Castings Company.  
b) Occupation 
Among the eight adults in East Bridgewater diagnosed with brain or CNS cancer, an occupation 
was reported for four individuals.  None of these four individuals reported occupations where 
exposures to the chemicals listed above were likely to have occurred, based on the available 
information.   
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3. Breast Cancer 
Breast cancer is the most frequently diagnosed cancer among women in both the United States 
and in Massachusetts and accounts for almost 30% of all newly diagnosed cancers among 
females (Henderson et al. 1996).  Breast cancer has the highest incidence rate of all cancers 
among women ages 35 and above, with higher incidence rates in the older age groups (Devesa et 
al. 1995).  According to the American Cancer Society, approximately 77% of new cases of breast 
cancer occur in women over age 50 (ACS 1999).   Breast cancer incidence and age have been 
shown to be related where the incidence increases from age 35 to 45, increasing at a slower rate 
from age 45 to 50, and at a steeper rate in post-menopausal women after age 50 (Kessler 1992).   
The risk of developing breast cancer can be influenced by a number of factors.  Epidemiological 
studies have determined some well-established risk factors for this cancer type.  The most well 
established risk factors for breast cancer are related to genetic and specific reproductive events in 
a woman’s life, such as age at first pregnancy, number of births, and age at menopause (Kessler 
1992).  Other factors such as a woman’s age and demographic characteristics (e.g., 
socioeconomic status) are known to increase breast cancer risk.  More recent research on breast 
cancer has included evaluation of the possible contributions of occupation or environmental 
factors in breast cancer development.  
a) Age and Gender 
Breast cancer occurred at about the rate expected in the town of East Bridgewater from 1982-
2000 (139 diagnoses observed vs. 135.1 expected, SIR=103).  The majority (99%, n = 137) of 
individuals diagnosed with breast cancer in the town were women.  Two men were diagnosed 
with breast cancer in East Bridgewater during this time.  This gender pattern is consistent with 
statewide trends.  The pattern of increasing breast cancer incidence with increasing age was 
observed among women diagnosed with breast cancer in East Bridgewater.  Approximately 70% 
of women diagnosed with breast cancer during the time period evaluated were over age 50, 
which is consistent with national trends.   
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4. Kidney and Renal Pelvis Cancer 
Kidney cancer is twice as common in males as it is in females and the incidence most often 
occurs in the fifth and sixth decades of life (50-70 year age group) (ACS 2001a).  
Epidemiological studies have shown that incidence rates of kidney cancer rise with increasing 
age before reaching a plateau at approximately age 70 (McLaughlin et al. 1996).  The etiology of 
kidney cancer is not fully understood.  However, a number of environmental, hormonal, cellular, 
and genetic factors have been studied as possible causal factors in the development of renal cell 
carcinoma.  Cigarette smoking is the most important known risk factor for renal cell cancer.  
Smoking increases the risk of developing renal cell cancer by 30% to 100% (ACS 2001a).  In 
both males and females, a statistically significant dose-response relationship between smoking 
and this cancer has been observed.  Approximately one-third of renal cell cancers in men and 
one-quarter of those in women may be caused by cigarette smoking (ACS 2001a). 
Although kidney cancer is not generally considered an occupationally associated cancer, some 
studies have suggested that environmental and occupational factors may be associated with its 
development.  Some studies have shown an increased incidence of this cancer type among 
leather tanners, shoe workers, and workers exposed to asbestos.  In addition, exposure to 
cadmium is associated with an increased incidence of kidney cancer, particularly among men 
who smoke.  In addition, workplace exposure to organic solvents, such as TCE, may increase the 
risk of this cancer (ACS 2001a).  More recently, renal cell carcinoma, the most common type of 
kidney cancer, has been suggested to be associated with occupational exposure to petroleum, tar, 
and pitch products.  However, studies of oil refinery workers and petroleum products distribution 
workers have not identified a definitive relationship between exposure to gasoline or other 
petroleum products and kidney cancer (Linehan et al. 1997, McLaughlin et al. 1996). 
a) Age and Gender 
The incidence of kidney cancer in East Bridgewater generally increased with increasing age.  
The average age of individuals diagnosed with kidney cancer in East Bridgewater during 1982–
2000 was 51 years, while the state mean was 64 years.  Fifty-six percent (n = 10) of individuals 
diagnosed were over the age of 50 at the time of diagnosis, which is consistent with the 
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literature.  More males (n = 10) than females (n = 8) were diagnosed with kidney cancer in East 
Bridgewater, which is consistent with state and national trends.   
b) Tobacco Use 
Of the 18 individuals diagnosed with kidney cancer in East Bridgewater during 1982–2000,  
73% of those with known smoking history were current/former smokers (n = 11).  Of individuals 
diagnosed with kidney cancer in Massachusetts during 1982–2000 with known smoking history, 
57% were current/former smokers.   
c) Occupation 
Review of occupation for individuals diagnosed with kidney cancer in East Bridgewater revealed 
that one individual might have worked a job in which occupational exposures potentially related 
to the development of kidney cancer may have been possible.  However, information regarding 
specific job duties that could help to further define exposure potential for this individual was not 
available.  Occupations reported for the remaining individuals are not likely to be related to an 
increased risk of this cancer type.  However, occupation was reported as retired, unknown, or 
housewife for 33% of these individuals (n = 6). 
5. Leukemia 
In 2006, leukemia is expected to affect approximately 35,070 individuals (20,000 males and 
15,070 females) in the United States, resulting in 22,280 deaths (ACS 2006).  In Massachusetts, 
approximately 770 individuals will be diagnosed with the disease in 2006, representing more 
than 2% of all cancer diagnoses (ACS 2006).  There are four major types of leukemia: acute 
lymphoid leukemia (ALL), acute myeloid leukemia (AML), chronic lymphoid leukemia (CLL), 
and chronic myeloid leukemia (CML).  There are also several rare types of leukemia (e.g., hairy 
cell leukemia, myelomonocytic leukemia).  In adults, the most common types are AML and 
CLL.  Leukemia is the most common type of childhood cancer, accounting for more than 30% of 
all cancers diagnosed in children.  The majority of these cases are of the ALL type (ACS 2003a). 
The various subtypes of leukemia occur with different frequencies in the population.  For the 
purpose of classification in this evaluation, if the histology (i.e., cell type) of the leukemia 
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diagnosis was not otherwise specified or not classified as one of the four main subtypes, then the 
individual case was categorized as “other.”  Available information regarding the expected 
distribution of leukemia by histology types can vary considerably depending on coding methods, 
making comparisons of type-specific incidence rates from different cancer registries difficult 
(Linet and Cartwright 1996).  In the state of Massachusetts during the time period 1982–2000, 
34% of all leukemia cases were AML, 26% were CLL, 13% were ALL, 11% were CML, and 
16% were other histology types. 
Several occupational exposures have been identified as playing a role in the development of 
leukemia.  For example, exposures to particular chemicals are thought to increase the risk of 
developing certain kinds of leukemia.  Exposures to ionizing radiation, chronic, high-dose 
exposure to pesticides, and other chemicals such as benzene, have also been suggested as 
possible risk factors for leukemia (Linet and Cartwright 1996).  Chronic occupational exposure 
to benzene has been established as a cause of AML.  High doses of radiation among survivors of 
atomic bomb blasts or nuclear reactor accidents are associated with an increased incidence of 
AML, CML, and ALL, but no association has been established for lower doses such as those 
used in medical diagnostics. 
a) Age and Gender 
The average age of individuals diagnosed with leukemia in East Bridgewater was 59 years, 
which mirrors the statewide experience.  Seventy-three percent (n = 16) were age 50 or older at 
the time of diagnosis.  One diagnosis occurred in a child, which is less than the number expected 
(2.5 cases expected).  A town-wide elevation in the incidence of leukemia in females during the 
middle time period, 1988–1993, was observed.  Leukemia occurred about as expected among 
females during the other two time periods, 1982–1987 and 1994–2000.  The incidence of 
leukemia among males was about as expected for all three smaller time periods.  
b) Histology 
The four main leukemia subtypes have different risk factors suspected to be associated with their 
development and generally occur with different frequency among adults and children. Of the 22 
individuals diagnosed with leukemia in East Bridgewater during 1982–2000, 23% were 
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diagnosed with AML subtype, 27% were diagnosed with CLL, 14% were diagnosed with ALL, 
9% were diagnosed with CML, and 27% were not specified or were diagnosed with other types 
of leukemia.  This distribution is somewhat similar to that seen statewide.  The one child 
diagnosed with leukemia in East Bridgewater was diagnosed with the ALL subtype, the most 
common subtype among children. 
Of the six females diagnosed with leukemia during 1988–1993, there were two cases of ALL, 
one case of CML, one case of hairy cell leukemia, one case of adult T-cell leukemia, and one 
case of an unspecified myeloid leukemia.  As previously mentioned, these leukemia cell types 
are different and have varied risk factors.   
c) Occupation 
Review of occupation for individuals diagnosed with leukemia in East Bridgewater revealed that 
at least one individual may have worked a job in which occupational exposures potentially 
related to the development of leukemia may have been possible.  However, information 
regarding specific job duties that could help to further define exposure potential for these 
individuals was not available.  Occupations reported for the remaining individuals are not likely 
to be related to an increased risk of this cancer type.  However, occupation was reported as 
retired or unknown for many of these individuals (32%, n = 7). 
6. Liver Cancer 
An estimated 18,510 people in the United States (12,600 men and 5,910 women) will be 
diagnosed with liver cancer in 2006, accounting for approximately 1% of all new cancers (ACS 
2006).  Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver, 
accounting for about 75% of all cases.  Men are at least two to three times more likely to develop 
liver cancer than women (Yu et al. 2000).  Although the risk of developing HCC increases with 
increasing age, the disease can occur in persons of any age (London and McGlynn 1996).  
Although chronic infection with hepatitis B virus (HBV) or hepatitis C virus (HCV) is the most 
significant risk factor for developing liver cancer (ACS 2001b), epidemiological and 
environmental evidence indicates that exposure to certain chemicals and toxins can also 
contribute significantly to the development of liver cancer.  For example, vinyl chloride, a 
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known human carcinogen used in the manufacturing of some plastics, and thorium dioxide, used 
in the past for certain x-ray tests, are risk factors for a rare type of liver cancer called 
angiosarcoma (ACS 2001b, London and McGlynn 1996).  These chemicals may also increase 
the risk of HCC, but to a lesser degree.  In addition, arsenic has been associated with an 
increased risk of liver cancer (ATSDR 2001). 
a) Age and Gender 
The three individuals diagnosed with liver cancer during 1982–2000 had a mean age of 52 years.  
For the most part, this observation was consistent with trends for this cancer type in the general 
population.  Two of the three diagnoses were males.   
b) Occupation 
The one individual diagnosed with liver cancer in East Bridgewater that reported an occupation 
was employed in an occupation not likely to be related to an increased risk of developing liver 
cancer.  Occupation was unknown or reported as “at home” for two individuals. 
7. Lung and Bronchus Cancer 
The American Cancer Society estimates that lung cancer will be diagnosed in 174,470 people in 
the United States in 2006, accounting for about 12% of all cancers (ACS 2006).  Lung cancer is 
the leading cause of cancer death among both men and women; more people die of lung cancer 
than of colon, breast, and prostate cancers combined (ACS 2000b).  According to 
epidemiological literature, the incidence of lung cancer increases sharply with age and peaks 
around approximately age 60 to 70.  Only two percent of lung cancers occur before the age of 40.  
In addition, lung cancer is generally observed more often among men than women (Blot and 
Fraumeni 1996, MCR 2002). 
Lung cancer is divided into two main types: small cell lung cancer and nonsmall cell lung 
cancer.  Nonsmall cell lung cancer is further sub-divided into three types: adenocarcinoma, 
squamous cell carcinoma, and large-cell undifferentiated carcinoma.  The different types of lung 
cancer occur with different frequencies in the population.  The American Cancer Society 
estimates that approximately 40% of all lung cancers are adenocarcinomas, 25-30% are 
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squamous cell carcinomas, 20% are small cell cancers, and 10-15% of cases are large cell 
carcinomas (ACS 2002).  Rates in Massachusetts are very similar to those seen nationally. 
About 87% of all lung cancers are thought to be caused directly by smoking cigarettes or by 
exposure to second hand smoke, or environmental tobacco smoke (ACS 2002).  An increase in 
cigarette smoking among women has produced lung cancer incidence rates that more closely 
resemble those experienced by males.  The risk of developing lung cancer depends on the 
intensity of one’s smoking habits (e.g., duration of habit, amount smoked, tar yield of cigarette, 
and filter type).  Smoking cessation decreases the elevated risk by about 50%; however, former 
smokers still carry a greater risk of developing lung cancer than those who have never smoked. 
Several occupational exposures have been identified as playing a role in the development of lung 
cancer.  For example, workplace exposure to asbestos is an established risk factor for this disease 
(ACS 2002).  Underground miners exposed to radon and uranium are also at an increased risk for 
developing lung cancer (ACS 2002; Samet and Eradze 2000).  Other occupations potentially 
associated with this cancer include chemical workers, talc miners and millers, paper and pulp 
workers, metal workers, butchers and meat packers, vineyard workers, carpenters and painters, 
and shipyard and railroad manufacture workers.  In addition to asbestos and radon, chemical 
compounds such as arsenic, chloromethyl ethers, chromium, vinyl chloride, nickel chromates, 
coal products, mustard gas, ionizing radiation, and fuels such as gasoline are also occupational 
risk factors for lung cancer.  Occupational exposure to these compounds in conjunction with 
cigarette smoking can dramatically increase the risk of developing lung cancer (Blot and 
Fraumeni 1996). 
a) Age and Gender 
Among the 123 individuals diagnosed with lung and bronchus cancer in East Bridgewater during 
1982–2000, the average age at diagnosis was 67 years.  None of these individuals were under the 
age of 40 at the time of diagnosis.  The incidence of lung and bronchus cancer occurred about as 
expected for both males and females.  
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b) Histology 
Of the 100 lung and bronchus cancer diagnoses in East Bridgewater with a specific histology 
classification, 41% were diagnosed as adenocarcinomas, 27% were squamous cell carcinomas, 
27% were small cell cancers, and 5% were large cell carcinomas.  This pattern is generally 
consistent with the distribution of histology types seen in the general population.  
c) Tobacco Use 
Of the 123 individuals diagnosed with lung and bronchus cancer in East Bridgewater during 
1982–2000, 95% of those with known smoking history were current/former smokers (n = 106).  
Of individuals diagnosed with lung and bronchus cancer in Massachusetts during 1982–2000 
with known smoking history, 92% were current/former smokers.   
d) Occupation 
Many individuals diagnosed with lung and bronchus cancer in East Bridgewater did not indicate 
working in jobs likely to have played a role in their cancer diagnosis.  However, 39 individuals 
(32%) reported either a history of asbestos exposure or occupations where exposures to asbestos 
or other chemical compounds thought to be associated with lung and bronchus cancer may have 
been possible.  Occupation was reported as retired, unknown, or at home for nearly half (43%, n 
= 53) of the individuals. 
8. Non-Hodgkin’s Lymphoma 
NHL can occur at all ages, however, the average age at diagnosis is in the early 60s and the 
incidence of this disease generally increases with age.  This disease is more common in men than 
in women (ACS 2003a).  The American Cancer Society estimates that approximately 58,870 
Americans will be diagnosed with NHL in 2006, making it the sixth most common cancer in the 
United States among both men and women, excluding non-melanoma skin cancers (ACS 2006).  
Although the primary factors related to the development of NHL include conditions that suppress 
the immune system and viral infections, certain occupational exposures have been associated 
with an increased risk of developing NHL, such as occupations related to chemicals or 
agriculture.  Farmers, herbicide and pesticide applicators, and grain workers appear to have the 
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most increased risk (Zahm et al. 1990 and 1993; Tatham et al. 1997).  An elevated risk for NHL 
development has also been noted among fence workers, orchard workers, and meat workers.  
High-dose exposure to benzene has been associated with NHL (ACS 2003b), however, a recent 
international cohort study indicated that petroleum workers exposed to benzene were not at an 
increased risk of NHL (Wong and Raabe 2000). 
a) Age and Gender 
The average age at diagnosis for individuals diagnosed with NHL in East Bridgewater during 
1982–2000 was 59 years, which is generally consistent with that seen in the general population.  
Sixty-one percent (n = 22) of diagnoses of NHL were males, which is similar to trends in the 
general population.  The elevation in NHL incidence among males in CT 5232.02 during the 
middle time period 1988–1993 was influenced by about four excess cases.  NHL occurred about 
as expected among males during the other two time periods, 1982–1987 and 1994–2000, in CT 
5232.02.  The incidence of NHL among females in CT 5232.02 was less than or about as 
expected for all three smaller time periods.  
b) Occupation 
Review of occupational information for individuals diagnosed with NHL in East Bridgewater 
revealed that at least one individual might have worked at a job in which occupational exposures 
potentially related to the development of NHL may have been possible.  However, information 
regarding specific job duties that could help to further define exposure potential for these 
individuals was not available.  Occupation was reported as retired, unknown, or at home for 39% 
of individuals (n = 14).  Therefore, it is difficult to assess the role that occupation may have 
played in the incidence of NHL among residents of East Bridgewater. 
D. Analysis of Geographic Distribution of Cancer Incidence 
In addition to determining incidence rates for each cancer type, a qualitative evaluation of the 
geographic pattern of cancer diagnoses was conducted, particularly as it relates to areas of 
environmental concern.  Place of residence at the time of diagnosis was mapped for each 
individual diagnosed with the cancer types evaluated in this report to assess any possible 
geographic concentrations of cases in relation to each other or in the vicinity of the OCRR site, 
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Alloy Castings Company, the Ashley Drive area, or other potential locations of environmental 
concern (i.e., MDEP 21E hazardous material and oil releases) located in the town of East 
Bridgewater.  As previously mentioned, cancer is one word that describes many different 
diseases.  Therefore, for the purposes of this evaluation, the geographic distribution of each 
cancer type was evaluated separately to determine whether an atypical pattern of any one type 
was occurring.  The geographic distributions of some specific types of cancer were also 
evaluated together because they may have similar etiologies (e.g., leukemia and NHL in 
children).   
Based on a review of address at the time of diagnosis for each individual diagnosed with the 
cancer types evaluated in this report, no apparent concentrations of cancer diagnoses (of any 
type) were observed in any one area of East Bridgewater.  There was no geographic pattern 
observed among the six females diagnosed with leukemia during the middle time period 1988–
1993, when a statistically significant elevation in leukemia incidence among females in East 
Bridgewater was observed.  There was no geographic pattern observed among the seven males 
diagnosed with NHL in CT 5232.02 during the middle time period 1988–1993, when a 
statistically significant elevation in NHL incidence among males was observed.  No apparent 
geographic concentrations of cancer diagnoses were noted in neighborhood areas surrounding 
the OCRR site, in the Ashley Drive area, and/or in relation to Alloy Castings. 
No other unusual spatial patterns or concentrations of cases at the neighborhood level that would 
suggest a common factor (environmental or nonenvironmental) related to cancer diagnoses 
among residents was apparent for any of the eight cancer types evaluated.  Any patterns that 
were observed appeared to be consistent with what would be expected based on the population 
distribution and areas of higher population density.  For example, in East Bridgewater, the 
majority of individuals with each type of cancer tended to be located in areas of the town where 
population and housing density is greater.  Although elevations in the incidence of some cancer 
types were noted in East Bridgewater during one or more time periods evaluated, in general, the 
geographic distribution of diagnoses for these cancer types seemed to coincide closely with the 
pattern of population and cases did not appear to be concentrated in any one area of town. 
  
 60
VIII. DISCUSSION 
At the request of Representative Kathleen Teahan, the East Bridgewater Board of Health, and 
concerned residents, the MDPH conducted an evaluation of cancer and possible environmental 
exposures in East Bridgewater.  The OCRR site consists of three distinct properties: Precise 
Engineering, Eastern States Steel, and an old MBTA railroad bed.  Historically, various 
manufacturing operations occupied the Precise Engineering and the Eastern States Steel 
properties.  The inactive MBTA railroad bed was originally part of the Old Colony Railroad.  
The EPA performed removal activities at the OCRR site in 2001; however, buildings and 
equipment in disrepair remain onsite, and an 800-foot section of the fencing has fallen down.  
Community concerns also focused on cancer in the Ashley Drive neighborhood and possible 
environmental exposures related to Alloy Castings Company, an active aluminum foundry.  
As part of this Public Health Assessment, the MDPH evaluated both cancer incidence data for 
East Bridgewater as a whole and for the census tracts that divide the town and reviewed available 
environmental information for the OCRR site to determine possible pathways of exposure for 
nearby residents.  In addition, the pattern of cancer was evaluated in neighborhoods within East 
Bridgewater census tracts to identify any unusual concentrations of cases and to evaluate 
community concerns about cancer and other locations of community environmental concern, 
including Alloy Castings Company near the Ashley Drive area.   
There are some potential exposure pathways that may have occurred in the past related to the 
OCRR site.  Past exposure to lead, arsenic, and PCBs in onsite surface soil and contaminants in 
surface water and sediment in the drainage ditch immediately adjacent to some Spring Street 
residences could have been possible for trespassers and residents accessing the site prior to 2001, 
when the EPA performed removal activities.  In addition, workers could have been exposed to 
contaminants such as PCBs and arsenic identified in onsite surface soil in the past.  However, 
upon considering conservative exposure doses for trespassers and workers and blood lead level 
for children, adverse health effects or increased cancer risk due to exposure to past 
contamination in onsite surface soil, surface water, and sediment were determined to be unlikely.   
It is also possible that residents on adjacent Spring Street properties and one West Union 
residence may have had contact with soil contamination identified in backyard surface soil of 
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residences abutting the site.  However, based on a review of available environmental data, lead 
was detected above the comparison value on an undeveloped property only.  Adverse health 
effects or increased cancer risk in children due to exposure to past arsenic contamination in 
residential surface soil was determined to be unlikely after considering conservative exposure 
doses.  Therefore, past exposure for abutting residents to both lead and arsenic is not likely to 
have resulted in adverse health effects.   
The OCRR site is located in a Zone II water supply protection area whose aquifer deposits could 
be pumped for public drinking water in an extreme drought situation.  However, municipal water 
supplies are tested and treated on a routine basis according to federal and state laws.  Therefore, 
it is not expected that groundwater contaminated with chemicals originating from the OCRR site 
would be consumed as drinking water. 
A potential data gap exists with respect to the detection of vinyl chloride at 1,170 ppb in an 
onsite groundwater monitoring well in 1988.  Although the MDEP reported that it is unlikely that 
residents downgradient from the OCRR site were or are impacted by vinyl chloride coming from 
the site, no groundwater data from any downgradient location were available for more recent 
years.  The elevated concentration of vinyl chloride in 1988 occurred in a shallow monitoring 
well (approximately 15 feet deep).  At the OCRR site, the depth to groundwater is about 2 feet 
below the surface.  The direction of groundwater flow in the shallow portion of the aquifer is 
generally to the south-southwest and appears to flow at a rate of 2 to 5 feet per year (SEA 
Consultants 1998).  Available soil data for this area suggest that subsurface soils are fine-grained 
silts and clay (SEA Consultants 1998).  The nearest residence that is downgradient of the 
monitoring well where vinyl chloride was detected is approximately 250 feet away on Spring 
Street.  If vinyl chloride is present in groundwater beneath downgradient homes at concentrations 
that are similar to the concentration detected in 1988, the potential exists for the volatilization of 
vinyl chloride into indoor air.  Because offsite groundwater conditions are unknown, it would be 
beneficial to address this data gap with additional investigation, for example, hydrogeological 
modeling or groundwater sampling at downgradient locations. 
Vinyl chloride exposure is associated with liver cancer; hence, the MDPH/CEH examined the 
pattern of liver cancer diagnoses in the Spring Street area, which is downgradient (to the south-
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southwest) of the OCRR site.  There were no liver cancer diagnoses from 1982 to the present 
among residents of Spring Street or among anyone in CT 5231 where the OCRR site is located.   
Assuming current site conditions, other present and future pathways of exposure were eliminated 
because the EPA performed removal actions at the OCRR site and nearby residences.  
Contaminants in surface soil, surface water, and sediment have been removed or are covered by 
clean soil and are no longer accessible to trespassers or nearby residents.  Future exposure of 
construction or utility workers to contamination in subsurface soil is considered unlikely if 
construction activities are undertaken using proper health and safety precautions.  Also, 
additional site remediation may be required in order for development to proceed.   
The cancers evaluated in this report were selected based on their potential association with 
contaminants of concern identified at the OCRR site and residents’ concerns about cancer in 
surrounding neighborhoods and the Ashley Drive area.  Although conservative estimates of 
exposure were determined to be unlikely to result in adverse health effects or increased cancer 
risk, certain cancer types (e.g., bladder, kidney, liver, lung and bronchus) were evaluated because 
of known or suspected links to contaminants identified at the site.  None of the eight cancer types 
evaluated were statistically significantly elevated in the census tract that contains the OCRR site 
(CT 5231), and the majority occurred approximately as expected.  For example, CT 5231 had no 
diagnoses of liver cancer, which has been associated with PCB and arsenic exposure.  Kidney 
cancer, which has been linked to arsenic and lead exposure, occurred less often than expected.  
Bladder cancer and lung and bronchus cancer, which have been associated with arsenic, were 
slightly elevated; however, the risk factor analysis suggested that tobacco use likely played a 
major role in diagnoses of these cancer types for some individuals.   
In the town of East Bridgewater as a whole, cancer incidence rates for the eight cancer types 
evaluated during the 19-year time period, 1982–2000, and the three smaller time periods were 
near expected rates based on cancer incidence in the state of Massachusetts.  No cancer type was 
statistically significantly elevated in CT 5231, where the OCRR site and Alloy Castings are 
located, for any of the time periods.  For East Bridgewater CT 5232.01, there were elevations in 
some cancer types, but none were statistically significant.  Most cancer types occurred 
approximately at or near expected rates in East Bridgewater CT 5232.02, however, a statistically 
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significant elevation was observed among males diagnosed with NHL during the middle time 
period, 1988–1993.  The geographic pattern of NHL did not indicate a concentration or an 
atypical distribution of males diagnosed in this census tract.  Also, there was no indication of a 
temporal trend in elevated NHL among males in this area of East Bridgewater.   
Leukemia among females occurred at a rate that was statistically significantly elevated in East 
Bridgewater as a whole during the middle time period 1988–1993.  The geographic pattern of 
leukemia did not indicate a concentration or an atypical distribution of females diagnosed in the 
area surrounding the OCRR site or Alloy Castings Company or in any other area of town.  Also, 
as previously discussed, leukemia is classified into four main types of disease that have different 
risk factors.  From 1988 to 1993 in East Bridgewater, a variety of leukemia types were 
diagnosed, and no pattern of any one type occurred, nor did the evaluation of geographic 
distribution of cases suggest that environmental factors played a primary role.  In addition, there 
was no trend over time in elevated leukemia among females.  For these reasons, it does not 
appear that the increased occurrence of leukemia observed among females in East Bridgewater 
from 1988 to 1993 is related to a common factor.   
In addition to an evaluation of cancer incidence rates, available risk factor information for those 
diagnosed with cancer was compared to known or established trends to assess whether any 
unexpected patterns existed in East Bridgewater for the time period evaluated.  In general, cancer 
trends observed in East Bridgewater were similar to those seen in the general population and in 
Massachusetts.  Data reviewed suggest that smoking likely played some role in the diagnosis of 
certain cancers (bladder, kidney, and lung and bronchus cancers) among some individuals in East 
Bridgewater.  Also, occupational exposures may have played a role for some individuals in the 
development of certain cancers, such as leukemia, NHL, and cancers of the bladder, brain and 
CNS, kidney, and lung and bronchus.  However, it is difficult to fully assess the extent to which 
these factors influenced overall cancer patterns in East Bridgewater due to incomplete 
information for some risk factors (e.g., occupation).   
Finally, analysis of the geographic distribution of place of residence for individuals diagnosed 
with cancer did not reveal any atypical spatial patterns that would suggest a common factor 
related to the incidence of cancer in East Bridgewater as a whole or in the three census tracts that 
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comprise the town.  That is, no unusual concentrations of individuals diagnosed with the eight 
cancer types evaluated were observed in the vicinity of the OCRR site, Alloy Castings Company, 
the Ashley Drive neighborhood, or any other area in East Bridgewater.  Based on the information 
reviewed in this evaluation, it does not appear that a common factor (environmental or 
nonenvironmental) played a major role in the incidence of cancer in the census tract where the 
OCRR site and Alloy Castings Company are located, in the census tracts that divide the town, or 
in the town of East Bridgewater as a whole during the 19-year time period, 1982–2000.   
IX. CHILD HEALTH CONSIDERATIONS 
ATSDR and MDPH recognize that the unique vulnerabilities of infants and children demand 
special emphasis in communities faced with contamination of their environment.  Children are at 
a greater risk than adults from certain kinds of exposure to hazardous substances emitted from 
waste sites.  They are more likely to be exposed because they play outdoors and because they 
often bring food into contaminated areas.  Because of their smaller stature, they might breathe 
dust, soil, and heavy vapors close to the ground.  Children are also smaller, resulting in higher 
doses of contaminant exposure per body weight.  The developing body systems of children can 
sustain permanent damage if certain toxic exposures occur during critical growth stages.  Most 
importantly, children depend completely on adults for risk identification and management 
decisions, housing decisions, and access to medical care.   
The incidence and patterns of cancer among children in East Bridgewater is discussed in Section 
VII (“Cancer Incidence in East Bridgewater”) of this report.  As discussed before, past exposure 
to onsite and offsite lead, arsenic, and PCB-contaminated surface soil could have been possible 
for children before the EPA completed removal activities in 2001.  In addition, past exposure to 
contaminants in surface water and sediment in the drainage ditch immediately adjacent to some 
Spring Street properties may have been possible for children.  However, it is unlikely that 
anyone would have had contact with soil, surface water, or sediment at the OCRR site for a 
sufficient frequency and duration of time to result in health effects.  Present and future exposures 
are not of concern because contaminated surface soils, surface water, and sediments at the site 
and adjacent residential properties were removed by the EPA.  No other exposures were 
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identified that would indicate that children are more likely than adults to be impacted by either 
the OCRR site or Alloy Castings Company. 
X. LIMITATIONS 
There are several limitations encountered when analyzing environmental data.  These limitations 
make it impossible to determine the role potential exposures to specific contaminants or to 
environmental media harboring those contaminants may have played in the development of an 
individual’s cancer or other health impact.  That is, due to historical and analytical data gaps in 
the environmental data, this type of evaluation cannot conclude what may have caused any one 
individual’s cancer or other illness, whether the cause is environmental, behavioral, viral, 
genetic, or a combination of these factors. 
This public health assessment is an investigation that considers descriptive health outcome data 
for cancer to determine whether the pattern or occurrence of selected cancers is unusual.  The 
purpose of this investigation is to evaluate the patterns of cancer in a geographical context in 
relation to available information about factors, including environmental factors, related to cancer 
to see whether further investigation seems warranted.  Information from descriptive analyses, 
which may suggest that a common etiology (or cause) is possible, can serve to identify areas 
where further public health actions may be warranted.  Inherent limitations in this type of 
analysis and the available data make it impossible to determine the precise causal relationships or 
synergistic roles that may have played a part in the development of individual cancers in these 
communities.  Also, this type of analysis cannot determine what may have caused any one 
individual’s cancer.  Cancers in general have a variety of risk factors known or suggested to be 
related to the etiology (cause) of the disease that could not be evaluated in this report.  It is 
believed that many cancers are related largely to behavioral factors such as cigarette smoking, 
diet, and alcohol consumption.  Other factors associated with cancer are socioeconomic status, 
heredity/genetics, race, and geography.  It is beyond the scope of this report to determine the 
causal relationship of these factors and the development of cancer or other health outcomes in 
East Bridgewater.  
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XI. CONCLUSIONS 
• Although some of the soil, surface water, and sediment at the OCRR site were 
contaminated in the past, the remediation activities conducted to date make it unlikely 
that individuals visiting or residing in neighborhoods adjacent to the site would be 
exposed presently or in the future.   
• Past intermittent exposures to onsite surface soil, surface water, and sediment and offsite 
surface soil may have been possible for trespassers, former workers, or residents living 
on adjacent properties.  However, based on the contaminant levels detected and the 
frequency and duration of contact assumed, it is unlikely that potential exposures related 
to the OCRR site would have resulted in adverse health effects.   
• Potential exposure to vinyl chloride volatilized to indoor air may be possible for 
downgradient Spring Street residents if the contaminant is present in shallow 
groundwater beneath homes at concentrations similar to those detected in onsite 
monitoring wells in 1988.  The MDEP reported that an investigation of the presence of 
VOCs in groundwater south of the site is being conducted (G. Martin, MDEP, personal 
communication, 2007).  These data should help to address this potential exposure 
pathway.   
• Trespassers could incur physical harm on the OCRR site because an 800-foot section of 
the fencing surrounding the property has fallen down and buildings and equipment in 
disrepair remain onsite.   
• If future redevelopment or changes in land use, such as a recreational rail trail, result in 
subsurface activities on the OCRR site, it is possible that construction and utility workers 
might have contact with onsite subsurface soil contaminants, such as arsenic, lead, PCBs, 
and PAHs.   
• In general, the eight cancer types evaluated in relation to the OCRR site or due to 
community concerns occurred near expected rates for the town of East Bridgewater as a 
whole and for the census tracts that comprise the town during the 19-year time period, 
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1982–2000.  In addition, none of the cancer types that are associated in the scientific 
literature with contaminants of concern identified at the OCRR site were statistically 
significantly elevated in CT 5231.  
• Leukemia was statistically significantly elevated among females in East Bridgewater as a 
whole during the middle time period, 1988–1993.  However, no apparent geographic 
concentrations of cases were noted and a variety of different subtypes of leukemia were 
represented, indicating the occurrence of different diseases.  
• Review of the geographic distribution of each of the cancer types in East Bridgewater 
revealed no apparent spatial patterns at the neighborhood level.  Further, no unusual 
concentrations of individuals diagnosed with cancer were observed in the vicinity of the 
OCRR site, Alloy Castings Company, in the Ashley Drive area, or in any other area of 
East Bridgewater.  
• Based on the information reviewed in this evaluation, including available environmental 
data for the OCRR site and risk factor information for individuals diagnosed with cancer, 
it does not appear that a common factor (environmental or nonenvironmental) played a 
major role in the incidence of cancer in the census tract containing the OCRR site and 
Alloy Castings Company or in the town of East Bridgewater as a whole during the 19-
year time period, 1982–2000.  
ATSDR requires that one of five conclusion categories be used to summarize findings of a 
public health assessment.  These categories are as follows: (1) Urgent Public Health Hazard; 
(2) Public Health Hazard; (3) Indeterminate Public Health Hazard; (4) No Apparent Public 
Health Hazard; (5) No Public Health Hazard.  A category is selected from site-specific 
conditions such as the degree of public health hazard based on the presence and duration of 
human exposure, contaminant concentration, the nature of toxic effects associated with site-
related contaminants, presence of physical hazards, and community health concerns.  
Therefore, based on MDPH’s evaluation of the available environmental data, the exposure 
pathway analysis, and risk factor information related to the cancer types evaluated in this 
analysis, ATSDR would classify the OCRR site, in the past, present, and future, as posing an 
Indeterminate Public Health Hazard.  This conclusion category was chosen based on a data 
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gap related to the potential for the presence of vinyl chloride in groundwater to the south of 
the OCRR site. 
XII. RECOMMENDATIONS 
• Because there are buildings and equipment in disrepair on the OCRR site, the fencing 
that surrounds the site should be properly maintained in order to prevent physical harm to 
potential trespassers.  
• The MDEP reported that the Town of East Bridgewater is conducting an assessment of 
the presence of VOCs in groundwater to the south of the OCRR site (G. Martin, MDEP, 
personal communication, 2007).  Upon request, the MDPH will review new groundwater 
data related to VOCs as they become available in order to assess potential exposure 
opportunities to vinyl chloride in indoor air for residents of downgradient Spring Street 
homes.     
• Any future development or changes in land use that result in subsurface activities at the 
OCRR site should be undertaken using proper health and safety precautions in order to 
minimize potential exposure to subsurface soil contaminants, or additional site cleanup 
may be required.      
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XIII. PUBLIC HEALTH ACTION PLAN 
The Public Health Action Plan for East Bridgewater, Massachusetts, contains recommendations 
for actions to be taken at and in the vicinity of the OCRR site and Alloy Castings Company.  The 
purpose of the Public Health Action Plan is to ensure that this public health assessment not only 
identifies potential public health hazards, but also provides a plan of action designed to mitigate 
and prevent adverse human health effects resulting from exposure to hazardous substances in the 
environment.  Included is a commitment on the part of the ATSDR/MDPH to follow up on this 
plan to ensure that it is implemented.  The public health actions to be implemented by 
ATSDR/MDPH are as follows: 
• Should new groundwater data be generated for VOCs in groundwater to the south of the 
OCRR site, upon request, the MDPH will assess potential exposure opportunities to vinyl 
chloride in indoor air upon request.  
• The MDPH will continue to monitor the incidence of all cancer types in the town of East 
Bridgewater through city/town cancer incidence reports published by the Massachusetts 
Cancer Registry. 
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MAPPED/NOT 
MAPPED SPILL ID RTN LOCATION AID ADDRESS  DATE MATERIALS SOURCES STATUS
MAPPED S88-0069 NA RESIDENCE 82 CROSS STREET 02/10/1988 #2 FUEL OIL AST UNKNOWN
MAPPED S88-0810 4-0751
APARTMENT & 
RETAIL STORES 55 NORTH BEDFORD STREET UNKNOWN METALS UNKNOWN UNKNOWN
MAPPED S89-0122 4-0860
CONRAD'S SERV 
STATION 49 CENTRAL ST 03/01/1989 GASOLINE UNKNOWN UNKNOWN
MAPPED S89-0761 NA ROADWAY 234 THATCHER ST 10/27/1989 DIESEL FUEL OTHER SOURCE: FUEL LINE UNKNOWN
MAPPED S90-0022 NA PROPERTY 582 WEST ST 07/15/1989 #2 FUEL OIL AST UNKNOWN
MAPPED S90-0113 NA
E BRIDGEWATER 
LANDFILL E BRIDGEWATER LANDFILL 02/17/1990 UNKNOWN: UNKNOWN
OTHER SOURCE: LEACHATE 
VENTS UNKNOWN
MAPPED S90-0152 NA FIRE STATION 268 BEDFORD ST UNKNOWN #2 FUEL OIL UNKNOWN UNKNOWN
MAPPED S90-0304 NA
PROPERTY/RESID
ENCE 90 HOBART ST 04/26/1990 #2 FUEL OIL (51-100 GALLONS) AST UNKNOWN
MAPPED S90-0410 NA BFI LANDFILL THATCHER ST UNKNOWN OTHER MATERIAL: FLUFF
OTHER SOURCE: 
TRANSPORTING UNKNOWN
MAPPED S90-0429 NA PROPERTY 475 POND ST UNKNOWN
OTHER MATERIAL: 
REFUSE/DRUM STORAGE
OTHER SOURCE: 
REFUSE/DRUMS UNKNOWN
MAPPED S90-0526 NA
PROPERTY/RESID
ENCE 115 SPRING ST UNKNOWN
UNKNOWN: UNKNOWN 
SUBSTANCE
OTHER SOURCE: RUST 
COLOR SUB UNKNOWN
MAPPED S90-0535 NA PROPERTY 396 HIGHLAND ST 07/19/1990
UNKNOWN: UNKNOWN 
MATERIAL
OTHER SOURCE: TREES 
DYING UNKNOWN
MAPPED S90-0731 NA ROADWAY 768 CENTRAL ST 10/03/1990 DIESEL FUEL VEH. FUEL TANK UNKNOWN
MAPPED S90-0783 NA ROADWAY 709 CENTRAL ST 10/19/1990 WASTE OIL
OTHER SOURCE: 
CONTAINERS UNKNOWN
MAPPED S91-0015 NA MUELLER CORP 530 SPRING ST UNKNOWN MISCELLANEOUS OIL PIPE/HOSE/LINE UNKNOWN
MAPPED S91-0304 NA WATERWAY SATUCKET RIVER/RTE 106 05/31/1991 OTHER MATERIAL: OIL SHEEN OTHER SOURCE: UNKNOWN UNKNOWN
MAPPED S91-0549 4-1311 PROPERTY RT 18, 117 N. BEDFORD ST UNKNOWN #2 FUEL OIL UST UNKNOWN
MAPPED S92-0006 NA TRANSFORMER 635 PLYMOUTH ST 01/04/1992
TRANSFORMER OIL (11-50 
GALLONS) TRANSFORMER UNKNOWN
MAPPED S92-0228 NA
FOXBORO 
COMPANY 600 N BEDFORD ST UNKNOWN #6 FUEL OIL UST UNKNOWN
MAPPED S92-0293 NA PROPERTY 103 EAST ST UNKNOWN LUBRICATING OIL OTHER SOURCE: DUMPING UNKNOWN
MAPPED S92-0478 NA
BATTI'S AUTO 
BODY 26 NORTH CENTRAL ST UNKNOWN GASOLINE UNKNOWN UNKNOWN
Table 1
Massachusetts Department of Environmental Protection 21E Hazardous Material and Oil Releases
 East Bridgewater, Massachusetts  
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Table 1 (Continued)
MAPPED/NOT 
MAPPED SPILL ID RTN LOCATION AID ADDRESS  DATE MATERIALS SOURCES STATUS
MAPPED S92-0525 NA
GENERAL MAIL 
FACILITY W UNION ST (E OF PEARL ST) UNKNOWN
OTHER MATERIAL: PETROLEUM 
HYDROCARBONS (251-500 )
OTHER SOURCE: FOUNDRY 
FILL UNKNOWN
MAPPED S92-0693 NA
SHAW'S 
SUPERMARKET 140 LAUREL ST 09/28/1992 DIESEL FUEL UST UNKNOWN
MAPPED S93-0090 NA FOXBORO CORP 600 N BEDFORD ST 11/09/1992 #4 FUEL OIL AST UNKNOWN
MAPPED S93-0110 NA ROADWAY N CENTRAL @ WILLOW AVE 02/21/1993 HYDRAULIC FLUID DRUM UNKNOWN
MAPPED S93-0539 9-9999 FLINT & SON AUTO NORTH CENTAL ST 07/29/1993 GASOLINE VEH. FUEL TANK UNKNOWN
MAPPED NA 4-0000060
MURRAY CARVER 
LANDFILL 15 WHITMAN ST 01/15/87
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE UNKNOWN ADQREG
MAPPED NA 4-0000061
E BRIDGEWATER 
LANDFILL BRIDGE ST 01/15/87
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE UNKNOWN ADQREG
MAPPED NA 4-0000526
COUNTRY 
CONVENIENCE 
STORE 
(COMMERCIAL) 210 POND ST 03/23/88 PETROLEUM BASED OIL UST TIER1C
MAPPED NA 4-0000594
PRECISE 
ENGINEERING 
(COMMERCIAL) 24 WEST UNION ST 01/15/89
UNKNOWN CHEMICAL OF TYPE - 
OIL; UNKNOWN CHEMICAL OF 
TYPE - HAZARDOUS MATERIAL UNKNOWN TIER1A
MAPPED NA 4-0000751
APARTMENTS & 
RETAIL STORES 
(COMMERCIAL; 
FORMER; 
FOUNDRY; 
RESIDNTIAL; 
WETLANDS) 55 NORTH BEDFORD ST 07/15/89
UNKNOWN CHEMICAL OF TYPE - 
HAZARDOUS MATERIAL UNCONTAIN; UNKNOWN RAO
MAPPED NA 4-0000860
CONRAD'S CITGO 
STATION 
(GASSTATION) 49 CENTRAL ST 03/23/89 GASOLINE UST TIER1C
MAPPED NA 4-0001311
SKIPS GAS & 
DIESEL 
(GASSTATION) 117 NORTH BEDFORD ST 07/15/93
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE UST RAO
MAPPED NA 4-0010354
CUMBERLAND 
FARMS 
(COMMERCIAL) 1055 WASHINGTON ST 03/28/94
GASOLINE (135 PPM); LEAD (.59 
PPM) UST RAO
MAPPED NA 4-0010458
CARRIAGE 
CROSSING PLAZA 
(COMMERCIAL) 225 BEDFORD ST 05/06/94
ETHENE, TETRACHLORO- (10 
GAL); ETHENE, TETRACHLORO- 
(10 GAL) PIPE RAO
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Table 1 (Continued)
MAPPED/NOT 
MAPPED SPILL ID RTN LOCATION AID ADDRESS  DATE MATERIALS SOURCES STATUS
MAPPED NA 4-0010463
SELF SERVE GAS 
STATION 
(COMMERCIAL; 
RESIDNTIAL) 475 NORTH BEDFORD ST 04/04/94
BENZENE (3300 PPB); BENZENE, 
METHYL- (16000 PPB); BENZENE, 
ETHYL- (3500 PPB); BENZENE, 
DIMETHYL (16000 PPB); 
PROPANE, 2-METHOXY-2-
METHYL- (8500 PPB); UNKNOWN 
CHEMICAL OF TYPE - 
HAZARDOUS MATERIAL (8500 
PPB) UST RAO
MAPPED NA 4-0010473
OFF PLEASANT ST 
(ROADWAY) 100 SUMMER ST 05/10/94
UNKNOWN CHEMICAL OF 
UNKNOWN TYPE (50 GAL) PIPE RAO
MAPPED NA 4-0010517
BLDG 5 
(INDUSTRIAL) 600 NORTH BEDFORD ST 05/26/94
FUEL OIL #2 (40 GAL); FUEL OIL 
#2 (15 GAL) PIPE RAO
MAPPED NA 4-0010811
NO LOCATION AID 
(RESIDNTIAL) 855 CENTRAL ST 10/01/94 GASOLINE (10 GAL) VEHICLE RAO
MAPPED NA 4-0010832
EAST 
BRIDGEWATER 
FIRE STATION 
(MUNICIPAL) 268 BEDFORD ST RTE 18 10/11/94
TOTAL PETROLEUM 
HYDROCARBONS (TPH) (50 
PPMV); FUEL OIL #2 PIPE RAO
MAPPED NA 4-0010943
AUGUST 
INTERIORS INC 
(INDUSTRIAL) 523 SPRING ST 11/22/94
FUEL OIL #2 (130 PPM); PHENOL, 
PENTACHLORO- (33 PPM) 8K GALCAP; UST RAO
MAPPED NA 4-0010944
NO LOCATION AID 
(RESIDNTIAL) 4 LYNN LEE TER 11/22/94 FUEL OIL #2 (25 GAL) AST RAO
MAPPED NA 4-0012061
HOPPYS SERVICE 
STA FMR 
(COMMERCIAL) 1325 PLYMOUTH ST 04/05/96 OIL AST; DRUMS RAO
MAPPED NA 4-0012116
NEXT TO EASTERN 
STATES STEEL 
(ABANSITE; 
INDUSTRIAL) 24 WEST UNION ST 04/24/96
1,1'-BIPHENYL, CHLORO-DERIVS. 
(110 MG/KG); ARSENIC (43 
MG/KG); LEAD (1100 MG/KG) UNKNOWN RAONR
MAPPED NA 4-0012315
AUGUST 
INTERIORS 523 SPRING ST 05/30/96
PHENOL, PENTACHLORO- (33 
PPM) UNKNOWN RAO
MAPPED NA 4-0012369
COMMERCIAL 
PROPERTY 
(COMMERCIAL) 4-6 WEST UNION ST 07/24/96 FUEL OIL #2 UST TIERII
MAPPED NA 4-0012450
EASTERN STATES 
STEEL 
(INDUSTRIAL) 36 COOK ST 08/23/96
UNKNOWN CHEMICAL OF TYPE - 
HAZARDOUS MATERIAL
DRUMS; NUMEROUS; 
UNKNOWN RAO
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Table 1 (Continued)
MAPPED/NOT 
MAPPED SPILL ID RTN LOCATION AID ADDRESS  DATE MATERIALS SOURCES STATUS
MAPPED NA 4-0012862
MARTELL 
RESIDENCE 
(RESIDNTIAL) 494 BEDFORD ST RTE 18 02/25/97 FUEL OIL #2 (150 GAL) AST RAO
MAPPED NA 4-0012940
EASTERN STATES 
STEEL 36 COOK ST 04/04/97
BENZ[A]ANTHRACENE (23 PPM); 
BENZ[E]ACEPHENANTHRYLENE 
(58 PPM); BENZO[A]PYRENE (29 
PPM); CHRYSENE (24 PPM); 
INDENO(1,2,3-CD)PYRENE (29 
PPM); DIBENZ[A,H]ANTHRACENE 
(6.5 PPM) UNKNOWN TIER1D
MAPPED NA 4-0013087
EASTERN STATES 
STEEL 
(COMMERCIAL) 36 COOK ST 06/11/97
1,1'-BIPHENYL, CHLORO-DERIVS. 
(1000 PPM); ARSENIC (110 PPM) UNKNOWN TIER1D
MAPPED NA 4-0013479
NO LOCATION AID 
(COMMERCIAL) 378 PLEASANT ST 11/12/97 WASTE OIL (173 PPMV) UST RAO
MAPPED NA 4-0013797
CUMBERLAND 
FARMS 
(COMMERCIAL) 1055 WASHINGTON ST 04/13/98 GASOLINE (100 PPM) UST REMOPS
MAPPED NA 4-0014224
NO LOCATION AID 
(INDUSTRIAL) 394 SPRING ST 10/02/98 WASTE OIL (50 GAL) DRUMS RAO
MAPPED NA 4-0014476
D&J TRUCKING 
(COMMERCIAL) 498 BEDFORD ST 01/17/99 FUEL OIL #2 (200 GAL) AST RAO
MAPPED NA 4-0015302
NO LOCATION AID 
(ROADWAY) 1668 CENTRAL ST 02/15/00 DIESEL FUEL (70 GAL) SADDLETANK RAO
MAPPED NA 4-0015508
PRIME ENERGY 
(COMMERCIAL) 49 CENTRAL ST 05/28/00 GASOLINE (20 GAL) UST RAO
MAPPED NA 4-0015548
NO LOCATION AID 
(RESIDNTIAL) 281 SPRING ST 06/16/00 FUEL OIL #2 (25 GAL) AST; PIPE RAO
MAPPED NA 4-0016093 CENTRAL SCHOOL 107 CENTRAL ST 03/01/01 FUEL OIL #2 (75 GAL) AST RAO
MAPPED NA 4-0016318 NO LOCATION AID 600 NORTH BEDFORD ST 06/18/01
ETHENE, 1,1-DICHLORO- (3.4 
PPB); BENZO(K)FLUORANTHENE 
(5.4 PPM) RAO
MAPPED NA 4-0016805 BFI LANDFILL 234 THATCHER ST 12/19/01 FUEL OIL #2 (100 PPM) PIPE; UST RAO
MAPPED NA 4-0016937
NO LOCATION AID 
(COMMERCIAL) 49 CENTRAL ST 03/08/02 GASOLINE (70.2 GAL) UNKNOWN TCLASS
MAPPED NA 4-0017187
SHAW'S 
DISTRIBUTION 
CENTER 140 LAUREL ST 06/27/02
CADMIUM (7.4 PPB); NICKEL (170 
PPB); ZINC (2400 PPB) UNKNOWN TIER1C  
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Table 1 (Continued)
MAPPED/NOT 
MAPPED SPILL ID RTN LOCATION AID ADDRESS  DATE MATERIALS SOURCES STATUS
MAPPED NA 4-0017840
IN FRONT OF # 75 
LEAF LN 
(ROADWAY) LEAF LN 06/02/03
UNKNOWN CHEMICAL OF TYPE - 
HAZARDOUS MATERIAL (20 GAL) PIPE UNCLSS
NOT MAPPED S88-0054 4-0526 UNKNOWN 210 FORD ST 02/02/1988 GASOLINE UST UNKNOWN
NOT MAPPED S89-0067 NA UNKNOWN
OFF HUDSON STREET NEAR 
HANSON UNKNOWN UNKNOWN DRUM UNKNOWN
NOT MAPPED S89-0828 NA ROADWAY WASHINGTON ST 11/26/1989 #2 FUEL OIL (SHEEN ) OTHER SOURCE: UNKNOWN UNKNOWN
NOT MAPPED S90-0453 NA PROPERTY OFF POND ST UNKNOWN
OTHER MATERIAL: SUSPECTED 
WASTE OIL DRUM UNKNOWN
NOT MAPPED S91-0284 NA TRANSFORMER BRIDGE ST - POLE 23 05/22/1991 TRANSFORMER OIL TRANSFORMER UNKNOWN
NOT MAPPED NA 4-0012198
POLE #26 
(ROADWAY) ELM ST 05/22/96
UNKNOWN CHEMICAL OF TYPE - 
OIL (20 GAL) TRANSFORM RAO
NOT MAPPED NA 4-0012727
POLE #9 
(RESIDNTIAL; 
ROADWAY) ELM ST 12/23/96
UNKNOWN CHEMICAL OF TYPE - 
OIL (22 GAL) TRANSFORM RAO
NOT MAPPED NA 4-0012933
POLE #2 
(RESIDNTIAL) KINGMAN CIR 04/02/97
UNKNOWN CHEMICAL OF TYPE - 
OIL (21 GAL) TRANSFORM RAO
Source:  MDEP Bureau of Waste Site Cleanup. 2004.  Downloadable Site Lists.  http://www.state.ma.us/dep/bwsc/sites/sdown.htm
Notes:
Spill ID - Spill Identification Number (applicable for releases reported prior to October 1993).  Definition: NA Not Applicable
RTN - Release Tracking Number.  Unique ID number assigned to releases not remediated by October 1993 and to those occuring October 1993-present.  Definition: NA Not Applicable. 
Location Aid - Place name of release
Address - Street location of release
Date - Date of release (releases prior to October 1993), or date release was reported to MDEP (for releases occurring October 1993-present)
Materials - Chemical(s) in release
Sources - Origin(s) of release contamination.  Definitions: AST Aboveground Storage Tank; UST Underground Storage Tank. 
Status - Remediation status of release.  Definitions: ADQREG Adequately Regulated; DEFT1B Default Tier 1B; DEPMOU DEP Memorandum of Understanding; DEPNDS Not a Disposal Site (DEP); DEPNFA No 
Further Action (DEP Determined); DPS Downgradient Property Status; DPSTRM Downgradient Property Status Terminated; INVSUB Submittal Invalidated by DEP; LSPNFA LSP No Further Action; PENNDS 
Pending Not a Disposal Site; PENNFA Pending No Further Action; RAO Release Action Outcome; RAONR Response Action Outcome Not Required; REMOPS Remedy Operation Status; SPECPR Special Project; 
STMRET Response Action Outcome Statement Retracted; TCLASS Tier Classification; TIER1A Tier 1A; TIER1B Tier 1B; TIER1C Tier 1C; TIERII Tier II; UNCLSS Unclassified; WCSPRM Waiver Completion 
Statement Permanent.
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Contaminant
Sample 
depth 
(feet)
Date of 
sample
Descriptive location of 
sample
Maximum 
concentration 
(ppm)
Background soil levels 
(ppm)
RMEG (child) = 20
RMEG (adult) = 300
Arochlor 1248 0.5 6/3/1997 S-3 (soil pile on ESS property) 690 Total PCBs: CREG = 0.4 -
Chronic EMEG (child) = 1
Chronic EMEG (adult) = 10
Arochlor 1260 0.5 6/3/1997 S-9 (soil pile on ESS property) 2.7 Total PCBs: CREG = 0.4 -
CREG = 0.5
Chronic EMEG (child), RMEG (child) = 20
Chronic EMEG (adult), RMEG (adult) = 200
0.005 - 0.02 (rural soil)
0.169 - 59 (urban soil)
0.002 - 1.3 (rural soil)
0.165 - 0.22 (urban soil)
0.02-0.03 (rural soil)
15 - 62 (urban soil)
0.01 -0.11 (rural soil)
0.3-26 (urban soil)
Chronic EMEG (child) = 10
Chronic EMEG (adult) = 100
Hexavalent Chromium: RMEG (child) = 200
Hexavlent Chromium: RMEG (adult) = 2,000
Dibenzo(a,h)anthracene 4-8 8/1997 TP-D (south of ESS main building) 11 EPA RBC (residential) = 0.087 -
0.01 - 0.015 (rural soil)
8.0 - 61 (urban soil)
PCBs (total) 0-0.25 9/1999 C 400 (northeast corner of ESS property) 22,500 CREG = 0.4 -
18,100 S-1 & GW-1 MDEP standard = 300Lead 0-1 11/18/1997 SP-1 (soil pile on PE property)
= 0.87
Benzo(k)fluoranthene 4-8 8/1997 TP-D (south of ESS main building) 27 EPA RBC (residential) = 0.87
Benzo(b)fluoranthene 4-8 8/1997 TP-D (south of ESS main building)
Benzo(a)pyrene 4-8 8/1997 TP-D (south of ESS main building)
Benzo(a)anthracene 4-8 8/1997 TP-D (south of ESS main building)
-
Comparison value (ppm)
20.7
33
42 CREG = 0.1
65 EPA RBC (residential)
Arochlor 1254 0.5
Arsenic 18,1004
= 0.87
0.01 - 1
Indeno(1,2,3-c,d)pyrene
<0.1 - 73*
EPA RBC (residential)
<10 - 300*
29 EPA RBC (residential)
Cadmium 0-1 11/18/1997
0-7 12/19/1985 composite of Test Pits A,B,C,D (ESS property)
SP-4 (soil pile on PE 
property)
= 0.87
8/1997 ESS property near former underground storage tanks
SP-2 (soil pile on PE 
property) 26.3
6/3/1997 S-3 (soil pile on ESS property)
11/18/1997 <1 - 8.8*
Chromium (total) 0-1 11/18/1997 SP-4 (soil pile on PE property) 428 1 - 1000*
†
Antimony 0-1
310
Table 2
Maximum concentrations of contaminants detected in onsite soil
samples at the Old Colony Railroad site that exceeded comparison values (samples taken from 1985-2000) 
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CREG = 0.02
Chronic EMEG (child); RMEG (child) = 3
Chronic EMEG (Adult), RMEG (adult) = 10
MDEP MMCL = 50
CREG = 0.6
MDEP MMCL = 5
Chronic EMEG (child) = 2
Chronic EMEG (adult) = 7
MDEP MMCL = 5
Hexavalent Chromium: RMEG (child) = 30
Hexavalent Chromium: RMEG (adult) = 300
MDEP MMCL = 100
Intermediate EMEG (child) = 3,000
Intermediate EMEG (adult) = 10,000
EPA RBC (tap water) = 61
MDEP MMCL = 70
Intermediate EMEG (child) = 2,000
Intermediate EMEG (adult) = 7,000
RMEG (child) = 200
RMEG (adult) = 700
  MDEP MMCL = 100
MCLG = 0
MDEP MMCL = 15
MDEP MMCL = 2
Methylmercury: Chronic EMEG (child) = 3
Methylmercury: Chronic EMEG (adult) = 10
RMEG (child) = 100
RMEG (adult) = 400
EPA RBC (tap water) = 0.1
MDEP MMCL = 5
1,2-Dichloroethylene, trans- 2/22/1988
10
Benzene 2/22/1988 OW-2 (PE property near chlorinated solvent storage) 18.4
Arsenic 2/22/1988 Composite of OW-1, OW-2, OW-3 (PE property)
Tetrachlorethylene 12/11/1997 SEA-2S (PE property) 186
60Cadmium 3/19/1996 OW-5 (PE property)
Drinking water comparison value (ppb)Contaminant Date of sample Descriptive location of sample
Maximum 
concentration (ppb)
1,020
Lead 3/19/1996
Mercury 2/22/1988
OW-5 (PE property)
OW-3 (PE property near former UST)
65
Chromium 3/19/1996 OW-5 (PE property) 90
1,2-Dichloroethylene, cis- 3/19/1996 OW-3 (PE property near former UST)
100
Composite of OW-1, OW-2, OW-3 (PE property) 140
Table 3
Maximum concentrations of contaminants detected in onsite groundwater samples at the Old Colony Railroad site
that exceeded comparison values  (samples taken from 1985-1999) 
†Background soil level for total chromium
ppm = parts per million
PE = Precise Engineering
< = less than
ESS = Eastern States Steel
PCBs = polychlorinated biphenyls
EPA RBC = EPA Region 3 Risk Based Concentration for soil (U.S. EPA, U.S. EPA 2004)
Data sources:  
Unless otherwise noted, soil background concentrations are from ATSDR Toxicological Profiles 2003 (on CD-ROM), ATSDR 2003.  
*Observed range for the Eastern United States (east of 96th meridian). USGS. Shacklette HT, Boerngen JG. 1984. Element Concentrations in Soils and Other Surficial Materials of the 
conterminous United States. U.S. Geological Survey Professional Paper 1270. Washington: United States Government Printing Office, 1984.  
Table 2 (Continued)
RMEG (adult/child) = Reference Dose Media Evaluation Guide (an estimate of a daily exposure to the general public, including sensitive subgroups, that is likely to be witho t appreciable risk 
of deleterious effects during a specified duration of exposure). (ATSDR, ATSDR 2003b)
Comparison values (source organization, reference):
Cambridge Analytical Associates. 1986. Draft: Environmental Site Assessment, Eastern States Steel, 36 Cook Street, East Bridgewater, Massachusetts. 
SEA Consultants, Inc. 1996. Phase I: Site Investigation, Precise Engineering, 24 West Union Street, East Bridgewater, Massachusetts.  
Cambridge Environmental, Inc. 1998. Method 3 Risk Characterization for the Precise Engineering Site, East Bridgewater, Massachusetts.  
Horsley and Witten, Inc. 1998. Scope of Work: Environmental Site Assessment, Eastern States Steel (RTN 4-12940), 36 Cook Street, East Bridgewater, Massachusetts.  
S-1 & GW-1 MDEP standard = Massachusetts Contingency Plan Method 1 soil category S-1 standards [310 CMR 40.0975(6)(a)] [Massachusetts Department of Environmental Protection 
(MDEP), MDEP 2003]
CREG = Cancer Risk Evaluation Guide for 1 x 10-6 excess cancer risk (ATSDR, ATSDR 2003b)
Chronic EMEG (adult/child) = Environmental Media Evaluation Guide (i.e., for adult or childhood exposures mirroring greater than 1 year) (ATSDR, ATSDR 2003b)
SEA Consultants, Inc. 1997. Phase II: Scope of Work, Precise Engineering. 
SEA Consultants, Inc. 1998. Phase II: Comprehensive Site Assessment, Precise Engineering. 
Roy F. Weston, Inc. 2001. Removal Program: Preliminary Assessment/Site Investigation Report for the Old Colony Railroad Site.  
Kupferman and Weber, Inc. 1990. Environmental Site Assessment: Update, 36 Cook Street, E. Bridgewater, Massachusetts. 
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Table 3 (Continued)
EPA RBC (tap water) = 0.026
MCLG = 0
MDEP MMCL = 5
CREG = 0.03
Chronic EMEG (child) = 0.2
Chronic EMEG (adult) = 0.7
MCLG = 0
MDEP MMCL = 2
ppb = parts per billion
PE = Precise Engineering
UST = Underground Storage Tank
Data sources:   
Intermediate EMEG (adult) = Environmental Media Evaluation Guide for adults (i.e., for exposures between 14 days and 1 year) (ATSDR, ATSDR 2003a)
EPA RBC = EPA Region 3 Risk Based Concentration for tap water (U.S. EPA, U.S. EPA 2004a)
MCLG = Maximum Contaminant Level Goal for drinking water (U.S. EPA, ATSDR 2003a)
Drinking water comparison value (ppb)Descriptive location of sample Maximum concentration (ppb)
Vinyl Chloride 2/22/1988 OW-3 (PE property near former UST) 1,170
313OW-3 (PE property near former UST)
MDEP MMCL = Massachusetts Department of Environmental Protection Massachusetts Maxiumum Contaminant Level for drinking water (MDEP, MDEP 2001)
RMEG (adult/child) = Reference Dose Media Evaluation Guides (an estimate of a daily exposure to the general public, including sensitive subgroups, that is likely to be without 
appreciable risk of deleterious effects during a specified duration of exposure). (ATSDR 2003a)
Chronic EMEG (adult/child) = Environmental Media Evaluation Guide (i.e., for adult or childhood exposures mirroring greater than 1 year) (ATSDR 2003a)
Comparison values (source organization, reference):
Intermediate EMEG (child) = Environmental Media Evaluation Guide for children (i.e., for exposures between 14 days and 1 year and considers vulnerabilities of children when it 
comes to environmental exposures). (ATSDR, ATSDR 2003a)
CREG = Cancer Risk Evaluation Guide for 1 x 10-6 excess cancer risk (ATSDR, ATSDR 2003a)
Trichloroethylene 2/22/1988
Contaminant Date of sample
Cambridge Analytical Associates.  1986.  Draft: Environmental Site Assessment, Eastern States Steel, 36 Cook Street, East Bridgewater, Massachusetts. 
SEA Consultants, Inc.  1996.  Phase I: Site Investigation, Precise Engineering, 24 West Union Street, East Bridgewater, Massachusetts.  
SEA Consultants, Inc.  1997.  Phase II: Scope of Work, Precise Engineering. 
SEA Consultants, Inc.  1998.  Phase II: Comprehensive Site Assessment, Precise Engineering. 
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Intermediate EMEG (child) = 2,000
Intermediate EMEG (adult) = 7,000
RMEG (child) = 200
RMEG (adult) = 700
MDEP MMCL = 100
RMEG (child) = 100
RMEG (adult) = 400
EPA RBC = 1.1
MDEP MMCL = 5
EPA RBC = 1.6
MCLG = 0
MDEP MMCL = 5
MCLG = 0
CREG = 0.03
Chronic EMEG (child) = 0.2
Chronic EMEG (adult) = 0.7
MDEP MMCL = 2
ppb = parts per billion
Data sources:   
SEA Consultants, Inc.  1997.  Phase II: Scope of Work, Precise Engineering. 
SEA Consultants, Inc.  1998.  Phase II: Comprehensive Site Assessment, Precise Engineering. 
EPA RBC = EPA Region 3 Risk Based Concentration for tap water U.S. EPA, U. S. EPA 2004)
176
Comparison values (source organization, reference):
5/27/1988Trichloroethylene 59.7Downstream reach of drainage ditch
14.5
Tetrachlorethylene
1,2-Dichloroethylene, 
trans- 5/27/1988 Downstream reach of drainage ditch 145
Drinking water comparison value (ppb)Contaminant Date of sample Descriptive location of sample Maximum concentration (ppb)
Intermediate EMEG (child) = Environmental Media Evaluation Guide for children (i.e., for exposures between 14 days and 1 year and considers vulnerabilities of 
children when it comes to environmental exposures).(ATSDR, ATSDR 2003a)
Intermediate EMEG (adult) = Environmental Media Evaluation Guide for adults (i.e., for exposures between 14 days and 1 year) (ATSDR, ATSDR 2003a)
CREG = Cancer Risk Evaluation Guide for 1 x 10-6 excess cancer risk (ATSDR, ATSDR 2003a)
MDEP MMCL = Massachusetts Maxiumum Contaminant Level for drinking water (MDEP, MDEP 2001)
MCLG = Maximum Contaminant Level Goal for drinking water (U.S. EPA, ATSDR 2003a)
RMEG (adult/child) = Reference Dose Media Evaluation Guides (an estimate of a daily exposure to the general public, including sensitive subgroups, that is 
likely to be without appreciable risk of deleterious effects during a specified duration of exposure) (ATSDR, ATSDR 2003a)
Chronic EMEG (adult/child) = Environmental Media Evaluation Guide (i.e., for adult or childhood exposures mirroring greater than 1 year) (ATSDR, ATSDR 
2003a)
Vinyl Chloride 5/27/1988 Downstream reach of drainage ditch
5/27/1988 Downstream reach of drainage ditch
Table 4
Maximum concentrations of contaminants detected in onsite surface water samples at the Old Colony Railroad site
that exceeded comparison values  (samples taken from 1988-1998) 
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CREG = 0.5
Chronic EMEG (child), RMEG (child) = 20
Chronic EMEG (adult), RMEG (adult) = 200
Benzo(a)anthracene 11/18/1997 SED-2 (midstream drainage ditch) 8.72 EPA RBC (residential) = 0.87 0.169 - 59 (urban soil)
CREG = 0.1
EPA RBC (residential) = 0.087
Benzo(b)fluoranthene 11/18/1997 SED-2 (midstream drainage ditch) 30.9 EPA RBC (residential) = 0.87 15 - 62 (urban soil)
Dibenzo(a,h)anthracene 11/18/1997 SED-2 (midstream drainage ditch) 49.4 EPA RBC (residential) = 0.087 -
Lead 11/18/1997 SED-1 (upstream drainage ditch) 436 S-1 & GW-1 MDEP standard = 300 160 - 840 (urban soil)
ppm = parts per million
< = less than
Data source:  
Soil background concentrations are from ATSDR Toxicological Profiles 2003 (on CD-ROM), ATSDR 2003.  
EPA RBC = EPA Region 3 Risk Based Concentration for soil (U.S. EPA, U.S. EPA 2004)
RMEG (adult/child) = Reference Dose Media Evaluation Guide (an estimate of a daily exposure to the general public, including sensitive subgroups, that is likely to be without 
appreciable risk of deleterious effects during a specified duration of exposure).  (ATSDR, ATSDR 2003b)
CREG = Cancer Risk Evaluation Guide for 1 x 10-6 excess cancer risk (ATSDR, ATSDR 2003b)
S-1 & GW-1 MDEP standard = Massachusetts Contingency Plan Method 1 soil category S-1 standards [310 CMR 40.0975(6)(a)] [Massachusetts Department of Environmental 
Protection (MDEP), MDEP 2003]
Benzo(a)pyrene
Comparison values (source organization, reference):
SEA Consultants, Inc.  1997.  Phase II: Scope of Work, Precise Engineering. 
11/18/1997
Chronic EMEG (adult/child) = Environmental Media Evaluation Guide (i.e., for adult or childhood exposures mirroring greater than 1 year) (ATSDR,   ATSDR 2003b)
SED-3 (downstream drainage ditch)
Comparison value for soil (ppm) Background soil levels (ppm)
<0.1 - 73
0.165 - 0.22 (urban soil)
Contaminant
Maximum 
concentration 
(ppm)
Date of 
sample Descriptive location of sample
SED-2 (midstream drainage ditch)
Arsenic 42.611/18/1997
19.7
Table 5
Maximum concentrations of contaminants detected in onsite sediment samples at the Old Colony Railroad site that exceeded 
comparison values (samples taken from 1985-1999) 
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 29 29.9 97 65 -- 139 20 21.7 92 56 -- 143 9 8.2 110 50 -- 208
Brain & CNS 9 15.4 58 27 -- 111 6 8.0 74 27 -- 163 3 7.4 NC NC -- NC
Breast 139 135.1 103 86 -- 121 2 0.9 NC NC -- NC 137 134.2 102 86 -- 121
Kidney & Renal Pelvis 18 19.2 94 56 -- 149 10 11.9 84 40 -- 155 8 7.3 110 47 -- 216
Leukemia 22 17.3 127 80 -- 193 10 9.7 103 49 -- 190 12 7.6 158 82 -- 276
Liver 3 4.7 NC NC -- NC 2 3.4 NC NC -- NC 1 1.2 NC NC -- NC
Lung & Bronchus 123 115.6 106 88 -- 127 75 68.9 109 86 -- 136 48 46.7 103 76 -- 136
NHL 36 30.0 121 85 -- 167 22 16.0 138 86 -- 209 14 13.9 101 55 -- 169
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma CNS = Central Nervous System
Data Source: Massachusetts Cancer Registry, Center for Health Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 6a
Cancer Incidence
East Bridgewater, Massachusetts
1982-2000
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 11 9.2 120 60 -- 214 6 6.7 90 33 -- 196 5 2.5 198 64 -- 462
Brain & CNS 3 4.4 NC NC -- NC 2 2.2 NC NC -- NC 1 2.2 NC NC -- NC
Breast 35 33.6 104 73 -- 145 0 0.2 NC NC -- NC 35 33.4 105 73 -- 146
Kidney& Renal Pelvis 1 4.2 NC NC -- NC 0 2.5 NC NC -- NC 1 1.7 NC NC -- NC
Leukemia 5 4.5 111 36 -- 260 3 2.5 NC NC -- NC 2 2.0 NC NC -- NC
Liver 1 0.9 NC NC -- NC 0 0.6 NC NC -- NC 1 0.3 NC NC -- NC
Lung & Bronchus 34 30.2 112 78 -- 157 24 19.6 122 78 -- 182 10 10.6 94 45 -- 173
NHL 9 6.8 133 61 -- 252 7 3.5 197 79 -- 407 2 3.2 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma CNS = Central Nervous System
Data Source: Massachusetts Cancer Registry, Center for Health Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 6b
Cancer Incidence
East Bridgewater, Massachusetts
1982-1987
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 6 9.2 66 24 -- 143 5 6.7 75 24 -- 176 1 2.5 NC NC -- NC
Brain & CNS 1 5.2 NC NC -- NC 0 2.6 NC NC -- NC 1 2.6 NC NC -- NC
Breast 43 42.2 102 74 -- 137 1 0.3 NC NC -- NC 42 42.0 100 72 -- 135
Kidney & Renal Pelvis 7 6.2 114 46 -- 234 3 3.9 NC NC -- NC 4 2.3 NC NC -- NC
Leukemia 9 4.8 178 81 -- 338 3 2.8 NC NC -- NC 6 2.1 289* 105 -- 630
Liver 0 1.3 NC NC -- NC 0 0.9 NC NC -- NC 0 0.3 NC NC -- NC
Lung & Bronchus 34 35.6 96 66 -- 134 18 21.5 84 50 -- 132 16 14.1 114 65 -- 185
NHL 12 9.2 131 68 -- 229 8 5.0 163 70 -- 320 4 4.2 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma CNS = Central Nervous System
Data Source: Massachusetts Cancer Registry, Center for Health Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 6c
Cancer Incidence
East Bridgewater, Massachusetts
1988-1993
 
  
 95
Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 12 11.8 102 52 -- 178 9 8.6 105 48 -- 199 3 3.2 NC NC -- NC
Brain & CNS 5 5.9 85 28 -- 199 4 3.3 NC NC -- NC 1 2.6 NC NC -- NC
Breast 61 60.9 100 77 -- 129 1 0.5 NC NC -- NC 60 60.5 99 76 -- 128
Kidney & Renal Pelvis 10 9.2 109 52 -- 200 7 5.7 122 49 -- 251 3 3.5 NC NC -- NC
Leukemia 8 8.3 97 42 -- 190 4 4.6 NC NC -- NC 4 3.7 NC NC -- NC
Liver 2 2.6 NC NC -- NC 2 2.0 NC NC -- NC 0 0.7 NC NC -- NC
Lung & Bronchus 55 51.7 106 80 -- 138 33 28.6 115 79 -- 162 22 23.1 95 60 -- 144
NHL 15 14.4 104 58 -- 172 7 7.8 90 36 -- 186 8 6.7 120 52 -- 237
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma CNS = Central Nervous System
Data Source: Massachusetts Cancer Registry, Center for Health Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 6d
Cancer Incidence
East Bridgewater, Massachusetts
1994-2000
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 9 7.3 123 56 -- 234 6 5.3 112 41 -- 244 3 1.9 NC NC -- NC
Brain & CNS 1 3.6 NC NC -- NC 1 1.9 NC NC -- NC 0 1.7 NC NC -- NC
Breast 29 30.9 94 63 -- 135 0 0.2 NC NC -- NC 29 30.7 95 63 -- 136
Kidney & Renal Pelvis 3 4.6 NC NC -- NC 1 2.9 NC NC -- NC 2 1.7 NC NC -- NC
Leukemia 4 4.1 NC NC -- NC 1 2.3 NC NC -- NC 3 1.8 NC NC -- NC
Liver 0 1.1 NC NC -- NC 0 0.8 NC NC -- NC 0 0.3 NC NC -- NC
Lung & Bronchus 32 27.9 115 78 -- 162 23 16.9 136 86 -- 204 9 10.9 82 38 -- 156
NHL 10 7.1 142 68 -- 261 4 3.8 NC NC -- NC 6 3.2 185 68 -- 403
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma CNS = Central Nervous System
Data Source: Massachusetts Cancer Registry, Center for Health Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 7a
Cancer Incidence
Census Tract 5231, East Bridgewater, Massachusetts
1982-2000
 
  
 97
Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 5 2.4 211 68 -- 492 3 1.7 NC NC -- NC 2 0.6 NC NC -- NC
Brain & CNS 0 1.1 NC NC -- NC 0 0.6 NC NC -- NC 0 0.5 NC NC -- NC
Breast 11 8.3 133 66 -- 237 0 0.0 NC NC -- NC 11 8.2 133 66 -- 239
Kidney & Renal Pelvis 0 1.1 NC NC -- NC 0 0.7 NC NC -- NC 0 0.4 NC NC -- NC
Leukemia 0 1.1 NC NC -- NC 0 0.6 NC NC -- NC 0 0.5 NC NC -- NC
Liver 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
Lung & Bronchus 8 7.9 101 44 -- 199 7 5.2 135 54 -- 278 1 2.7 NC NC -- NC
NHL 4 1.7 NC NC -- NC 3 0.9 NC NC -- NC 1 0.8 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma CNS = Central Nervous System
Data Source: Massachusetts Cancer Registry, Center for Health Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 7b
Cancer Incidence
Census Tract 5231, East Bridgewater, Massachusetts
1982-1987
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 1 2.3 NC NC -- NC 1 1.7 NC NC -- NC 0 0.6 NC NC -- NC
Brain & CNS 0 1.2 NC NC -- NC 0 0.6 NC NC -- NC 0 0.6 NC NC -- NC
Breast 5 9.8 51 17 -- 119 0 0.1 NC NC -- NC 5 9.7 52 17 -- 120
Kidney & Renal Pelvis 2 1.5 NC NC -- NC 0 1.0 NC NC -- NC 2 0.5 NC NC -- NC
Leukemia 3 1.2 NC NC -- NC 0 0.7 NC NC -- NC 3 0.5 NC NC -- NC
Liver 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
Lung & Bronchus 13 8.8 148 79 -- 254 8 5.4 148 64 -- 291 5 3.3 149 48 -- 349
NHL 3 2.2 NC NC -- NC 1 1.2 NC NC -- NC 2 1.0 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma CNS = Central Nervous System
Data Source: Massachusetts Cancer Registry, Center for Health Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 7c
Cancer Incidence
Census Tract 5231, East Bridgewater, Massachusetts
1988-1993
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 3 2.5 NC NC -- NC 2 1.8 NC NC -- NC 1 0.7 NC NC -- NC
Brain & CNS 1 1.3 NC NC -- NC 1 0.7 NC NC -- NC 0 0.6 NC NC -- NC
Breast 13 13.2 98 52 -- 168 0 0.1 NC NC -- NC 13 13.1 99 53 -- 170
Kidney & Renal Pelvis 1 2.0 NC NC -- NC 1 1.2 NC NC -- NC 0 0.8 NC NC -- NC
Leukemia 1 1.8 NC NC -- NC 1 1.0 NC NC -- NC 0 0.8 NC NC -- NC
Liver 0 0.6 NC NC -- NC 0 0.4 NC NC -- NC 0 0.1 NC NC -- NC
Lung & Bronchus 11 11.1 99 50 -- 178 8 6.1 131 56 -- 257 3 4.9 NC NC -- NC
NHL 3 3.1 NC NC -- NC 0 1.7 NC NC -- NC 3 1.5 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma CNS = Central Nervous System
Data Source: Massachusetts Cancer Registry, Center for Health Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 7d
Cancer Incidence
Census Tract 5231, East Bridgewater, Massachusetts
1994-2000
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 5 7.7 65 21 -- 152 4 5.4 NC NC -- NC 1 2.3 NC NC -- NC
Brain & CNS 3 3.5 NC NC -- NC 3 1.8 NC NC -- NC 0 1.7 NC NC -- NC
Breast 30 32.4 92 62 -- 132 0 0.2 NC NC -- NC 30 32.2 93 63 -- 133
Kidney & Renal Pelvis 1 4.5 NC NC -- NC 1 2.8 NC NC -- NC 0 1.8 NC NC -- NC
Leukemia 5 4.2 118 38 -- 276 3 2.3 NC NC -- NC 2 2.0 NC NC -- NC
Liver 0 1.1 NC NC -- NC 0 0.8 NC NC -- NC 0 0.3 NC NC -- NC
Lung & Bronchus 28 27.5 102 68 -- 147 17 16.4 104 60 -- 166 11 11.1 99 49 -- 177
NHL 6 7.3 83 30 -- 180 3 3.8 NC NC -- NC 3 3.5 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma CNS = Central Nervous System
Data Source: Massachusetts Cancer Registry, Center for Health Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 8a
Cancer Incidence
Census Tract 5232.01, East Bridgewater, Massachusetts
1982-2000
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 0 2.4 NC NC -- NC 0 1.7 NC NC -- NC 0 0.7 NC NC -- NC
Brain & CNS 1 1.0 NC NC -- NC 1 0.5 NC NC -- NC 0 0.5 NC NC -- NC
Breast 7 8.4 84 34 -- 173 0 0.0 NC NC -- NC 7 8.3 84 34 -- 174
Kidney & Renal Pelvis 0 1.0 NC NC -- NC 0 0.6 NC NC -- NC 0 0.4 NC NC -- NC
Leukemia 1 1.1 NC NC -- NC 1 0.6 NC NC -- NC 0 0.5 NC NC -- NC
Liver 0 0.2 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
Lung & Bronchus 12 7.3 166 85 -- 289 9 4.7 191 87 -- 362 3 2.5 NC NC -- NC
NHL 2 1.7 NC NC -- NC 1 0.9 NC NC -- NC 1 0.8 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma CNS = Central Nervous System
Data Source: Massachusetts Cancer Registry, Center for Health Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 8b
Cancer Incidence
Census Tract 5232.01, East Bridgewater, Massachusetts
1982-1987
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 3 2.3 NC NC -- NC 2 1.7 NC NC -- NC 1 0.7 NC NC -- NC
Brain & CNS 0 1.2 NC NC -- NC 0 0.6 NC NC -- NC 0 0.6 NC NC -- NC
Breast 12 10.2 118 61 -- 206 0 0.1 NC NC -- NC 12 10.1 119 61 -- 208
Kidney & Renal Pelvis 1 1.5 NC NC -- NC 1 0.9 NC NC -- NC 0 0.6 NC NC -- NC
Leukemia 2 1.2 NC NC -- NC 1 0.7 NC NC -- NC 1 0.5 NC NC -- NC
Liver 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
Lung & Bronchus 5 8.4 60 19 -- 139 3 5.1 NC NC -- NC 2 3.3 NC NC -- NC
NHL 1 2.2 NC NC -- NC 0 1.2 NC NC -- NC 1 1.1 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma CNS = Central Nervous System
Data Source: Massachusetts Cancer Registry, Center for Health Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 8c
Cancer Incidence
Census Tract 5232.01, East Bridgewater, Massachusetts
1988-1993
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 2 3.1 NC NC -- NC 2 2.2 NC NC -- NC 0 0.9 NC NC -- NC
Brain & CNS 2 1.3 NC NC -- NC 2 0.7 NC NC -- NC 0 0.6 NC NC -- NC
Breast 11 14.4 76 38 -- 137 0 0.1 NC NC -- NC 11 14.3 77 38 -- 138
Kidney & Renal Pelvis 0 2.2 NC NC -- NC 0 1.3 NC NC -- NC 0 0.8 NC NC -- NC
Leukemia 2 2.0 NC NC -- NC 1 1.1 NC NC -- NC 1 1.0 NC NC -- NC
Liver 0 0.6 NC NC -- NC 0 0.5 NC NC -- NC 0 0.2 NC NC -- NC
Lung & Bronchus 11 12.5 88 44 -- 158 5 6.8 73 24 -- 171 6 5.6 106 39 -- 232
NHL 3 3.5 NC NC -- NC 2 1.8 NC NC -- NC 1 1.7 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma CNS = Central Nervous System
Data Source: Massachusetts Cancer Registry, Center for Health Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 8d
Cancer Incidence
Census Tract 5232.01, East Bridgewater, Massachusetts
1994-2000
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 15 14.9 101 56 -- 166 10 10.9 92 44 -- 169 5 4.0 126 40 -- 293
Brain & CNS 5 8.3 60 19 -- 140 2 4.3 NC NC -- NC 3 4.0 NC NC -- NC
Breast 80 71.8 111 88 -- 139 2 1.5 NC NC -- NC 78 71.3 109 86 -- 137
Kidney & Renal Pelvis 14 10.0 139 76 -- 234 8 6.2 128 55 -- 253 6 3.8 157 57 -- 341
Leukemia 13 9.0 144 77 -- 247 6 5.1 118 43 -- 257 7 4.0 180 72 -- 370
Liver 3 2.4 NC NC -- NC 2 1.8 NC NC -- NC 1 0.6 NC NC -- NC
Lung & Bronchus 63 60.2 105 80 -- 134 35 35.6 98 68 -- 137 28 24.6 114 76 -- 165
NHL 20 15.5 129 79 -- 200 15 8.4 179 100 296 5 7.1 71 23 -- 165
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma CNS = Central Nervous System
Data Source: Massachusetts Cancer Registry, Center for Health Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 9a
Cancer Incidence
Census Tract 5232.02, East Bridgewater, Massachusetts
1982-2000
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 6 4.5 134 49 -- 291 3 3.3 NC NC -- NC 3 1.2 NC NC -- NC
Brain & CNS 2 2.3 NC NC -- NC 1 1.2 NC NC -- NC 1 1.1 NC NC -- NC
Breast 17 16.9 100 59 -- 161 0 0.1 NC NC -- NC 17 16.8 101 59 -- 162
Kidney & Renal Pelvis 1 2.1 NC NC -- NC 0 1.3 NC NC -- NC 1 0.8 NC NC -- NC
Leukemia 4 2.3 NC NC -- NC 2 1.3 NC NC -- NC 2 1.0 NC NC -- NC
Liver 1 0.4 NC NC -- NC 0 0.3 NC NC -- NC 1 0.1 NC NC -- NC
Lung & Bronchus 14 15.1 93 51 -- 156 8 9.7 82 35 -- 162 6 5.4 112 41 -- 243
NHL 3 3.4 NC NC -- NC 3 1.8 NC NC -- NC 0 1.6 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma CNS = Central Nervous System
Data Source: Massachusetts Cancer Registry, Center for Health Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 9b
Cancer Incidence
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 2 4.5 NC NC -- NC 2 3.3 NC NC -- NC 0 1.2 NC NC -- NC
Brain & CNS 1 2.8 NC NC -- NC 0 1.4 NC NC -- NC 1 1.4 NC NC -- NC
Breast 26 22.3 117 76 -- 171 1 0.2 NC NC -- NC 25 22.2 113 73 -- 167
Kidney & Renal Pelvis 4 3.2 NC NC -- NC 2 2.0 NC NC -- NC 2 1.2 NC NC -- NC
Leukemia 4 2.5 NC NC -- NC 2 1.5 NC NC -- NC 2 1.1 NC NC -- NC
Liver 0 0.7 NC NC -- NC 0 0.5 NC NC -- NC 0 0.2 NC NC -- NC
Lung & Bronchus 16 18.4 87 50 -- 141 7 11.0 64 26 -- 131 9 7.4 122 55 -- 231
NHL 8 4.7 169 73 -- 332 7 2.6 272* 109 -- 560 1 2.2 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma CNS = Central Nervous System
Data Source: Massachusetts Cancer Registry, Center for Health Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 9c
Cancer Incidence
Census Tract 5232.02, East Bridgewater, Massachusetts
1988-1993
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Cancer Type Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 7 6.2 112 45 -- 231 5 4.6 108 35 -- 253 2 1.6 NC NC -- NC
Brain & CNS 2 3.3 NC NC -- NC 1 1.8 NC NC -- NC 1 1.4 NC NC -- NC
Breast 37 33.3 111 78 -- 153 1 0.3 NC NC -- NC 36 33.1 109 76 -- 151
Kidney & Renal Pelvis 9 5.1 178 81 -- 338 6 3.2 189 69 -- 411 3 1.9 NC NC -- NC
Leukemia 5 4.5 112 36 -- 262 2 2.5 NC NC -- NC 3 1.9 NC NC -- NC
Liver 2 1.4 NC NC -- NC 2 1.1 NC NC -- NC 0 0.3 NC NC -- NC
Lung & Bronchus 33 28.2 117 81 -- 164 20 15.7 127 78 -- 197 13 12.5 104 55 -- 178
NHL 9 7.8 116 53 -- 220 5 4.3 117 38 -- 274 4 3.5 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
NHL = Non-Hodgkin's Lymphoma CNS = Central Nervous System
Data Source: Massachusetts Cancer Registry, Center for Health Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 9d
Cancer Incidence
Census Tract 5232.02, East Bridgewater, Massachusetts
1994-2000
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Appendix A: Coding Definitions of Cancer Site/Type* 
  
ICD-O-1 and Other 
Pre-ICD-O-2 Codes 
ICD-O-2 Codes ICD-O-3 Codes 
Cancer Site / Type 
Site code Histology code Site code Histology code Site code Histology code 
Bladder 188.0-188.9 except 9590-
9980 
C67.0-C67.9 except 9590-
9989 
C67.0-C67.9 except 9590-
9989 
Brain & Central 
Nervous System 
(CNS) 
191.0-192.9 
 † 
C70.0-C72.9 
† 
C70.0-C72.9 
‡ 
Breast 174.0-174.9, 
175.9 
except 9590-
9980 
C50.0-C50.9 except 9590-
9989 
C50.0-C50.9 except 9590-
9989 
Kidney &  
Renal Pelvis 
189.0, 189.1 except 9590-
9980 
C64.9, C65.9 
 
except 9590-
9989 
C64.9, C65.9 
 
except 9590-
9989 
Leukemia 
 
 
 
 
140.0-199.9 
 
includes O9800-
O9943, O9951, 
P9803-P9943, 
B9803-B9943 
1. C00.0-
C80.9 
 
AND 
 
2. C42.0, 
C42.1, C42.4 
1. includes 9800-
9822, 9824-
9826, 9828-9941 
 
2. includes 9823, 
9827 
1. C00.0-
C80.9 
 
AND 
 
2. C42.0, 
C42.1, C42.4 
1. includes 9733, 
9742, 9800-
9820, 9826, 
9831-9948, 
9963-9964 
2. includes 9823, 
9827 
Liver 155.0 except 9590-
9980 
C22.0 except 9590-
9989 
C22.0 except 9590-
9989 
Lung & Bronchus 162.2-162.9 except 9050-
9053, 9590-9980 
C34.0-C34.9 except 9590-
9989 
C34.0-C34.9 except 9590-
9989 
Non-Hodgkin's 
Lymphoma (NHL) 
 
 
 
 
 
140.0-199.9 
 
includes O9590-
O9642, O9670-
O9710, O9750, 
P9593-P9643, 
P9693-P9713, 
P9753, B9593-
B9643, B9703 
1. C00.0-
C80.9 
 
AND 
2. All sites 
except C42.0, 
C42.1, C42.4 
1. includes 9590-
9595, 9670-9717 
 
2. includes 9823, 
9827 
1. C00.0-
C80.9 
 
AND 
2. All sites 
except C42.0, 
C42.1, C42.4 
1. includes 9590-
9596, 9670-9729
 
2. includes 9823, 
9827 
*Includes invasive tumors only, selected by excluding in situ stages J0, S0, TTISNXM0, TTANXMX, TTANXM0, TTAN0MX, TTISN0M0, TTISNXMX, TTISN0MX, TTISN0M0, TTIN0M0, 
TTIN0MX, TTINXM0, and TTINXMX (1982-1994 data) or by specifying behavior code (1995-2000 data). 
  
 110
Appendix A (Continued) 
†Histology codes for Brain and Central Nervous System (pre-ICD-O-3) 
ICD-O   O 9370, 9380, 9381, 9382, 9390, 9391, 9392, 9400, 9401, 9403, 9410, 9411, 9420, 9421, 9422, 9423, 9424, 9430, 9440, 
9441, 9442, 9443, 9450, 9451, 9460, 9470, 9471, 9472, 9473, 9480, 9481, 9490, 9500, 9501, 9502, 9503, 9530, 9539, 
9540, 9560, 9561. 
SNOP  P 9363, 9383, 9393, 9403, 9413, 9423, 9433, 9443, 9453, 9463, 9473, 9483, 9493, 9503, 9533, 9543, 9563. 
HLTHSTT  B 9383, 9393, 9403, 9433, 9443, 9453, 9463, 9473, 9483, 9493, 9503, 9530, 9533, 9537, 9543, 9563. 
‡Histology codes for Brain and Central Nervous System (ICD-O-3) 
ICD-O   O 9370, 9371, 9372, 9380, 9381, 9382, 9390, 9391, 9392, 9400, 9401, 9410, 9411, 9420, 9421, 9423, 9424, 9430, 9440, 
9441, 9442, 9450, 9451, 9460, 9470, 9471, 9472, 9473, 9474, 9480, 9490, 9500, 9501, 9502, 9503, 9530, 9539, 9540, 
9560, 9561, 9571. 
  111
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Bladder Cancer 
 
The American Cancer Society estimates that bladder cancer will affect 63,210 people in the United States 
in 2005, accounting for 7% of all cancers diagnosed in the United States among men and 2% among 
women.  In Massachusetts, bladder cancer accounts for approximately 6% of all cancers diagnosed among 
males and females combined (ACS, 2005).  Males are three times more likely to develop bladder cancer 
than females and whites are two times more likely to develop this disease than blacks.  The risk of bladder 
cancer increases with age and the mean age at diagnosis is 68-69 years (ACS, 2000). 
 
The greatest risk factor for bladder cancer is cigarette smoking.  Smokers are more than twice as likely to 
develop bladder cancer compared to nonsmokers (ACS, 2000).  The risk of developing bladder cancer 
increases with the number of packs smoked per day and with duration of smoking.  Further, the risk of 
bladder cancer may be higher in women than in men who smoke comparable numbers of cigarettes 
(Castelao et al., 2001).  Approximately 25-60% of all bladder cancers can be attributed to tobacco use 
(Johansson and Cohen, 1997).  Smoking cessation has been found to reduce the risk of developing 
bladder cancer by 30% to 60% (Silverman et al., 1996). 
 
Studies have also revealed a number of occupations that are associated with bladder cancer.  In fact, 
exposures to chemicals in the workplace account for an estimated 20-25% of all bladder cancers 
diagnosed among men in the United States (Johansson and Cohen, 1997).  Occupational exposure to 
aromatic amines, such as benzidine and 2-naphthylamine, increases the risk of bladder cancer (ACS, 
2000).  These chemicals were common in the dye industry in the past.  A higher risk of bladder cancer has 
also been observed among aromatic amine manufacturing workers as well as among workers in the 
rubber, leather, textiles, printing, and paint products industries (ACS, 2000; Silverman et al., 1996).  The 
development of new chemicals, changed worker exposures, and the elimination of many known bladder 
carcinogens in the workplace have caused shifts in those occupations considered to be high risk.  For 
example, risks among dye, rubber, and leather workers have declined over time, while other occupations 
such as motor vehicle operation (e.g., drivers of trucks, buses, and taxis) and the aluminum industry have 
emerged as potential high-risk occupations (Silverman et al., 1996).  However, specific occupational 
exposures in these occupations have not been confirmed and study findings are not consistent.  Further, 
the risk of bladder cancer from occupational exposures may be increased among smokers (ACS, 2000). 
 
Dietary factors such as consumption of fried foods as well as foods high in fat and cholesterol have been 
found to be associated with increased bladder cancer risk (Silverman et al., 1996).  Use of the Chinese 
herb, Aristocholia fangchi, found in some dietary supplements, has also been linked with bladder cancer 
(ACS, 2000).  Use of some anti-cancer drugs (e.g., cyclophosphamide and chlornaphazine), use of 
phenacetin, and infection with Shistosoma haematobium (a parasite found in Africa) are thought to be 
associated with the development of bladder cancer, however, not all epidemiological studies have 
produced convincing findings (Silverman et al., 1996). 
 
Other risk factors for bladder cancer include a personal history of bladder cancer, certain rare birth defects 
involving the bladder, and exposure to ionizing radiation (ACS, 2000; Silverman et al., 1996).  Exposure 
to chlorinated by-products in drinking water has also been suggested to increase bladder cancer risk, 
however, a recent population-based study found that an association was present only among smokers 
(Cantor et al., 1998). 
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Brain and CNS Cancer 
 
Brain and central nervous system (CNS) tumors can be either malignant (cancerous) or benign (non-
cancerous).  Primary brain tumors (i.e., brain cancer) comprise two main types: gliomas and malignant 
meningiomas.  Gliomas are a general classification of malignant tumors that include a variety of types, 
named for the cells from which they arise: astrocytomas, oligodendrogliomas, and ependymomas.  
Meningiomas arise from the meninges, which are tissues that surround the outer part of the spinal cord 
and brain.  Although meningiomas are not technically brain tumors, as they occur outside of the brain, 
they account for about 50% of all reported primary brain and spinal cord tumors.  The majority of 
meningiomas (about 85%) are benign and can be cured by surgery.  Therefore, approximately 7.5% of 
brain and CNS tumors are malignant meningiomas.  In addition to these main types, there are a number of 
rare brain tumors, including medulloblastomas, which develop from the primitive stem cells of the 
cerebellum and are most often seen in children.  Also, the brain is a site where both primary and 
secondary malignant tumors can arise; secondary brain tumors generally originate elsewhere in the body 
and then metastasize, or spread, to the brain (ACS, 1999a).  The American Cancer Society estimates that 
18,500 Americans (10,620 men and 7,880 women) will be diagnosed with primary brain cancer 
(including cancers of the central nervous system, or spinal cord) and approximately 12,760 people (7,280 
men and 5,480 women) will die from this disease in 2005 (ACS, 2005). 
 
Brain and spinal cord cancers account for over 20% of all cancer types diagnosed among children aged 0-
14 (ACS, 2005).  About half of all childhood brain tumors are astrocytomas and 25% are 
medulloblastomas (ACS, 1999b).  After a peak in childhood (generally under 10 years of age), the risk of 
brain cancer increases with age from age 25 to age 75.  In adults, the most frequent types of brain tumors 
are astrocytic tumors (mainly astrocytomas and glioblastoma multiforme).  Incidence rates are higher in 
males than in females for all types.  In general, the highest rates of brain and nervous system cancer tend 
to occur in whites.   However, this varies somewhat by type; the incidence of gliomas is lower among 
black men and women than whites, but for meningiomas, the reverse is true (Preston-Martin and Mack, 
1996). 
 
Despite numerous scientific and medical investigations, and analyses, the causes of brain cancer are still 
largely unknown.  Among the possible risk factors investigated in relation to this type of cancer are 
ionizing radiation, electromagnetic fields, occupational exposures, exposure to N-nitroso compounds, 
head trauma, and genetic disorders. 
 
The most established risk factor (and only established environmental risk factor) for brain tumors (either 
cancerous or non-cancerous) is high-dose exposure to ionizing radiation (i.e., x-rays and gamma rays).  
Most radiation-induced brain tumors are caused by radiation to the head from the treatment of other 
cancers (ACS, 1999a).  Meningiomas are the most common type of tumors that occur from this type of 
exposure, but gliomas may also occur (Preston-Martin and Mack, 1996).  Among adults, the risk of 
developing meningiomas has been associated with full-mouth dental x-rays taken decades ago when 
radiation doses were higher than today.  Although the relationship between low-dose radiation exposure 
and increased risk of brain tumors has been debated in several studies, prenatal exposure from diagnostic 
x-rays has been related to an increase in childhood brain tumors (Preston-Martin and Mack, 1996). 
 
In recent years, there has been increasing public concern and scientific interest regarding the relationship 
of electromagnetic fields (EMF) to brain cancer.  However, results from recent epidemiological 
investigations provide little or no evidence of an association between residential EMF exposure (e.g., 
from power lines and home appliances) and brain tumors (Kheifets, 2001).  Studies also suggest that the 
use of handheld cellular telephones is not associated with an increased risk of primary brain cancer 
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(Muscat et al., 2000).  However, given the relatively recent use of cellular phones, evidence is preliminary 
and few studies have been conducted. 
 
Other environmental factors such as exposure to vinyl chloride (used in the manufacturing of some 
plastics) and aspartame (a sugar substitute) have been suggested as possible risk factors for brain cancer 
but no conclusive evidence exists implicating these factors (ACS, 1999a).  Although some occupational 
studies have suggested that electrical and electric utility workers may be at a slightly increased risk of 
brain cancer, these studies have important limitations, such as exposure misclassifications and a lack of 
dose-response relationships (Kheifets, 2001).  Some researchers have also reported an increased risk of 
brain tumors in adults among veterinarians and farmers.  Exposure to farm animals and pets have been 
considered as possible risk factors because of their association with bacteria, pesticides, solvents, and 
certain animal oncogenic (cancer-related) viruses (Yeni-Komshian and Holly, 2000).  However, the 
relationship between farm life and brain cancer remains controversial. 
 
Recent reports have proposed a link between occupational exposure to lead and brain cancer risk, but 
further analytic studies are warranted to test this hypothesis (Cocco et al., 1998).  In a recent case-control 
study, the concentrations of metal and non-metal compounds in brain biopsies from patients with primary 
brain tumors were compared to results from an analysis of tumor-free brain tissue.  Statistically 
significant associations were observed between the presence of brain tumors and the concentrations of 
silicon, magnesium, and calcium (Hadfield et al., 1998).  However, further research using a larger sample 
size is needed to determine whether exposure to these elements plays a role in the development of brain 
cancer.  Other occupations that may be associated with elevated risks include workers in certain health 
professions (e.g., pathologists and physicians), agricultural workers, workers in the nuclear industry, and 
workers in the rubber industry, although specific exposures have not been established (Preston-Martin and 
Mack, 1996).  Studies investigating the possible association between occupational exposure of parents (in 
particular, paper or pulp-mill, aircraft, rubber, metal, construction, and electric workers) and the onset of 
brain tumors in their children have provided inconsistent results (Preston-Martin and Mack, 1996). 
 
The association between the development of brain cancer and nitrites and other N-nitroso compounds, 
among the most potent of carcinogens, has been heavily researched.  N-nitroso compounds have been 
found in tobacco smoke, cosmetics, automobile interiors, and cured meats.  A recent study concluded that 
an increased risk of pediatric brain tumor may be associated with high levels of nitrite intake from 
maternal cured meat consumption during pregnancy (Pogoda and Preston-Martin, 2001).  However, the 
role of nitrites and cured meats in the development of brain cancer remains controversial (Blot et al., 
1999; Bunin, 2000).  Because most people have continuous, low level exposure to N-nitroso compounds 
throughout their lives, further studies, especially cohort studies, are needed to determine if this exposure 
leads to an increased risk of brain tumors (Preston-Martin, 1996). 
 
Injury to the head has been suggested as a possible risk factor for later development of brain tumors but 
most researchers agree that there is no conclusive evidence for an association (ACS, 1999b).  Head 
trauma is most strongly associated with the development of meningiomas compared with other types of 
brain tumor.  Several studies have found an increased risk in women with histories of head trauma; in 
men who boxed; and in men with a previous history of head injuries.  Gliomas are the most common type 
of childhood brain tumor and have been positively associated with trauma at birth (e.g., Cesarean section, 
prolonged labor, and forceps delivery).  However, other studies have found no association (Preston-
Martin and Mack, 1996). 
 
In addition, rare cases of brain and spinal cord cancer run in some families.  Brain tumors in some persons 
are associated with genetic disorders such as neurofibromatosis types I and II, Li-Fraumeni syndrome, 
and tuberous sclerosis.  Neurofibromatosis type I (von Recklinghausen’s disease) is the most common 
inherited cause of brain or spinal cord tumors and occurs in about one out of every 3,000 people (Preston-
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Martin and Mack, 1996).  The disease may be associated with optic gliomas or other gliomas of the brain 
or spinal cord (ACS, 1999b).  Of those afflicted with the disease, about 5-10% will develop a central 
nervous system tumor (Preston-Martin and Mack, 1996).  In addition, von Hippell-Lindau disease is 
associated with an inherited tendency to develop blood vessel tumors of the cerebellum (ACS, 1999a).  
However, malignant (or cancerous) brain tumors are rare in these disorders; inherited syndromes that 
predispose individuals to brain tumors appear to be present in fewer than 5% of brain tumor patients 
(Preston-Martin and Mack, 1996). 
 
Other possible risk factors investigated for brain cancer have included alcohol consumption, use of 
barbiturates, smoking and exposure to second-hand smoke, pesticides, and infectious diseases (i.e., 
tuberculosis and chicken pox).  To date, studies on these risk factors have yielded inconclusive results.  
Further, the majority of individuals diagnosed with brain cancer have no known risk factors (ACS, 
1999a). 
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Breast Cancer  
Breast cancer is the most frequently diagnosed cancer among women in both the United States and in 
Massachusetts.  According to the North American Association of Central Cancer Registries, female breast 
cancer incidence in Massachusetts is the fifth highest among all states (Chen et al, 2000).  Although 
during the 1980s breast cancer in the United States increased by about 4% per year, the incidence has 
leveled off to about 110.6 cases per 100,000 (ACS 2000).  A similar trend occurred in Massachusetts and 
there was even a slight decrease in incidence (1%) between 1993 and 1997 (MCR 2000). 
 
In the year 2005, approximately 211,240 women in the United States will be diagnosed with breast cancer 
(ACS 2005).  Worldwide, female breast cancer incidence has increased, mainly among women in older 
age groups whose proportion of the population continues to increase as well (van Dijck, 1997).  A 
woman’s risk for developing breast cancer can change over time due to many factors, some of which are 
dependent upon the well-established risk factors for breast cancer.  These include increased age, an early 
age at menarche (menstruation) and/or late age at menopause, late age at first full-term pregnancy, family 
history of breast cancer, and high levels of estrogen.  Other risk factors that may contribute to a woman’s 
risk include benign breast disease and lifestyle factors such as diet, body weight, lack of physical activity, 
consumption of alcohol, and exposure to cigarette smoke.  Data on whether one’s risk may be affected by 
exposure to environmental chemicals or radiation remains inconclusive.  However, studies are continuing 
to investigate these factors and their relationship to breast cancer.   
 
Family history of breast cancer does affect one’s risk for developing the disease.  Epidemiological studies 
have found that females who have a first-degree relative with premenopausal breast cancer experience a 
3-fold greater risk.  However, no increase in risk has been found for females with a first degree relative 
with postmenopausal breast cancer.  If women have a first-degree relative with bilateral breast cancer 
(cancer in both breasts) at any age then their risk increases five-fold.  Moreover, if a woman has a mother, 
sister or daughter with bilateral premenopausal breast cancer, their risk increases nine fold. (Broeders and 
Verbeek, 1997).  In addition, twins have a higher risk of breast cancer compared to non-twins (Weiss et 
al, 1997).  
 
A personal history of benign breast disease is also associated with development of invasive breast cancer.  
Chronic cystic or fibrocystic disease is the most commonly diagnosed benign breast disease.  Women 
with cystic breast disease experience a 2-3 fold increase in risk for breast cancer (Henderson et al, 1996).  
 
According to recent studies, approximately 10% of breast cancers can be attributed to inherited mutations 
in breast cancer related genes.  Most of these mutations occur in the BRCA1 and BRCA2 genes.  
Approximately 50% to 60% of women who inherit BRCA1 or BRCA2 gene mutations will develop 
breast cancer by the age of 70 (ACS 2001). 
 
Cumulative exposure of the breast tissue to estrogen and progesterone hormones may be one of the 
greatest contributors to risk for breast cancer (Henderson et al, 1996).  Researchers suspect that early 
exposures to a high level of estrogen, even during fetal development, may add to one’s risk of developing 
breast cancer later in life.  Other studies have found that factors associated with increased levels of 
estrogen (i.e., neonatal jaundice, severe prematurity, and being a fraternal twin) may contribute to an 
elevated risk of developing breast cancer (Ekbom et al, 1997).  Conversely, studies have revealed that 
women whose mothers experienced toxemia during pregnancy (a condition associated with low levels of 
estrogen) had a significantly reduced risk of developing breast cancer.  Use of estrogen replacement 
therapy is another factor associated with increased hormone levels and it has been found to confer a 
modest (less than two-fold) elevation in risk when used for 10-15 years or longer (Kelsey, 1993).  
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Similarly, more recent use of oral contraceptives or use for 12 years or longer seems to confer a modest 
increase in risk for bilateral breast cancer in premenopausal women (Ursin et al, 1998). 
 
Cumulative lifetime exposure to estrogen may also be increased by certain reproductive events during 
one’s life. Women who experience menarche at an early age (before age 12) have a 20% increase in risk 
compared to women who experience menarche at 14 years of age or older (Broeders and Verbeek, 1997; 
Harris et al, 1992).  Women who experience menopause at a later age (after the age of 50) have a slightly 
elevated risk for developing the disease (ACS 2001). Furthermore, the increased cumulative exposure 
from the combined effect of early menarche and late menopause has been associated with elevated risk 
(Lipworth, 1995).  In fact, women who have been actively menstruating for 40 or more years are thought 
to have twice the risk of developing breast cancer than women with 30 years or less of menstrual activity 
(Henderson et al, 1996).  Other reproductive events have also shown a linear association with risk for 
breast cancer (Wohlfahrt, 2001).  Specifically, women who gave birth for the first time before age 18 
experience one-third the risk of women who have carried their first full-term pregnancy after age 30 
(Boyle et al, 1988).  The protective effect of earlier first full-term pregnancy appears to result from the 
reduced effect of circulating hormones on breast tissue after pregnancy (Kelsey, 1993).  
 
Diet, and particularly fat intake, is another factor suggested to increase a woman’s risk for breast cancer.  
Currently, a hypothesis exists that the type of fat in a woman's diet may be more important than her total 
fat intake (ACS 1998; Wynder et al, 1997).  Monounsaturated fats (olive oil and canola oil) are associated 
with lower risk while polyunsaturated (corn oil, tub margarine) and saturated fats (from animal sources) 
are linked to an elevated risk.  However, when factoring in a woman’s weight with her dietary intake, the 
effect on risk becomes less clear (ACS 1998).  Many studies indicate that a heavy body weight elevates 
the risk for breast cancer in postmenopausal women (Kelsey, 1993), probably due to fat tissue as the 
principal source of estrogen after menopause (McTiernan, 1997).  Therefore, regular physical activity and 
a reduced body weight may decrease one’s exposure to the hormones believed to play an important role in 
increasing breast cancer risk (Thune et al, 1997).  
 
Aside from diet, regular alcohol consumption has also been associated with increased risk for breast 
cancer (Swanson et al, 1996; ACS 2001).  Women who consumed one alcoholic beverage per day 
experienced a slight increase in risk (approximately 10%) compared to non-drinkers, however those who 
consumed 2 to 5 drinks per day experienced a 1.5 times increased risk (Ellison et al., 2001; ACS 2001).  
Despite this association, the effects of alcohol on estrogen metabolism have not been fully investigated 
(Swanson et al, 1996).  
 
To date, no specific environmental factor, other than ionizing radiation, has been identified as a cause of 
breast cancer.  The role of cigarette smoking in the development of breast cancer is unclear.  Some studies 
suggest a relationship between passive smoking and increased risk for breast cancer; however, confirming 
this relationship has been difficult due to the lack of consistent results from studies investigating first-
hand smoke exposure (Laden and Hunter, 1998). 
 
Studies on exposure to high doses of ionizing radiation demonstrate a strong association with breast 
cancer risk.  These studies have been conducted in atomic bomb survivors from Japan as well as patients 
that have been subjected to radiotherapy in treatments for other conditions (i.e., Hodgkin’s Disease, non-
Hodgkin’s Lymphoma, tuberculosis, post-partum mastitis, and cervical cancer) (ACS 2001).  However, it 
has not been shown that radiation exposures experienced by the general public or people living in areas of 
high radiation levels, from industrial accidents or nuclear activities, are related to an increase in breast 
cancer risk (Laden and Hunter, 1998). Investigations of electromagnetic field exposures in relation to 
breast cancer have been inconclusive as well. 
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Occupational exposures associated with increased risk for breast cancer have not been clearly identified.  
Experimental data suggests that exposure to certain organic solvents and other chemicals (e.g., benzene, 
trichloropropane, vinyl chloride, polycyclic aromatic hydrocarbons (PAHs)) causes the formation of 
breast tumors in animals and thus may contribute to such tumors in humans (Goldberg and Labreche, 
1996).  Particularly, a significantly elevated risk for breast cancer was found for young women employed 
in solvent-using industries (Hansen, 1999). Although risk for premenopausal breast cancer may be 
elevated in studies on the occupational exposure to a combination of chemicals, including benzene and 
PAHs, other studies on cigarette smoke (a source of both chemicals) and breast cancer have not shown an 
associated risk (Petralia et al, 1999).  Hence, although study findings have yielded conflicting results, 
evidence does exist to warrant further investigation into the associations. 
 
Other occupational and environmental exposures have been suggested to confer an increased risk for 
breast cancer in women, such as exposure to polychlorinated biphenyls (PCBs), chlorinated hydrocarbon 
pesticides (DDT and DDE), and other endocrine-disrupting chemicals.  Because these compounds affect 
the body’s estrogen production and metabolism, they can contribute to the development and growth of 
breast tumors (Davis et al, 1997; Holford et al, 2000; Laden and Hunter, 1998). However, studies on this 
association have yielded inconsistent results and follow-up studies are ongoing to further investigate any 
causal relationship (Safe, 2000). 
 
When considering a possible relationship between any exposure and the development of cancer, it is 
important to consider the latency period.  Latency refers to the time between exposure to a causative 
factor and the development of the disease outcome, in this case breast cancer.  It has been reported that 
there is an 8 to 15 year latency period for breast cancer (Petralia 1999; Aschengrau 1998; Lewis-Michl 
1996).  That means that if an environmental exposure were related to breast cancer, it may take 8 to 15 
years after exposure to a causative factor for breast cancer to develop.  
 
Socioeconomic differences in breast cancer incidence may be a result of current screening participation 
rates.  Currently, women of higher socioeconomic status (SES) have higher screening rates, which may 
result in more of the cases being detected in these women.  However, women of higher SES may also 
have an increased risk for developing the disease due to different reproductive patterns (i.e., parity, age at 
first full-term birth, and age at menarche).  Although women of lower SES show lower incidence rates of 
breast cancer in number, their cancers tend to be diagnosed at a later stage (Segnan, 1997).  Hence, rates 
for their cancers may appear lower due to the lack of screening participation rather than a decreased risk 
for the disease.  Moreover, it is likely that SES is not in itself the associated risk factor for breast cancer.  
Rather, SES probably represents different patterns of reproductive choices, occupational backgrounds, 
environmental exposures, and lifestyle factors (i.e., diet, physical activity, cultural practices) (Henderson 
et al, 1996). 
 
Despite the vast number of studies on the causation of breast cancer, known factors are estimated to 
account for less than half of breast cancers in the general population (Madigan et al, 1995).  Researchers 
are continuing to examine potential risks for developing breast cancer, especially environmental factors.   
 
References 
American Cancer Society. 2005. Cancer Facts & Figures 2005.  Atlanta: American Cancer Society, Inc.   
American Cancer Society. 2001. The Risk Factors for Breast Cancer from: 
http://www3.cancer.org/cancerinfo/print_cont.asp?ct=5&st=pr&language=english  
American Cancer Society, 2000. Cancer Facts and Figures 2000. 
American Cancer Society. 1998. The Risk Factors for Breast Cancer from: http://cancer.org/bcn/info/brrisk.html 
RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES 
 
Source: Community Assessment Program, Center for Environmental Health, Massachusetts Department of Public Health. 
March, 2005   
 120
Aschengrau A, Paulu C, Ozonoff D. 1998. Tetrachloroethylene contaminated drinking water and risk of breast 
cancer. Environ Health Persp 106(4):947-953. 
Boyle P, Leake R. Progress in understanding breast cancer: epidemiological and biological interactions.  Breast 
Cancer Res 1988;11(2):91-112. 
Broeders MJ, Verbeek AL. Breast cancer epidemiology and risk factors. Quarterly J Nuclear Med 1997;41(3)179-
188. 
Chen VW, Howe HL, Wu XC, Hotes JL, Correa CN (eds).  Cancer in North America, 1993-1997.  Volume 1: 
Incidence.  Springfield, IL: North American Association of Central Cancer Registries, April 2000. 
Davis DL, Axelrod D, Osborne M, Telang N, Bradlow HL, Sittner E. Avoidable causes of Breast Cancer: The 
Known, Unknown, and the Suspected. Ann NY Acad Sci 1997;833:112-28. 
Ekbom A, Hsieh CC, Lipworth L, Adami HQ, Trichopoulos D. Intrauterine Environment and Breast Cancer Risk in 
Women: A Population-Based Study. J Natl Cancer Inst 1997;89(1):71-76. 
Ellison RC, Zhang Y, McLennan CE, Rothman KJ. Exploring the relation of alcohol consumption to the risk of 
breast cancer. Am J Epi 2001; 154:740-7. 
Goldberg MS, Labreche F. Occupational risk factors for female breast cancer: a review. Occupat Environ Med 
1996;53(3):145-156. 
Hansen J. Breast Cancer Risk Among Relatively Young Women Employed in Solvent-Using Industries.  Am J 
Industr Med 1999;36(1):43-47. 
Harris JR, Lippman ME, Veronesi U, Willett W. Breast Cancer (First of Three Parts). N Engl J Med 
1992;327(5):319-328. 
Henderson BE, Pike MC, Bernstein L, Ross RK. 1996. Breast Cancer, chapter 47 in Cancer Epidemiology and 
Prevention. 2nd ed. Schottenfeld D and Fraumeni JF Jr.,eds. Oxford University Press. pp: 1022-1035. 
Holford TR, Zheng T, Mayne ST, Zahm SH, Tessari JD, Boyle P. Joint effects of nine polychlorinated biphenyl 
(PCB) congeners on breast cancer risk. Int J Epidemiol 2000;29(6):975-982. 
Kelsey JL. Breast Cancer Epidemiology. Epidemiol Reviews 1993;15:7-16. 
Laden F, Hunter DJ. Environmental Risk Factors and Female Breast Cancer. Ann Rev of Public Health 
1998;19:101-123. 
Lewis-Michl EL, Melius JM, Kallenbach LR, Ju CL, Talbot TO, Orr MF, and Lauridsen PE. 1996.  Breast cancer 
risk and residence near industry or traffic in Nassau and Suffolk counties, Long Island, New York.  Arch Environ 
Health 51(4):255-265. 
Lipworth L. Epidemiology of breast cancer. Eur J Cancer Prev 1995;4:7-30. 
Massachusetts Cancer Registry 2000. Cancer Incidence and Mortality in Massachusetts 1993-1997: Statewide 
Report. March 2000.  Massachusetts Department of Public Health, Bureau of Health Statistics, Research and 
Evaluation, Massachusetts Cancer Registry. Boston, MA. 
Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN.  Proportion of Breast Cancer Cases in the United 
States Explained by Well-Established Risk Factors.  J Natl Cancer Inst 1995;87(22):1681-5. 
McTiernan A. Exercise and Breast Cancer—Time To Get Moving? The N Engl J Med 1997;336(18):1311-1312. 
Petralia SA, Vena JE, Freudenheim JL, Dosemeci M, Michalek A, Goldberg MA, Brasure J, Graham S. Risk of 
premenopausal breast cancer in association with occupational exposure to polycyclic aromatic hydrocarbons and 
benzene. Scandin J Work Envir Health 1999;25(3):215-221. 
Safe SH. Endocrine Disruptors and Human Health—Is There a Problem?  An Update.  Environ Health Perspec 
2000;108(6):487-493.  
Segnan N. Socioeconomic status and cancer screening. International Agency for Research on Cancer 1997;138:369-
376. 
RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES 
 
Source: Community Assessment Program, Center for Environmental Health, Massachusetts Department of Public Health. 
March, 2005   
 121
Swanson CA, Coates RJ, Malone KE, Gammon MD, Schoenberg JB, Brogan DJ, McAdams M, Potischman N, 
Hoover RN, Brinton LA. Alcohol Consumption and Breast Cancer Risk among Women under Age 45 Years. 
Epidemiology 1997;8(3):231-237. 
Thune I, Brenn T, Lund E, Gaard M. Physical Activity and the Risk of Breast Cancer.  N Engl J Med 
1997;336(18):1269-1275 
Ursin G, Ross RK, Sullivan-Haley J, Hanisch R, Henderson B, and Bernstein L. Use of oral contraceptives and risk 
of breast cancer in young women. Breast Cancer Res 1998;50(2):175-184. 
van Dijck JAAM, Broeders MJM, Verbeek ALM. Mammographic Screening in Older Women, Is It Worthwhile? 
Drugs and Aging 1997;10(2):69-79. 
Weiss HA, Potischman NA, Brinton L, Brogan D, Coates RJ, Gammon MD, Malone KE, Schoenberg JB. Prenatal 
and Perinatal Factors for Breast Cancer in Young Women. Epidemiology 1997;8(2):181-187. 
Wohlfahrt J, Melbye M. Age at Any Birth is Associated with Breast Cancer Risk. Epidemiology 2001;12(1):68-73. 
Wynder E, Cohen LA, Muscat JE, Winters B, Dwyer JT, Blackburn G. Breast Cancer: Weighing the Evidence for a 
Promoting Role of Dietary Fat. J Natl Cancer Inst 1997;89(11)766-775. 
RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES 
 
Source: Community Assessment Program, Center for Environmental Health, Massachusetts Department of Public Health. 
March, 2005   
 122
Kidney cancer 
 
Kidney cancer involves a number of tumor types located in various areas of the kidney and renal system.  
Renal cell cancer (which affects the main area of the kidney) accounts for over 90% of all malignant 
kidney tumors (ACS, 2001).  The American Cancer Society estimates that there will be approximately 
36,160 cases of kidney and upper urinary tract cancer, resulting in more than 12,660 deaths in 2005 
(ACS, 2004).  The incidence and mortality from kidney cancer is higher in urban areas, which may be due 
to increased access to diagnostic services and other factors such as smoking.  Kidney cancer is twice as 
common in males as it is in females and the incidence most often occurs in the fifth and sixth decades of 
life (50-70 year age group) (ACS, 2001).  The gender distribution of this disease may be attributed to the 
fact that men are more likely to smoke and are more likely to be exposed to potentially carcinogenic 
chemicals at work. 
 
Since 1970, United States incidence rates for renal cell cancer have risen between 2 and 4% annually among 
the four major race and gender groups (i.e., white males, white females, black males, and black females) 
(Chow et al., 1999; McLaughlin et al., 1996).  Rapid increases in incidence among blacks as compared to 
among whites have resulted in an excess of the disease among blacks; age-adjusted incidence rates between 
1975 and 1995 for white men, white women, black men, and black women were 9.6, 4.4, 11.1, and 4.9 per 
100,000 person-years, respectively (Chow et al., 1999).  Rising incidence rates may be partially due to the 
increased availability of screening for kidney cancer. 
 
The etiology of kidney cancer is not fully understood.  However, a number of environmental, hormonal, 
cellular, and genetic factors have been studied as possible causal factors in the development of renal cell 
carcinoma.  Cigarette smoking is the most important known risk factor for renal cell cancer.  Smoking 
increases the risk of developing renal cell cancer by 30% to 100% (ACS, 2001).  In both males and females, a 
statistically significant dose-response relationship between smoking and this cancer has been observed.  
Approximately one-third of renal cell cancers in men and one-quarter of those in women may be caused by 
cigarette smoking (ACS, 2001).  
 
Virtually every study that has examined body weight and renal cell cancer has observed a positive 
association.  Some studies suggest that obesity is a factor in 20% of people who develop kidney cancer (ACS, 
2001).  This is especially true among women and researchers suspect that this may be related to changes in 
certain hormones, such as estrogen in women (ACS, 2001; McLaughlin et al., 1996).   A diet high in protein 
(meat, animal fats, milk products, margarine and oils) has been implicated in epidemiological studies as a risk 
factor for renal cell carcinoma (ACS, 2001; McLaughlin et al., 1996).  Consumption of adequate amounts of 
fruits and vegetables lowers the risk of renal cell cancer.  In addition, use of diuretics and antihypertensive 
medications are associated with increased risk of renal cell carcinoma.  However, hypertension has also been 
linked to kidney cancer and it is not clear whether the disease or the medications used to treat them is the 
cause (ACS, 2001).  Long-term use of pain relievers such as phenacetin (and possibly acetaminophen and 
aspirin) increases the risk for cancer of the renal pelvis and renal cell carcinoma (ACS, 2001). 
 
Certain medical conditions that affect the kidneys have also been shown to increase kidney cancer risk.  
There is an increased incidence of renal carcinoma in patients with end-stage renal disease who develop 
acquired cystic disease of the kidney.  This phenomenon is seen among patients on long-term dialysis for 
renal failure (Linehan et al., 1997).  In addition, an association has been established between the incidence 
of von Hippel-Lindau disease and certain other inherited conditions in families and renal cell carcinoma, 
suggesting that genetic and hereditary risk factors may be important in the development of kidney cancer 
(ACS, 2001; McLaughlin et al., 1996). 
 
Environmental and occupational factors have also been associated with the development of kidney cancer.  
Some studies have shown an increased incidence of this cancer type among leather tanners, shoe workers, 
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and workers exposed to asbestos.  Exposure to cadmium is associated with an increased incidence of kidney 
cancer, particularly in men who smoke (ACS, 2001; Linehan et al,. 1997).   In addition, workplace exposure 
to organic solvents, particularly trichloroethylene, may increase the risk of this cancer (ACS, 2001).  
Although occupational exposure to petroleum, tar, and pitch products has been implicated in the development 
of kidney cancer, most studies of oil refinery workers and petroleum products distribution workers have not 
identified a definitive relationship between gasoline exposure and renal cancer (Linehan et al., 1997; 
McLaughlin et al., 1996). 
 
Wilms’ tumor is the most common type of kidney cancer affecting children and accounts for approximately 
5% to 6% of all kidney cancers and about 6% of all childhood cancers.  This cancer is more common among 
African Americans than other races and among females than males.  Wilms’ tumor most often occurs in 
children under the age of 5 years.  The causes of Wilms’ tumor are not known, but certain birth defect 
syndromes and other genetic risk factors (such as family history or genetic mutations) are connected with this 
cancer.  However, most children who develop Wilms’ tumor do not have any known birth defects or inherited 
gene changes.  No environmental risk factors, either before or after a child’s birth, have been shown to be 
associated with the development of Wilms’ tumor (ACS, 1999). 
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Leukemia 
 
Leukemia is the general term that includes a group of different cancers that occur in the blood forming 
organs and result in the formation of abnormal amounts and types of white blood cells in the blood and 
bone marrow.  Individuals with leukemia generally maintain abnormally high amounts of leukocytes or 
white blood cells in their blood.  This condition results in an individual’s inability to maintain certain 
body functions, particularly a person’s ability to combat infection. 
 
In 2005, leukemia is expected to affect approximately 34,810 individuals (19,640 males and 15,420 
females) in the United States, resulting in 22,570 deaths.  In Massachusetts, approximately 770 
individuals will be diagnosed with the disease in 2005, representing more than 2% of all cancer 
diagnoses.  There are four major types of leukemia: acute lymphoid leukemia (ALL), acute myeloid 
leukemia (AML), chronic lymphoid leukemia (CLL), and chronic myeloid leukemia (CML).  There are 
also a few rare types, such as hairy cell leukemia.  In adults, the most common types are AML and CLL.  
Leukemia is the most common type of childhood cancer, accounting for about 30% of all cancers 
diagnosed in children.  The majority of these cases are of the ALL type (ACS, 2005). 
 
While ALL occurs predominantly among children (peaking between ages 2 and 3 years), an elevation in 
incidence is also seen among older individuals.  The increase in incidence among older individuals begins 
at approximately 40-50 years of age, peaking at about age 85 (Linet and Cartwright, 1996).  ALL is more 
common among whites than African Americans and among males than females (Weinstein and Tarbell, 
1997).  Exposure to high-dose radiation (e.g., by survivors of atomic bomb blasts or nuclear reactor 
accidents) is a known environmental risk factor associated with the development of ALL (Scheinberg et 
al., 1997).  Significant radiation exposure (e.g., diagnostic x-rays) before birth may carry up to a 5-fold 
increased risk of developing ALL (ACS 2000b).  However, few studies report an increased risk of 
leukemia associated with residing in proximity to nuclear plants or occupational exposure to low-dose 
radiation (Linet and Cartwright, 1996; Scheinberg et al., 1997).  It is unclear whether exposure to 
electromagnetic fields (EMF) plays a role in the development of ALL, however, most studies to date have 
found little or no risk (ACS 2000b). 
 
Few other risk factors for ALL have been identified.  There is evidence that genetics may play an 
important role in the development of this leukemia type.  Studies indicate that siblings of twins who 
develop leukemia are at an increased risk of developing the disease.  Children with Down’s syndrome are 
10 to 20 times more likely to develop acute leukemia (Weinstein and Tarbell, 1997).  In addition, other 
genetic diseases, such as Li-Fraumeni syndrome and Klinefelter’s syndrome, are associated with an 
increased risk of developing leukemia.  Patients receiving medication that suppresses the immune system 
(e.g., organ transplant patients) may be more likely to develop ALL (ACS 2000b).  ALL has not been 
definitively linked to chemical exposure, however, childhood ALL may be associated with maternal 
occupational exposure to pesticides during pregnancy (Infante-Rivard et al., 1999).  Certain rare types of 
adult ALL are caused by human T-cell leukemia/lymphoma virus-I (HTLV-I) (ACS, 2000a).  Some 
reports have linked other viruses with various types of leukemia, including Epstein-Barr virus and 
hepatitis B virus.  Still others propose that leukemia may develop as a response to viral infection.  
However, no specific virus has been identified as related to ALL (Linet and Cartwright, 1996).  Recent 
reports also suggest an infectious etiology for some childhood ALL cases, although a specific viral agent 
has not been identified and findings from studies exploring contact among children in day-care do not 
support this hypothesis (Greaves MF, 1997; Kinlen and Balkwill, 2001; Rosenbaum et al., 2000). 
 
Although AML can occur in children (usually during the first two years of life), AML is the most 
common leukemia among adults, with an average age at diagnosis of 65 years (ACS, 2000a and 2000b).  
This type of leukemia is more common among males than among females but affects African Americans 
and whites at similar rates (Scheinberg et al., 1997).  High-dose radiation exposure (e.g., by survivors of 
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atomic bomb blasts or nuclear reactor accidents), long-term occupational exposure to benzene, and 
exposure to certain chemotherapy drugs, especially alkylating agents (e.g., mechlorethamine, 
cyclophosphamide), have been associated with an increased risk of developing AML among both children 
and adults (ACS, 2000a and 2000b; Linet and Cartwright, 1996).  The development of childhood AML is 
suspected to be related to parental exposure to pesticides and other chemicals, although findings are 
inconsistent (Linet and Cartwright, 1996).  Recent studies have suggested a link between electromagnetic 
field (EMF) exposure (e.g., from power lines) and leukemia (Minder and Pfluger, 2001; Schuz et al., 
2001).  However, there is conflicting evidence regarding EMF exposure and leukemia and it is clear that 
most cases are not related to EMF (ACS, 2000a; Kleinerman et al., 2000). 
 
Other possible risk factors related to the development of AML include cigarette smoking and genetic 
disorders.  It is estimated that approximately one-fifth of cases of AML are caused by smoking 
(Scheinberg et al., 1997).  Also, a small number of AML cases can be attributed to rare inherited 
disorders.  These include Down’s syndrome in children, Fanconi’s anemia, Wiskott-Aldrich syndrome, 
Bloom’s syndrome, Li-Fraumeni syndrome, and ataxia telangiectasia (ACS, 2000a and 2000b).  Recently, 
scientists have suggested that a mutation in a gene responsible for the deactivation of certain toxic 
metabolites may have the ability to increase the risk of acute myeloid leukemia in adults.  However, 
further research is necessary in order to confirm the findings of this study (Smith et al., 2001).  
 
CLL is chiefly an adult disease; the average age at diagnosis is about 70 years (ACS 1999).  Twice as 
many men as women are affected by this type of leukemia (Deisseroth et al., 1997).  While genetics and 
diseases of the immune system have been suggested as playing a role in the development of CLL, high-
dose radiation and benzene exposure have not (ACS, 1999; Weinstein and Tarbell, 1997).  It is thought 
that individuals with a family history of CLL are two to four times as likely to develop the disease.  Some 
studies have identified an increased risk of developing CLL (as well as ALL, AML, and CML) among 
farmers due to long-term exposure to herbicides and/or pesticides (Linet and Cartwright, 1996).  In 
addition, many researchers believe that cigarette smoking plays a role in some chronic leukemias.  The 
role of EMF in the development of chronic leukemia remains controversial (ACS, 1999).  Although 
viruses have been implicated in the etiology of other leukemias, there is no evidence that viruses cause 
CLL (Deisseroth et al., 1997). 
 
Of all the leukemias, CML is among the least understood.  While this disease can occur at any age, CML 
is extremely rare in children (about 2% of leukemias in children) and the average age of diagnosis is 40 to 
50 years (ACS 1999).  Incidence rates are higher in males than in females, but unlike the other leukemia 
types, rates are higher in blacks than in whites in the United States (Linet and Cartwright, 1996).  High-
dose radiation exposure may increase the risk of developing CML (ACS, 1999).  Finally, CML has been 
associated with chromosome abnormalities such as the Philadelphia chromosome (Weinstein and Tarbell, 
1997). 
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Liver Cancer 
 
An estimated 17,550 people in the UNITED STATES (12,130 men and 5,420 women) will be diagnosed 
with liver cancer in 2005, accounting for approximately 1% of all new cancers (ACS, 2005).  
Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver, accounting for about 
75% of all cases.  Rarer forms of malignant liver cancer include cholangiocarcinomas, angiosarcomas, 
and hepatoblastomas in children.  Although HCC is approximately ten times more common in developing 
countries in East and Southeast Asia and Africa, incidence is rapidly increasing in the United States 
(ACS, 2001).  Rates of HCC in the UNITED STATES have increased by 70% over the past two decades 
(Yu et al., 2000).  Similar trends have been observed in Canada and Western Europe.  The primary reason 
for the higher rates observed in recent years is the increase in hepatitis C virus infection, an important 
factor related to liver cancer (El-Serag, 2001; El-Serag and Mason, 2000).  Men are at least two to three 
times more likely to develop liver cancer than women (Yu et al., 2000).  Incidence rates are also higher 
among African Americans than whites.  Although the risk of developing HCC increases with increasing 
age, the disease can occur in persons of any age (London and McGlynn, 1996). 
 
Several important risk factors for liver cancer have been identified.  Chronic infection with hepatitis B 
virus (HBV) and hepatitis C virus (HCV) are the most significant risk factors for developing liver cancer 
(ACS, 2001).  It is estimated that 80% of HCC cases worldwide can be attributed to HBV infection (Yu et 
al., 2000).  However, HBV accounts for only about a quarter of the cases in the UNITED STATES and 
infection with HCV plays a much larger role in the incidence of this cancer.  HBV and HCV can be 
spread through intravenous drug use (e.g., the sharing of contaminated needles), unprotected sexual 
intercourse, and transfusion of and contact with unscreened blood and blood products.  In addition, 
mothers who are infected with these viruses can pass them on to their children at birth or in early infancy 
(ACS, 2001). 
 
Cirrhosis is also a major risk factor for the development of liver cancer.  Cirrhosis is a progressive disease 
that causes inflammation and scar tissue to form on the liver, which can often lead to cancer.  Researchers 
estimate that 60% to 80% of HCC cases are associated with cirrhosis.  However, it is unclear if cirrhosis 
itself causes liver cancer or if the underlying causes of cirrhosis contribute to the development of this 
disease (Garr et al., 1997).  Most liver cirrhosis in the UNITED STATES occurs as a result of chronic 
alcohol abuse, but HBV and HCV are also major causes of cirrhosis (ACS, 2001).  In addition, certain 
inherited metabolic diseases, such as hemochromatosis, which causes excess iron accumulation in the 
body, can lead to cirrhosis (ACS, 2001).  Some studies have shown that people with hemochromatosis are 
at an increased risk of developing liver cancer (Fracanzani et al., 2001). 
 
Epidemiological and environmental evidence indicates that exposure to certain chemicals and toxins can 
also contribute significantly to the development of liver cancer.  For example, chronic consumption of 
alcoholic beverages has been associated with liver cancer (Wogan, 2000).  As noted above, it is unclear if 
alcohol itself causes HCC or if underlying cirrhosis is the cause (London and McGlynn, 1996).  However, 
it is clear that alcohol abuse can accelerate liver disease and may act as a co-carcinogen in the 
development of liver cancer (Ince and Wands, 1999).  Long-term exposure to aflatoxin can also cause 
liver cancer.  Aflatoxins are carcinogenic agents produced by a fungus found in tropical and subtropical 
regions.  Individuals may be exposed to aflatoxins if they consume contaminated peanuts and other foods 
that have been stored under hot, humid conditions (Wogan, 2000).  Vinyl chloride, a known human 
carcinogen used in the manufacturing of some plastics, and thorium dioxide, used in the past for certain x-
ray tests, are risk factors for a rare type of liver cancer called angiosarcoma (ACS, 2001; London and 
McGlynn, 1996).  These chemicals may also increase the risk of HCC, but to a lesser degree.  The impact 
of both thorium dioxide and vinyl chloride on the incidence of liver cancer was much greater in the past, 
since thorium dioxide has not been used for decades and exposure of workers to vinyl chloride is now 
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strictly regulated in the UNITED STATES (ACS, 2001).  Drinking water contaminated with arsenic may 
increase the risk of liver cancer in some parts of the world (ACS, 2001; ATSDR, 2001). 
 
The use of oral contraceptives by women may also be a risk factor in the development of liver cancer.  
However, most of the studies linking oral contraceptives and HCC involved types of oral contraceptives 
that are no longer used.  There is some indication that the increased risk may be confined to oral 
contraceptives containing mestranol.  It is not known if the newer oral contraceptives, which contain 
different types and doses of estrogen and different combinations of estrogen with other hormones, 
significantly increase the risk of HCC (ACS, 2001; London and McGlynn, 1996).  Long-term anabolic 
steroid use may slightly increase the risk of HCC; however, a definitive relationship has not been 
established (ACS, 2001; London and McGlynn, 1996).  Although many researchers believe that cigarette 
smoking plays a role in the development of liver cancer, the evidence for this is still inconclusive (Mizoue 
et al., 2000; London and McGlynn, 1996). 
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Lung Cancer 
 
Lung cancer generally arises in the epithelial tissue of the lung.  Several different histologic or cell types 
of lung cancer have been observed.  The various types of lung cancer occur in different regions of the 
lung and each type is associated with slightly different risk factors (Blot and Fraumeni 1996).  The most 
common type of lung cancer in the United States today is adenocarcinoma which accounts for about 40% 
of all lung cancers (ACS, 2000).  The greatest established risk factor for all types of lung cancer is 
cigarette smoking, followed by occupational and environmental exposures. 
 
The incidence of lung cancer increases sharply with age peaking at about age 60 or 70.  Lung cancer is 
very rare in people under the age of 40.  The incidence is greater among men than women (probably 
because men are more likely to be smokers than women) and among blacks than whites (Blot and 
Fraumeni, 1996).  The American Cancer Society estimates that lung cancer will be diagnosed in 172,570 
people in the UNITED STATES in 2005, accounting for about 13% of all cancers (ACS, 2005).  Lung 
cancer is the leading cause of cancer death among both men and women; more people die of lung cancer 
than of colon, breast, and prostate cancers combined (ACS, 2000).  In Massachusetts, incidence rates in 
1997 were 76.7 per 100,000 and 49.2 per 100,000 for males and females, respectively (MCR, 2000).  
Nationwide, the incidence rate declined significantly in men during the 1990s, most likely as a result of 
decreased smoking rates over the past 30 years.  Rates for women have continued to increase, but at a 
much slower pace and have begun to level off.  This is because decreasing smoking patterns among 
women have lagged behind those of men (ACS, 2005).  Trends in lung cancer incidence suggest that the 
disease has become increasingly associated with populations of lower socioeconomic status, since these 
individuals have higher rates of smoking than individuals of other groups (Blot and Fraumeni 1996). 
 
More than 80% of all lung cancers are caused directly by smoking cigarettes and many of the rest are due 
to exposure to second hand smoke, or environmental tobacco smoke.  The longer a person has been 
smoking and the higher the number of cigarettes smoked per day, the greater the risk of lung cancer.  
Smoking cessation decreases the elevated risk by about 50%, however, former smokers still carry a 
greater risk than those who have never smoked (ACS, 2000). 
 
Workplace exposures have also been identified as playing important roles in the development of lung 
cancer.  Occupational exposure to asbestos is an established risk factor for this disease; asbestos workers 
are about seven times more likely to die from lung cancer than the general population (ACS, 2000).  
Underground miners exposed to radon and uranium are at an increased risk for developing lung cancer 
(ACS, 2000; Samet and Eradze, 2000).  Chemical workers, talc miners and millers, paper and pulp 
workers, carpenters, metal workers, butchers and meat packers, vineyard workers, carpenters and painters, 
and shipyard and railroad manufacture workers are some of the occupations associated with an increased 
risk of lung cancer (Blot and Fraumeni, 1996; Pohlablen et al., 2000).  In addition to asbestos and radon, 
chemical compounds such as arsenic, chloromethyl ethers, chromium, vinyl chloride, nickel chromates, 
coal products, mustard gas, ionizing radiation, and fuels such as gasoline are also occupational risk factors 
for lung cancer (ACS, 2000; Blot and Fraumeni, 1996).  Industrial sand workers exposed to crystalline 
silica are also at an increased risk for lung cancer (Rice et al., 2001; Steenland and Sanderson, 2001).  
Occupational exposure to the compounds noted above in conjunction with cigarette smoking dramatically 
increases the risk of developing lung cancer (Blot and Fraumeni, 1996). 
 
As noted above, exposure to radon (a naturally occurring radioactive gas produced by the breakdown of 
radium and uranium) has been associated with increased risk of developing lung cancer among miners.  
Recently, a number of studies have demonstrated that exposure to elevated levels of residential radon may 
also increase lung cancer risk (Lubin and Boice, 1997; Kreienbrock et al., 2001; Tomasek et al., 2001).  
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Epidemiological evidence suggests that radon may be the second leading cause of lung cancer after 
smoking (Samet and Eradze, 2000).  However, actual lung cancer risk is determined by cumulative 
lifetime exposure to indoor radon.  Therefore, normal patterns of residential mobility suggest that most 
people living in high-radon homes experience lifetime exposures equivalent to residing in homes with 
lower radon levels (Warner et al., 1996). 
 
Tuberculosis and some types of pneumonia may increase the risk of lung cancer due to scarred lung tissue 
(ACS, 2000).  In addition, people who have had lung cancer have a higher risk of developing another 
tumor.  A family history of lung cancer may also slightly increase the risk, however, it is unclear whether 
this is due to inherited factors or environmental tobacco smoke (ACS, 2000). 
 
Air pollution may increase the risk of developing lung cancer, however, this risk is much lower than that 
due to cigarette smoking (ACS, 2000). 
 
Diet has also been implicated in the etiology of lung cancer, however, the exact relationship is unclear.  
Diets high in fruits and vegetables decrease lung cancer risk, but the reasons for this are unknown 
(Brownson et al., 1998).  A recent study showed a positive association between total fat, monounsaturated 
fat, and saturated fat and lung cancer among males, however, this effect was not observed among women 
(Bandera et al., 1997). 
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Non-Hodgkin’s Lymphoma 
 
Lymphomas are cancers involving the cells of the lymphatic system.  The majority of lymphomas involve 
the lymph nodes and spleen but the disease may also affect other areas within the body.  Non-Hodgkin’s 
lymphoma (NHL) is a classification of all lymphomas except Hodgkin’s disease.  Thus NHL is a mixed 
group of diseases that is characterized by the malignant increase in specific cells of the immune system (B 
or T lymphocytes).  B-cell lymphomas are more common than T-cell lymphomas, accounting for about 
85% of all cases of NHL (ACS, 2003).  The various types of NHL are thought to represent different 
diseases with different causes (Scherr and Mueller, 1996).  NHL can occur at all ages, however, the 
average age at diagnosis is in the early 60s and the incidence of this disease generally increases with age.  
This disease is more common in men than in women and affects whites more often than African 
Americans or Asian Americans (ACS, 2003).  The American Cancer Society estimates that approximately 
56,390 Americans will be diagnosed with NHL in 2005, making it the fifth most common cancer in the 
United States among women and the sixth most common cancer among men, excluding non-melanoma 
skin cancers (ACS, 2005). 
 
Overall, between 1973 and 1997, the incidence of NHL in the UNITED STATES grew 81% (Garber, 
2001), although during the 1990s, the rate of increase appears to have stabilized (ACS, 2005).  In 
Massachusetts, the incidence of NHL increased 50% during 1982-1997 from 10.5 cases per 100,000 to 
15.7 cases per 100,000 (MCR, 1997 and 2000).  The increase in NHL incidence has been attributed to 
better diagnosis, greater exposure to causative agents, and, to a lesser extent, the increasing incidence of 
AIDS-related lymphomas (Devesa and Fears, 1992; Scherr and Mueller, 1996).  Although the primary 
factors related to the development of NHL include conditions that suppress the immune system, viral 
infections, and certain occupational exposures, these factors are thought to account for only a portion of 
the increase observed in this cancer type (Scherr and Mueller, 1996).  The observation that the rate of 
increase is declining for NHL may be attributed in part to increased use of antiretroviral therapy to slow 
HIV progression (Wingo et al., 1998). 
 
NHL is more common among people who have abnormal or compromised immune systems, such as those 
with inherited diseases that suppress the immune system, individuals with autoimmune disorders, and people 
taking immunosuppressant drugs following organ transplants.  Genetic predisposition (e.g., inherited immune 
deficiencies) only accounts for a small proportion of NHL cases (Scherr and Mueller, 1996).  AIDS patients 
have a 100- to 300-fold higher risk for NHL than the general population (again, these cases account for only a 
minor part of overall NHL incidence) (Garber, 2001).  NHL has also been reported to occur more frequently 
among individuals with conditions that require medical treatment resulting in suppression of the immune 
system, such as cancer chemotherapy.  However, current evidence suggests that the development of NHL is 
related to suppression of the individual’s immune system as a result of treatment, rather than the treatment 
itself (Scherr and Mueller, 1996). 
 
Several viruses have been shown to play a role in the development of NHL.  Among organ transplant 
recipients, suppression of the immune system required for acceptance of the transplant leads to a loss of 
control or the reactivation of viruses that have been dormant in the body (e.g., Epstein-Barr Virus [EBV] and 
herpesvirus infections).  In addition, because cancer-causing viruses are known to cause lymphomas in 
various animals, it has been proposed that these types of viruses may also be associated with the development 
of NHL among humans without compromised immune systems.  Infection with the human T-cell 
leukemia/lymphoma virus (HTLV-I) is known to cause T-cell lymphoma among adults.  However, this is a 
relatively rare infection and most likely contributes only a small amount to the total incidence of NHL 
(Scherr and Mueller, 1996).  EBV infection is common among the general population and has been shown to 
play a role in the development of most cases of transplant and AIDS related NHL.  The combination of 
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immune system deficiencies and EBV infection may cause some people to develop NHL (ACS, 2003).  
Although viruses are causal factors for some subtypes of NHL, to date, studies have shown that the role of 
EBV in the development of NHL in the general population may not be large (Scherr and Mueller, 1996).  
Moreover, the high prevalence of EBV in the general population suggests that EBV may be only one of 
several factors in the development of this cancer. 
 
Recent studies have found that a type of bacteria, Helicobacter pylori, a common cause of stomach ulcers, 
can also cause some lymphomas of the stomach (ACS, 2003).  An important implication of this finding is that 
treatment with antibiotics could prevent some NHL of the stomach. 
 
Some occupations have been associated with an increased risk of developing NHL, such as occupations 
related to chemicals or agriculture.  Farmers, herbicide and pesticide applicators, and grain workers appear to 
have the most increased risk (Zahm, 1990 and 1993; Tatham et al., 1997).  Studies conducted among 
agricultural workers have demonstrated increases in NHL among those using herbicides for more than 20 
days per year and individuals who mix or apply herbicides.  A greater incidence of NHL appears to be related 
specifically to exposure to the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) and organophosphate 
insecticides (Wigle et al., 1990; Zahm et al., 1990; Zahm et al., 1993).  Further studies of exposure to these 
chemicals and NHL incidence have shown that the increased risk is attributed to a specific impurity, 2,3,7,8-
tetrachlorodibenzo-p-dioxin or 2,3,7,8-TCDD, present in these herbicides.  However, reports of accidental 
industrial exposures to TCDD alone have not demonstrated an increased risk of NHL (Scherr and Mueller, 
1996).  An elevated risk for NHL development has also been noted among fence workers, orchard workers, 
and meat workers.  High-dose exposure to benzene has been associated with NHL (ACS, 2003), however, a 
recent international cohort study indicated that petroleum workers exposed to benzene were not at an 
increased risk of NHL (Wong and Raabe, 2000). 
 
In addition, epidemiological studies of long-term users of permanent hair coloring products have 
suggested an increased incidence of NHL (Zahm et al., 1992; Scherr and Mueller, 1996).  However, a 
recent population based study found no association between the use of hair color products and an 
increased risk of developing NHL.  The researchers further stated that results from this study and previous 
studies, including experimental animal studies, provide little convincing evidence linking NHL with 
normal use of hair dye (Holly et al., 1998). 
 
Although radiation (e.g., nuclear explosions or radioactive fallout from reactor accidents) has been implicated 
in the development of some cancers, including NHL (ACS, 2003), there is little evidence for an increased risk 
of lymphoma due to radiation (Scherr and Mueller, 1996). 
 
Recent studies have suggested that contamination of drinking water with nitrate may be associated with an 
increased risk of NHL (Ward et al., 1996).  Nitrate forms N-nitroso compounds which are known carcinogens 
and can be found in smoked or salt-dried fish, bacon, sausages, other cured meats, beer, pickled vegetables, 
and mushrooms. 
 
Smoking has also been suggested to increase the risk of NHL.  A study that evaluated the history of tobacco 
use and deaths from NHL determined that people who had ever smoked had a two-fold increase of dying 
from NHL as compared to those who never smoked.  Further, a four-fold increase was found among the 
heaviest smokers (Linet et al., 1992).  In addition, a more recent study that primarily examined occupation 
and NHL risk found a significant association with high levels of cigarette smoking and all NHL types 
(Tatham et al., 1997).  However, a recent review of 5 cohort studies and 14 case-control studies concludes 
that results of epidemiological studies have been inconsistent and that smoking has not been determined to be 
a definitive risk factor in the development of NHL (Peach and Barnett, 2000). 
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A recent Danish study has linked the use of tricyclic and tetracyclic antidepressants to NHL, however, more 
research is needed on this possible association (Dalton et al., 2000). 
 
Although NHL is associated with a number of risk factors, the causes of this disease remain unknown.  Most 
patients with NHL do not have any known risk factors (ACS, 2003). 
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ATSDR Glossary of Terms 
 
The Agency for Toxic Substances and Disease Registry (ATSDR) is a federal public health 
agency with headquarters in Atlanta, Georgia, and 10 regional offices in the United States. 
ATSDR's mission is to serve the public by using the best science, taking responsive public health 
actions, and providing trusted health information to prevent harmful exposures and diseases 
related to toxic substances. ATSDR is not a regulatory agency, unlike the UNITED STATES 
Environmental Protection Agency (EPA), which is the federal agency that develops and enforces 
environmental laws to protect the environment and human health. This glossary defines words 
used by ATSDR in communications with the public. It is not a complete dictionary of 
environmental health terms. If you have questions or comments, call ATSDR's toll-free 
telephone number, 1-888-42-ATSDR (1-888-422-8737). 
 
 
 
General Terms 
 
Absorption  
The process of taking in. For a person or an animal, absorption is the process of a substance 
getting into the body through the eyes, skin, stomach, intestines, or lungs.  
 
Acute  
Occurring over a short time [compare with chronic].  
 
Acute exposure  
Contact with a substance that occurs once or for only a short time (up to 14 days) [compare with 
intermediate duration exposure and chronic exposure].  
 
Additive effect  
A biologic response to exposure to multiple substances that equals the sum of responses of all the 
individual substances added together [compare with antagonistic effect and synergistic effect].  
 
Adverse health effect  
A change in body function or cell structure that might lead to disease or health problems  
 
Aerobic  
Requiring oxygen [compare with anaerobic].  
 
Ambient  
Surrounding (for example, ambient air).  
 
Anaerobic  
Requiring the absence of oxygen [compare with aerobic].  
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Analyte  
A substance measured in the laboratory. A chemical for which a sample (such as water, air, or 
blood) is tested in a laboratory. For example, if the analyte is mercury, the laboratory test will 
determine the amount of mercury in the sample.  
 
Analytic epidemiologic study  
A study that evaluates the association between exposure to hazardous substances and disease by 
testing scientific hypotheses.  
 
Antagonistic effect  
A biologic response to exposure to multiple substances that is less than would be expected if the 
known effects of the individual substances were added together [compare with additive effect 
and synergistic effect].  
 
Background level  
An average or expected amount of a substance or radioactive material in a specific environment, 
or typical amounts of substances that occur naturally in an environment.  
 
Biodegradation  
Decomposition or breakdown of a substance through the action of microorganisms (such as 
bacteria or fungi) or other natural physical processes (such as sunlight).  
 
Biologic indicators of exposure study  
A study that uses (a) biomedical testing or (b) the measurement of a substance [an analyte], its 
metabolite, or another marker of exposure in human body fluids or tissues to confirm human 
exposure to a hazardous substance [also see exposure investigation].  
 
Biologic monitoring  
Measuring hazardous substances in biologic materials (such as blood, hair, urine, or breath) to 
determine whether exposure has occurred. A blood test for lead is an example of biologic 
monitoring.  
 
Biologic uptake  
The transfer of substances from the environment to plants, animals, and humans.  
 
Biomedical testing  
Testing of persons to find out whether a change in a body function might have occurred because 
of exposure to a hazardous substance.  
 
Biota  
Plants and animals in an environment. Some of these plants and animals might be sources of 
food, clothing, or medicines for people.  
 
Body burden  
The total amount of a substance in the body. Some substances build up in the body because they 
are stored in fat or bone or because they leave the body very slowly.  
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CAP [see Community Assistance Panel.]  
 
Cancer  
Any one of a group of diseases that occur when cells in the body become abnormal and grow or 
multiply out of control.  
 
Cancer risk  
A theoretical risk for getting cancer if exposed to a substance every day for 70 years (a lifetime 
exposure). The true risk might be lower.  
 
Carcinogen  
A substance that causes cancer.  
 
Case study  
A medical or epidemiologic evaluation of one person or a small group of people to gather 
information about specific health conditions and past exposures.  
 
Case-control study  
A study that compares exposures of people who have a disease or condition (cases) with people 
who do not have the disease or condition (controls). Exposures that are more common among the 
cases may be considered as possible risk factors for the disease.  
 
CAS registry number  
A unique number assigned to a substance or mixture by the American Chemical Society 
Abstracts Service. 
 
Central nervous system  
The part of the nervous system that consists of the brain and the spinal cord.  
 
CERCLA [see Comprehensive Environmental Response, Compensation, and Liability Act of 
1980]  
 
Chronic  
Occurring over a long time [compare with acute].  
 
Chronic exposure  
Contact with a substance that occurs over a long time (more than 1 year) [compare with acute 
exposure and intermediate duration exposure]  
 
Cluster investigation 
A review of an unusual number, real or perceived, of health events (for example, reports of 
cancer) grouped together in time and location. Cluster investigations are designed to confirm 
case reports; determine whether they represent an unusual disease occurrence; and, if possible, 
explore possible causes and contributing environmental factors.  
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Community Assistance Panel (CAP)  
A group of people from a community and from health and environmental agencies who work 
with ATSDR to resolve issues and problems related to hazardous substances in the community. 
CAP members work with ATSDR to gather and review community health concerns, provide 
information on how people might have been or might now be exposed to hazardous substances, 
and inform ATSDR on ways to involve the community in its activities.  
 
Comparison value (CV)  
Calculated concentration of a substance in air, water, food, or soil that is unlikely to cause 
harmful (adverse) health effects in exposed people. The CV is used as a screening level during 
the public health assessment process. Substances found in amounts greater than their CVs might 
be selected for further evaluation in the public health assessment process.  
 
Completed exposure pathway [see exposure pathway].  
 
Comprehensive Environmental Response, Compensation, and Liability Act of 1980 
(CERCLA)  
CERCLA, also known as Superfund, is the federal law that concerns the removal or cleanup of 
hazardous substances in the environment and at hazardous waste sites. ATSDR, which was 
created by CERCLA, is responsible for assessing health issues and supporting public health 
activities related to hazardous waste sites or other environmental releases of hazardous 
substances. This law was later amended by the Superfund Amendments and Reauthorization Act 
(SARA). 
 
Concentration  
The amount of a substance present in a certain amount of soil, water, air, food, blood, hair, urine, 
breath, or any other media.  
 
Contaminant  
A substance that is either present in an environment where it does not belong or is present at 
levels that might cause harmful (adverse) health effects.  
 
Delayed health effect  
A disease or an injury that happens as a result of exposures that might have occurred in the past.  
 
Dermal  
Referring to the skin. For example, dermal absorption means passing through the skin.  
 
Dermal contact  
Contact with (touching) the skin [see route of exposure].  
 
Descriptive epidemiology  
The study of the amount and distribution of a disease in a specified population by person, place, 
and time.  
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Detection limit  
The lowest concentration of a chemical that can reliably be distinguished from a zero 
concentration.  
 
Disease prevention  
Measures used to prevent a disease or reduce its severity.  
 
Disease registry  
A system of ongoing registration of all cases of a particular disease or health condition in a 
defined population.  
 
DOD  
United States Department of Defense.  
 
DOE  
United States Department of Energy.  
 
Dose (for chemicals that are not radioactive)  
The amount of a substance to which a person is exposed over some time period. Dose is a 
measurement of exposure. Dose is often expressed as milligram (amount) per kilogram (a 
measure of body weight) per day (a measure of time) when people eat or drink contaminated 
water, food, or soil. In general, the greater the dose, the greater the likelihood of an effect. An 
"exposure dose" is how much of a substance is encountered in the environment. An "absorbed 
dose" is the amount of a substance that actually got into the body through the eyes, skin, 
stomach, intestines, or lungs.  
 
Dose (for radioactive chemicals)  
The radiation dose is the amount of energy from radiation that is actually absorbed by the body. 
This is not the same as measurements of the amount of radiation in the environment.  
 
Dose-response relationship  
The relationship between the amount of exposure [dose] to a substance and the resulting changes 
in body function or health (response).  
 
Environmental media  
Soil, water, air, biota (plants and animals), or any other parts of the environment that can contain 
contaminants.  
 
Environmental media and transport mechanism  
Environmental media include water, air, soil, and biota (plants and animals). Transport 
mechanisms move contaminants from the source to points where human exposure can occur. The 
environmental media and transport mechanism is the second part of an exposure pathway.  
 
EPA  
United States Environmental Protection Agency.  
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Epidemiologic surveillance [see Public health surveillance]. 
 
Epidemiology  
The study of the distribution and determinants of disease or health status in a population; the 
study of the occurrence and causes of health effects in humans.  
 
Exposure  
Contact with a substance by swallowing, breathing, or touching the skin or eyes. Exposure may 
be short-term [acute exposure], of intermediate duration, or long-term [chronic exposure].  
 
Exposure assessment  
The process of finding out how people come into contact with a hazardous substance, how often 
and for how long they are in contact with the substance, and how much of the substance they are 
in contact with.  
 
Exposure-dose reconstruction  
A method of estimating the amount of people's past exposure to hazardous substances. Computer 
and approximation methods are used when past information is limited, not available, or missing.  
 
Exposure investigation  
The collection and analysis of site-specific information and biologic tests (when appropriate) to 
determine whether people have been exposed to hazardous substances.  
 
Exposure pathway  
The route a substance takes from its source (where it began) to its end point (where it ends), and 
how people can come into contact with (or get exposed to) it. An exposure pathway has five 
parts: a source of contamination (such as an abandoned business); an environmental media and 
transport mechanism (such as movement through groundwater); a point of exposure (such as a 
private well); a route of exposure (eating, drinking, breathing, or touching), and a receptor 
population (people potentially or actually exposed). When all five parts are present, the exposure 
pathway is termed a completed exposure pathway.  
 
Exposure registry  
A system of ongoing followup of people who have had documented environmental exposures.  
 
Feasibility study  
A study by EPA to determine the best way to clean up environmental contamination. A number 
of factors are considered, including health risk, costs, and what methods will work well.  
 
Geographic information system (GIS)  
A mapping system that uses computers to collect, store, manipulate, analyze, and display data. 
For example, GIS can show the concentration of a contaminant within a community in relation to 
points of reference such as streets and homes.  
 
Grand rounds  
Training sessions for physicians and other health care providers about health topics.  
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Groundwater  
Water beneath the earth's surface in the spaces between soil particles and between rock surfaces 
[compare with surface water].  
 
Half-life (t½)  
The time it takes for half the original amount of a substance to disappear. In the environment, the 
half-life is the time it takes for half the original amount of a substance to disappear when it is 
changed to another chemical by bacteria, fungi, sunlight, or other chemical processes. In the 
human body, the half-life is the time it takes for half the original amount of the substance to 
disappear, either by being changed to another substance or by leaving the body. In the case of 
radioactive material, the half life is the amount of time necessary for one half the initial number 
of radioactive atoms to change or transform into another atom (that is normally not radioactive). 
After two half lives, 25% of the original number of radioactive atoms remain.  
 
Hazard  
A source of potential harm from past, current, or future exposures.  
 
Hazardous Substance Release and Health Effects Database (HazDat)  
The scientific and administrative database system developed by ATSDR to manage data 
collection, retrieval, and analysis of site-specific information on hazardous substances, 
community health concerns, and public health activities.  
 
Hazardous waste  
Potentially harmful substances that have been released or discarded into the environment.  
 
Health consultation  
A review of available information or collection of new data to respond to a specific health 
question or request for information about a potential environmental hazard. Health consultations 
are focused on a specific exposure issue. Health consultations are therefore more limited than a 
public health assessment, which reviews the exposure potential of each pathway and chemical 
[compare with public health assessment].  
 
Health education  
Programs designed with a community to help it know about health risks and how to reduce these 
risks.  
 
Health investigation  
The collection and evaluation of information about the health of community residents. This 
information is used to describe or count the occurrence of a disease, symptom, or clinical 
measure and to evaluate the possible association between the occurrence and exposure to 
hazardous substances.  
 
Health promotion  
The process of enabling people to increase control over, and to improve, their health.  
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Health statistics review  
The analysis of existing health information (i.e., from death certificates, birth defects registries, 
and cancer registries) to determine if there is excess disease in a specific population, geographic 
area, and time period. A health statistics review is a descriptive epidemiologic study.  
 
Indeterminate public health hazard  
The category used in ATSDR's public health assessment documents when a professional 
judgment about the level of health hazard cannot be made because information critical to such a 
decision is lacking.  
 
Incidence  
The number of new cases of disease in a defined population over a specific time period [contrast 
with prevalence].  
 
Ingestion  
The act of swallowing something through eating, drinking, or mouthing objects. A hazardous 
substance can enter the body this way [see route of exposure].  
 
Inhalation  
The act of breathing. A hazardous substance can enter the body this way [see route of exposure].  
 
Intermediate duration exposure  
Contact with a substance that occurs for more than 14 days and less than a year [compare with 
acute exposure and chronic exposure].  
 
In vitro  
In an artificial environment outside a living organism or body. For example, some toxicity 
testing is done on cell cultures or slices of tissue grown in the laboratory, rather than on a living 
animal [compare with in vivo].  
 
In vivo  
Within a living organism or body. For example, some toxicity testing is done on whole animals, 
such as rats or mice [compare with in vitro].  
 
Lowest-observed-adverse-effect level (LOAEL)  
The lowest tested dose of a substance that has been reported to cause harmful (adverse) health 
effects in people or animals.  
 
Medical monitoring  
A set of medical tests and physical exams specifically designed to evaluate whether an 
individual's exposure could negatively affect that person's health.  
 
Metabolism  
The conversion or breakdown of a substance from one form to another by a living organism.  
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Metabolite  
Any product of metabolism.  
 
mg/kg  
Milligram per kilogram.  
 
mg/cm2  
Milligram per square centimeter (of a surface).  
 
mg/m3  
Milligram per cubic meter; a measure of the concentration of a chemical in a known volume (a 
cubic meter) of air, soil, or water.  
 
Migration  
Moving from one location to another.  
 
Minimal risk level (MRL)  
An ATSDR estimate of daily human exposure to a hazardous substance at or below which that 
substance is unlikely to pose a measurable risk of harmful (adverse), noncancerous effects. 
MRLs are calculated for a route of exposure (inhalation or oral) over a specified time period 
(acute, intermediate, or chronic). MRLs should not be used as predictors of harmful (adverse) 
health effects [see reference dose].  
 
Morbidity  
State of being ill or diseased. Morbidity is the occurrence of a disease or condition that alters 
health and quality of life.  
 
Mortality  
Death. Usually the cause (a specific disease, a condition, or an injury) is stated.  
 
Mutagen  
A substance that causes mutations (genetic damage).  
 
Mutation  
A change (damage) to the DNA, genes, or chromosomes of living organisms.  
 
National Priorities List for Uncontrolled Hazardous Waste Sites (National Priorities List or 
NPL)  
EPA's list of the most serious uncontrolled or abandoned hazardous waste sites in the United 
States. The NPL is updated on a regular basis. 
 
National Toxicology Program (NTP) 
Part of the Department of Health and Human Services. NTP develops and carries out tests to 
predict whether a chemical will cause harm to humans.  
 
 
  146
No apparent public health hazard  
A category used in ATSDR's public health assessments for sites where human exposure to 
contaminated media might be occurring, might have occurred in the past, or might occur in the 
future, but where the exposure is not expected to cause any harmful health effects.  
 
No-observed-adverse-effect level (NOAEL)  
The highest tested dose of a substance that has been reported to have no harmful (adverse) health 
effects on people or animals.  
 
No public health hazard  
A category used in ATSDR's public health assessment documents for sites where people have 
never and will never come into contact with harmful amounts of site-related substances.  
 
NPL [see National Priorities List for Uncontrolled Hazardous Waste Sites] 
 
Physiologically based pharmacokinetic model (PBPK model)  
A computer model that describes what happens to a chemical in the body. This model describes 
how the chemical gets into the body, where it goes in the body, how it is changed by the body, 
and how it leaves the body.  
 
Pica  
A craving to eat nonfood items, such as dirt, paint chips, and clay. Some children exhibit pica-
related behavior.  
 
Plume  
A volume of a substance that moves from its source to places farther away from the source. 
Plumes can be described by the volume of air or water they occupy and the direction they move. 
For example, a plume can be a column of smoke from a chimney or a substance moving with 
groundwater.  
 
Point of exposure  
The place where someone can come into contact with a substance present in the environment 
[see exposure pathway].  
 
Population  
A group or number of people living within a specified area or sharing similar characteristics 
(such as occupation or age).  
 
Potentially responsible party (PRP)  
A company, government, or person legally responsible for cleaning up the pollution at a 
hazardous waste site under Superfund. There may be more than one PRP for a particular site.  
 
ppb  
Parts per billion.  
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ppm  
Parts per million.  
 
Prevalence  
The number of existing disease cases in a defined population during a specific time period 
[contrast with incidence].  
 
Prevalence survey  
The measure of the current level of disease(s) or symptoms and exposures through a 
questionnaire that collects self-reported information from a defined population.  
 
Prevention  
Actions that reduce exposure or other risks, keep people from getting sick, or keep disease from 
getting worse.  
 
Public availability session  
An informal, drop-by meeting at which community members can meet one-on-one with ATSDR 
staff members to discuss health and site-related concerns. 
 
Public comment period  
An opportunity for the public to comment on agency findings or proposed activities contained in 
draft reports or documents. The public comment period is a limited time period during which 
comments will be accepted.  
 
Public health action  
A list of steps to protect public health.  
 
Public health advisory  
A statement made by ATSDR to EPA or a state regulatory agency that a release of hazardous 
substances poses an immediate threat to human health. The advisory includes recommended 
measures to reduce exposure and reduce the threat to human health.  
 
Public health assessment (PHA)  
An ATSDR document that examines hazardous substances, health outcomes, and community 
concerns at a hazardous waste site to determine whether people could be harmed from coming 
into contact with those substances. The PHA also lists actions that need to be taken to protect 
public health [compare with health consultation].  
 
Public health hazard  
A category used in ATSDR's public health assessments for sites that pose a public health hazard 
because of long-term exposures (greater than 1 year) to sufficiently high levels of hazardous 
substances or radionuclides that could result in harmful health effects.  
 
Public health hazard categories  
Public health hazard categories are statements about whether people could be harmed by 
conditions present at the site in the past, present, or future. One or more hazard categories might 
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be appropriate for each site. The five public health hazard categories are no public health hazard, 
no apparent public health hazard, indeterminate public health hazard, public health hazard, and 
urgent public health hazard.  
 
Public health statement 
The first chapter of an ATSDR toxicological profile. The public health statement is a summary 
written in words that are easy to understand. The public health statement explains how people 
might be exposed to a specific substance and describes the known health effects of that 
substance.  
 
Public health surveillance 
The ongoing, systematic collection, analysis, and interpretation of health data. This activity also 
involves timely dissemination of the data and use for public health programs. 
 
Public meeting  
A public forum with community members for communication about a site.  
 
Radioisotope  
An unstable or radioactive isotope (form) of an element that can change into another element by 
giving off radiation.  
 
Radionuclide  
Any radioactive isotope (form) of any element.  
 
RCRA [see Resource Conservation and Recovery Act (1976, 1984)]  
 
Receptor population  
People who could come into contact with hazardous substances [see exposure pathway].  
 
Reference dose (RfD)  
An EPA estimate, with uncertainty or safety factors built in, of the daily lifetime dose of a 
substance that is unlikely to cause harm in humans.  
 
Registry  
A systematic collection of information on persons exposed to a specific substance or having 
specific diseases [see exposure registry and disease registry].  
 
Remedial investigation  
The CERCLA process of determining the type and extent of hazardous material contamination at 
a site.  
 
Resource Conservation and Recovery Act (1976, 1984) (RCRA) 
This Act regulates management and disposal of hazardous wastes currently generated, treated, 
stored, disposed of, or distributed.  
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RFA  
RCRA Facility Assessment. An assessment required by RCRA to identify potential and actual 
releases of hazardous chemicals.  
 
RfD [see reference dose] 
 
Risk  
The probability that something will cause injury or harm.  
 
Risk reduction  
Actions that can decrease the likelihood that individuals, groups, or communities will experience 
disease or other health conditions.  
 
Risk communication  
The exchange of information to increase understanding of health risks.  
 
Route of exposure  
The way people come into contact with a hazardous substance. Three routes of exposure are 
breathing [inhalation], eating or drinking [ingestion], or contact with the skin [dermal contact].  
 
Safety factor [see uncertainty factor]  
 
SARA [see Superfund Amendments and Reauthorization Act]  
 
Sample  
A portion or piece of a whole. A selected subset of a population or subset of whatever is being 
studied. For example, in a study of people the sample is a number of people chosen from a larger 
population [see population]. An environmental sample (for example, a small amount of soil or 
water) might be collected to measure contamination in the environment at a specific location.  
 
Sample size  
The number of units chosen from a population or an environment.  
 
Solvent  
A liquid capable of dissolving or dispersing another substance (for example, acetone or mineral 
spirits).  
 
Source of contamination  
The place where a hazardous substance comes from, such as a landfill, waste pond, incinerator, 
storage tank, or drum. A source of contamination is the first part of an exposure pathway.  
 
Special populations  
People who might be more sensitive or susceptible to exposure to hazardous substances because 
of factors such as age, occupation, sex, or behaviors (for example, cigarette smoking). Children, 
pregnant women, and older people are often considered special populations.  
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Stakeholder  
A person, group, or community who has an interest in activities at a hazardous waste site.  
 
Statistics  
A branch of mathematics that deals with collecting, reviewing, summarizing, and interpreting 
data or information. Statistics are used to determine whether differences between study groups 
are meaningful.  
 
Substance  
A chemical.  
 
Substance-specific applied research  
A program of research designed to fill important data needs for specific hazardous substances 
identified in ATSDR's toxicological profiles. Filling these data needs would allow more accurate 
assessment of human risks from specific substances contaminating the environment. This 
research might include human studies or laboratory experiments to determine health effects 
resulting from exposure to a given hazardous substance.  
 
Superfund [see Comprehensive Environmental Response, Compensation, and Liability Act of 
1980 (CERCLA) and Superfund Amendments and Reauthorization Act (SARA)  
 
Superfund Amendments and Reauthorization Act (SARA)  
In 1986, SARA amended the Comprehensive Environmental Response, Compensation, and 
Liability Act of 1980 (CERCLA) and expanded the health-related responsibilities of ATSDR. 
CERCLA and SARA direct ATSDR to look into the health effects from substance exposures at 
hazardous waste sites and to perform activities including health education, health studies, 
surveillance, health consultations, and toxicological profiles.  
 
Surface water  
Water on the surface of the earth, such as in lakes, rivers, streams, ponds, and springs [compare 
with groundwater].  
 
Surveillance [see public health surveillance]  
 
Survey  
A systematic collection of information or data. A survey can be conducted to collect information 
from a group of people or from the environment. Surveys of a group of people can be conducted 
by telephone, by mail, or in person. Some surveys are done by interviewing a group of people 
[see prevalence survey].  
 
Synergistic effect  
A biologic response to multiple substances where one substance worsens the effect of another 
substance. The combined effect of the substances acting together is greater than the sum of the 
effects of the substances acting by themselves [see additive effect and antagonistic effect].  
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Teratogen  
A substance that causes defects in development between conception and birth. A teratogen is a 
substance that causes a structural or functional birth defect.  
 
Toxic agent  
Chemical or physical (for example, radiation, heat, cold, microwaves) agents that, under certain 
circumstances of exposure, can cause harmful effects to living organisms.  
 
Toxicological profile  
An ATSDR document that examines, summarizes, and interprets information about a hazardous 
substance to determine harmful levels of exposure and associated health effects. A toxicological 
profile also identifies significant gaps in knowledge on the substance and describes areas where 
further research is needed.  
 
Toxicology  
The study of the harmful effects of substances on humans or animals.  
 
Tumor  
An abnormal mass of tissue that results from excessive cell division that is uncontrolled and 
progressive. Tumors perform no useful body function. Tumors can be either benign (not cancer) 
or malignant (cancer).  
 
Uncertainty factor  
Mathematical adjustments for reasons of safety when knowledge is incomplete. For example, 
factors used in the calculation of doses that are not harmful (adverse) to people. These factors are 
applied to the lowest-observed-adverse-effect-level (LOAEL) or the no-observed-adverse-effect-
level (NOAEL) to derive a minimal risk level (MRL). Uncertainty factors are used to account for 
variations in people's sensitivity, for differences between animals and humans, and for 
differences between a LOAEL and a NOAEL. Scientists use uncertainty factors when they have 
some, but not all, the information from animal or human studies to decide whether an exposure 
will cause harm to people [also sometimes called a safety factor].  
 
Urgent public health hazard  
A category used in ATSDR's public health assessments for sites where short-term exposures 
(less than 1 year) to hazardous substances or conditions could result in harmful health effects that 
require rapid intervention.  
 
Volatile organic compounds (VOCs)  
Organic compounds that evaporate readily into the air. VOCs include substances such as 
benzene, toluene, methylene chloride, and methyl chloroform.  
 
Other glossaries and dictionaries: 
Environmental Protection Agency (http://www.epa.gov/OCEPAterms/) 
 
National Center for Environmental Health (CDC) 
(http://www.cdc.gov/nceh/dls/report/glossary.htm) 
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National Library of Medicine (NIH) 
(http://www.nlm.nih.gov/medlineplus/mplusdictionary.html) 
 
For more information on the work of ATSDR, please contact: 
 
Office of Policy and External Affairs 
Agency for Toxic Substances and Disease Registry 
1600 Clifton Road, N.E. (MS E-60) 
Atlanta, GA 30333 
Telephone: (404) 498-0080  
 
 
 
 
